
<html lang="en"     class="pb-page"  data-request-id="fb371b26-6cf3-42e9-b4c8-bc91ced10a57"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2018.61.issue-5;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.8b00028;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Radiosynthesis and in Vivo Evaluation of [11C]MPC-6827, the First Brain Penetrant Microtubule PET Ligand" /></meta><meta name="dc.Creator" content="J. S. Dileep  Kumar" /></meta><meta name="dc.Creator" content="Kiran Kumar  Solingapuram Sai" /></meta><meta name="dc.Creator" content="Jaya  Prabhakaran" /></meta><meta name="dc.Creator" content="Hakeem R.  Oufkir" /></meta><meta name="dc.Creator" content="Gayathri  Ramanathan" /></meta><meta name="dc.Creator" content="Christopher T.  Whitlow" /></meta><meta name="dc.Creator" content="Hima  Dileep" /></meta><meta name="dc.Creator" content="Akiva  Mintz" /></meta><meta name="dc.Creator" content="J. John  Mann" /></meta><meta name="dc.Description" content="Abnormalities of microtubules (MTs) are implicated in the pathogenesis of many CNS diseases. Despite the potential of an MT imaging agents, no PET ligand is currently available for in vivo imaging ..." /></meta><meta name="Description" content="Abnormalities of microtubules (MTs) are implicated in the pathogenesis of many CNS diseases. Despite the potential of an MT imaging agents, no PET ligand is currently available for in vivo imaging ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 19, 2018" /></meta><meta name="dc.Type" content="rapid-communication" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00028" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright Â© 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00028" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00028" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00028" /></link>
        
    
    

<title>Radiosynthesis and in Vivo Evaluation of [11C]MPC-6827, the First Brain Penetrant Microtubule PET Ligand | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00028" /></meta><meta property="og:title" content="Radiosynthesis and in Vivo Evaluation of [11C]MPC-6827, the First Brain Penetrant Microtubule PET Ligand" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.8b00028/20180302/images/large/jm-2018-00028q_0004.jpeg" /></meta><meta property="og:description" content="Abnormalities of microtubules (MTs) are implicated in the pathogenesis of many CNS diseases. Despite the potential of an MT imaging agents, no PET ligand is currently available for in vivo imaging of MTs in the brain. We radiolabeled [11C]MPC-6827, a high affinity MTA, and demonstrated its specific binding in rat and mice brain using PET imaging. Our experiments show that [11C]MPC-6827 has specific binding to MT in brain, and it is the first MT-binding PET ligand." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00028"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00028">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00028&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00028&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00028&amp;href=/doi/10.1021/acs.jmedchem.8b00028" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 2118-2123</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01824" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Brief Article</span><a href="/doi/10.1021/acs.jmedchem.8b00099" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Radiosynthesis and in Vivo Evaluation of [<sup>11</sup>C]MPC-6827, the First Brain Penetrant Microtubule PET Ligand</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">J. S. Dileep Kumar</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">J. S. Dileep Kumar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, 1051 Riverside Drive, New York, New York 10032, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: 646-774-7522. Fax: 646-774-7521. E-mail: <a href="/cdn-cgi/l/email-protection#c7acb2aaa6b5a3ae87a9beb4b7aee9a4a8abb2aaa5aea6e9a2a3b2"><span class="__cf_email__" data-cfemail="29425c44485b4d406947505a5940074a46455c444b4048074c4d5c">[emailÂ protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=J.+S.+Dileep++Kumar">J. S. Dileep Kumar</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6688-3991" title="Orcid link">http://orcid.org/0000-0001-6688-3991</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Kiran Kumar Solingapuram Sai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kiran Kumar Solingapuram Sai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiology, Wake Forest Medical Center, Winston Salem, North Carolina 27157, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kiran+Kumar++Solingapuram+Sai">Kiran Kumar Solingapuram Sai</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Jaya Prabhakaran</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jaya Prabhakaran</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, 1051 Riverside Drive, New York, New York 10032, United States</div><div class="loa-info-affiliations-info">Department of Psychiatry, Columbia University Medical Center, New York, New York 10032, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jaya++Prabhakaran">Jaya Prabhakaran</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Hakeem R. Oufkir</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hakeem R. Oufkir</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiology, Wake Forest Medical Center, Winston Salem, North Carolina 27157, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hakeem+R.++Oufkir">Hakeem R. Oufkir</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Gayathri Ramanathan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gayathri Ramanathan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiology, Wake Forest Medical Center, Winston Salem, North Carolina 27157, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gayathri++Ramanathan">Gayathri Ramanathan</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Christopher T. Whitlow</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christopher T. Whitlow</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiology, Wake Forest Medical Center, Winston Salem, North Carolina 27157, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+T.++Whitlow">Christopher T. Whitlow</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Hima Dileep</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hima Dileep</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, 1051 Riverside Drive, New York, New York 10032, United States</div><div class="loa-info-affiliations-info">Department of Psychiatry, Columbia University Medical Center, New York, New York 10032, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hima++Dileep">Hima Dileep</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Akiva Mintz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Akiva Mintz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiology, Wake Forest Medical Center, Winston Salem, North Carolina 27157, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Akiva++Mintz">Akiva Mintz</a></span></div></div></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor">J. John Mann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">J. John Mann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, 1051 Riverside Drive, New York, New York 10032, United States</div><div class="loa-info-affiliations-info">Department of Psychiatry, Columbia University Medical Center, New York, New York 10032, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=J.+John++Mann">J. John Mann</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00028&amp;href=/doi/10.1021%2Facs.jmedchem.8b00028" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 2118â2123</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 19, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>8 January 2018</li><li><span class="item_label"><b>Published</b> online</span>19 February 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 March 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00028" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00028</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2118%26pageCount%3D6%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJ.%2BS.%2BDileep%2BKumar%252C%2BKiran%2BKumar%2BSolingapuram%2BSai%252C%2BJaya%2BPrabhakaran%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D5%26contentID%3Dacs.jmedchem.8b00028%26title%3DRadiosynthesis%2Band%2Bin%2BVivo%2BEvaluation%2Bof%2B%255B11C%255DMPC-6827%252C%2Bthe%2BFirst%2BBrain%2BPenetrant%2BMicrotubule%2BPET%2BLigand%26numPages%3D6%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2123%26publicationDate%3DMarch%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00028"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1068</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">8</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00028" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Radiosynthesis and in Vivo Evaluation of [11C]MPC-6827, the First Brain Penetrant Microtubule PET Ligand&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;J.&quot;,&quot;last_name&quot;:&quot;S. Dileep Kumar&quot;},{&quot;first_name&quot;:&quot;Kiran&quot;,&quot;last_name&quot;:&quot;Kumar Solingapuram Sai&quot;},{&quot;first_name&quot;:&quot;Jaya&quot;,&quot;last_name&quot;:&quot;Prabhakaran&quot;},{&quot;first_name&quot;:&quot;Hakeem&quot;,&quot;last_name&quot;:&quot;R. Oufkir&quot;},{&quot;first_name&quot;:&quot;Gayathri&quot;,&quot;last_name&quot;:&quot;Ramanathan&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;T. Whitlow&quot;},{&quot;first_name&quot;:&quot;Hima&quot;,&quot;last_name&quot;:&quot;Dileep&quot;},{&quot;first_name&quot;:&quot;Akiva&quot;,&quot;last_name&quot;:&quot;Mintz&quot;},{&quot;first_name&quot;:&quot;J.&quot;,&quot;last_name&quot;:&quot;John Mann&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;19&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;2118-2123&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00028&quot;},&quot;abstract&quot;:&quot;Abnormalities of microtubules (MTs) are implicated in the pathogenesis of many CNS diseases. Despite the potential of an MT imaging agents, no PET ligand is currently available for in vivo imaging of MTs in the brain. We radiolabeled [11C]MPC-6827, a high affinity MTA, and demonstrated its specific binding in rat and mice brain using PET imaging. Our experiments show that [11C]MPC-6827 has specific binding to MT in brain, and it is the first MT-binding PET ligand.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00028&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00028" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00028&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00028" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00028&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00028" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00028&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00028&amp;href=/doi/10.1021/acs.jmedchem.8b00028" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00028" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00028" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00028%26sid%3Dliteratum%253Aachs%26pmid%3D29457976%26genre%3Darticle%26aulast%3DKumar%26date%3D2018%26atitle%3DRadiosynthesis%2Band%2Bin%2BVivo%2BEvaluation%2Bof%2B%255B11C%255DMPC-6827%252C%2Bthe%2BFirst%2BBrain%2BPenetrant%2BMicrotubule%2BPET%2BLigand%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D5%26spage%3D2118%26epage%3D2123%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/jmcmar.2018.61.issue-5/20180308/jmcmar.2018.61.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.8b00028/20180302/images/medium/jm-2018-00028q_0004.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.8b00028/20180302/images/large/jm-2018-00028q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00028&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Abnormalities of microtubules (MTs) are implicated in the pathogenesis of many CNS diseases. Despite the potential of an MT imaging agents, no PET ligand is currently available for in vivo imaging of MTs in the brain. We radiolabeled [<sup>11</sup>C]MPC-6827, a high affinity MTA, and demonstrated its specific binding in rat and mice brain using PET imaging. Our experiments show that [<sup>11</sup>C]MPC-6827 has specific binding to MT in brain, and it is the first MT-binding PET ligand.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16030" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16030" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Microtubules (MTs) are a major component of cytoskeletal polymers and comprise repeating, noncovalently bound Î±- and Î²-tubulin heterodimers.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> A major function of MT is to serve as cellular conveyer belt ferrying vesicles, granules, and organelles like mitochondria and chromosomes throughout cells. Mutations associated with MT dynamics lead to an imbalance between cell divisions, causing reduced or excessive cell proliferation that can result in cancer, birth disorders, and brain diseases.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3â5)</a> MT-targeting agents (MTA) are among the most successful in anticancer therapy, and many MT-related drugs are in various stages of clinical development. Three classes of ligands (e.g., vinca alkaloids, paclitaxel, and derivatives and colchicine) are currently marketed for the treatment of several malignancies and other diseases.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6â8)</a> However, these drugs have several limitations preventing their clinical applications such as high level of neurological and bone marrow toxicity, emergence of drug-resistant tumor cells due to the overproduction of multidrug resistance protein 1 (MDR1), permeability glycoprotein (P-gp), breast cancer resistance protein (BCRP), and overexpression of different tubulins or tubulin mutations. To overcome these hurdles, several new generation MTAs exhibiting promising results are in clinical trials for cancer and tauopathies.<a onclick="showRef(event, 'ref5 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref5 ref8 ref9 ref10">(5,8â10)</a></div><div class="NLM_p">MTs in mammalian brain comprise approximately 20% of total brain protein compared with 3â4% of total protein in somatic tissues.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> In the brain, MTs act as a quantum computer involving a complex cascade of biological processes that include mitotic division, relocation of migrating neurons, and the extension of dendritic and axonal processes. Disruption of the structural integrity of the MT network and interruption of MT function contribute to the pathophysiology of central nervous system (CNS) disorders such as Alzheimerâs disease (AD).<a onclick="showRef(event, 'ref5 ref11'); return false;" href="javascript:void(0);" class="ref ref5 ref11">(5,11)</a> MT loss is also reported in Parkinsonâs disease (PD), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD), amyotrophic lateral sclerosis (ALS), hereditary spastic paraplegia (HSP), multiple sclerosis (MS), Huntingtonâs disease (HD), traumatic brain injury (TBI), chronic traumatic encephalopathy (CTE), and spinal cord injury (SCI).<a onclick="showRef(event, 'ref4 ref5 ref12 ref13 ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref12 ref13 ref14 ref15 ref16 ref17 ref18">(4,5,12â18)</a> MT loss or reduction in MT mass from axons and dendrites is also associated with normal aging and neuropsychiatric diseases.<a onclick="showRef(event, 'ref5 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref5 ref18 ref19">(5,18,19)</a> MTs, specifically the Î²III-tubulin isoform, are overabundant in high-grade gliomas, particularly in glioblastoma multiform (GBM).<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20â22)</a> Most older MT-binding drugs did not show benefits in the context of GBM or brain malignancies despite efficacy in non-CNS cancers. The lack of a MT binding imaging agent hampers drug development for brain diseases involving MTs. A BBB penetrating PET ligand that can quantify MTs noninvasively would permit imaging a variety of CNS disorders including brain malignancies and the conduct of target occupancy studies of potential therapeutic drugs.</div><div class="NLM_p last">[<sup>11</sup>C]Paclitaxel, [<sup>18</sup>F]fluoropaclitaxel, and [<sup>11</sup>C]docetaxel are the successful radiotracers reported so far for MT imaging.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Of the three tracers, [<sup>18</sup>F]fluoropaclitaxel and [<sup>11</sup>C]docetaxel have been assessed in preclinical and clinical studies. Because docetaxel and paclitaxel are well-characterized substrates of efflux transporters (P-gp, MDR1, BCRP), they have little uptake brain and are not suitable for brain imaging.<a onclick="showRef(event, 'ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25">(23â25)</a> [<sup>11</sup>C]colchicine, another MT binding drug (IC<sub>50</sub> = 3 Î¼M), has been radiolabeled it does not show binding in rodent brain.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> Radiosynthesis of [<sup>18</sup>F]fluoro and [<sup>11</sup>C]analogues of 2-methoxyestradiol (an active in vivo metabolite of estrogen), a weak MT ligand, hypoxia inducible factor 1 (HIF-1), and G-protein coupled estrogen receptor (GPER) agonist and [<sup>18</sup>F] derivative of chelidonine, another weak MT ligand, have also been reported.<a onclick="showRef(event, 'ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30">(28â30)</a> However, no in vivo data are reported for these potential radiotracers. In summary, hitherto there is no successful PET radiotracer available for imaging MTs in brain. Our screen of MT ligands identified MPC-6827 as a candidate ligand. MPC-6827 (verubulin aka Azixa, IC<sub>50</sub> = 1.5 nM to MT) was selected based on its high MT affinity, selectivity, optimal pharmacokinetics, pharmacodynamics, and in vivo preclinical and clinical information available from literature.<a onclick="showRef(event, 'ref31 ref32 ref33 ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33 ref34 ref35 ref36">(31â36)</a> Furthermore, formation of the <i>O</i>-demethylated compound MPI-0440627 (<b>4</b>) is likely the major metabolic pathway for MPC-6827 in rodents and human subjects.<a onclick="showRef(event, 'ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36">(34â36)</a> Therefore, radiolabeling of the methoxy group resulting in [<sup>11</sup>C]MPC-6827, via radiomethylation of MPI-0440627 (desmethyl-MPC-6827) is the most suitable strategy because of the possibility of nonradioactive metabolite formation. This may be an advantage of [<sup>11</sup>C]MPC-6827 for in vivo applications due to the absence of other competing radioactive metabolites via <i>O</i>-demethylation pathway. Herein, we describe the radiosynthesis and in vivo evaluation of <i>O</i>-[<sup>11</sup>C]MPC-6827 aka [<sup>11</sup>C]MPC-6827 in rodents.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15001" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15001" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Synthesis of MPC-6827 (<b>3</b>) was accomplished via modifications of a previously reported method.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Binding affinity and cross selectivity of MPC-6827 to a large panel of brain targets was assessed through NIMH-PDSP. Except for histamine-4 receptor (H<sub>4</sub>R, <i>K</i><sub>i</sub> = 155 nM) and sigma-1 receptor (Ï<sub>1</sub>R, <i>K</i><sub>i</sub> = 426 nM), MPC-6827 did not show significant affinity (<i>K</i><sub>i</sub> = >10000 Î¼M) for all other tested biogenic brain receptors, transporters, enzymes, and protein targets (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Both H<sub>4</sub>R and Ï<sub>1</sub> are in comparatively low abundance relative to MTs and therefore are unlikely to interfere with the PET imaging MT quantification by [<sup>11</sup>C]MPC-6827.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Affinity of MPC-6827 to Brain Targets<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">targets</th><th class="colsep0 rowsep0" align="center" char=".">affinity (nM)</th><th class="colsep0 rowsep0" align="center">targets</th><th class="colsep0 rowsep0" align="center" char=".">affinity (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MT</td><td class="colsep0 rowsep0" align="char" char=".">1.5<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a></td><td class="colsep0 rowsep0" align="left">5-HT1A-1E</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT2A-2C</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="left">5-HT3-7</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT2A-2C</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT3â7</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="left">Î±1A-1C</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Î±2A-2C</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="left">Î²1â3</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AMPA</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="left">BZP</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ca+ channel</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="left">CB1, CB2</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">D1-D5</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="left">DAT</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DOR</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="left">H1</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">H2</td><td class="colsep0 rowsep0" align="char" char=".">155</td><td class="colsep0 rowsep0" align="left">H3, H4</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HERG</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="left">GABA</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ÎP</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ÎÎP</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="left">KA</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="left">mGluR</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MDR1</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="left">MOR</td><td class="colsep0 rowsep0" align="char" char=".">6479</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NET</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="left">NK</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NMÎA</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="left">NOP</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="left">oxytocin</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PBR</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="left">PKC</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SERT</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="left">Ï1</td><td class="colsep0 rowsep0" align="char" char=".">426</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ï2</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="left">NaÂ +Â channel</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">smoothened</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="left">VMATÂ 1,2</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">MT, microtubule; 5-HT, 5-hydroxytryptamin; A, adenosine; Î±, alpha; Î²,: beta; BZP, benzodiazepine; AMPA, <i>R</i>-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; CB, cannabinoid; D, dopamine; DAT, dopamine transporters; DOR, Î´ opioid receptors; EP, prostanoid receptors: GABA, Î³-amino butyric acid; H, histamine; hERG, human ether-a-go-go; KA, kainate; KOR, Îº opioid receptors; M, muscarinic; MDR, multidrug resistance; MOR, Î¼ opioid receptor; mGluR, metabotropic glutamate receptors; NMDA, <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartic acid; NK, neurokinin; NET, norepinephrine transporter; NT, neurotrophin; PKC, protein kinase C; SERT, serotonin transporter; V, vasopressin; VMAT, vesicular monoamine transporter.</p></div></div></div><div class="NLM_p">Desmethyl-MPC-6827 (<b>4</b>) was synthesized by <i>O</i>-demethylation of MPC-6827 with BBr<sub>3</sub> in 85% yield (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The desmethyl product <b>4</b>, synthesized via demethylation of the parent molecule, usually contains a very small amount of MPC-6827 (<1%, not detectable by NMR but visible by HPLC) and therefore may interfere with the estimation of specific activity of [<sup>11</sup>C]MPC-6827. To avoid this situation, we synthesized the radiolabeling precursor <b>4</b> via an alternate route by coupling compound <b>1</b> with 4-(methylamino)phenol (<b>5</b>) in 80% yield (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Radiosynthesis of [<sup>11</sup>C]MPC-6827 was performed and validated in a GE-FX2MeI/FX2M module by reacting precursor <b>4</b> with [<sup>11</sup>C]CH<sub>3</sub>I in the presence of sodium hydroxide as base (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). [<sup>11</sup>C]MPC-6827 was produced with a radiochemical yield (RCY) of 40 Â± 5% (<i>n</i> = 20) in >99% radiochemical purity and a specific activity of 2 Â± 0.5 Ci/Î¼mol (corrected to end of synthesis (EOS)) in 100% success rate. [<sup>11</sup>C]MPC-6827 was stable in 5% ethanolâsaline formulation under sterile conditions for 4 h (<i>n</i> = 4), and the log <i>P</i><sub>oct/water</sub> was estimated as 3.8 by shake flask method (<i>n</i> = 4).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.8b00028/20180302/images/medium/jm-2018-00028q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.8b00028/20180302/images/large/jm-2018-00028q_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of MPC-6827 and Radiosynthesis of [<sup>11</sup>C]MPC-6827</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.8b00028/20180302/images/large/jm-2018-00028q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00028&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">After reliably successful radiosyntheses and stability measurements, we examined the in vivo binding of [<sup>11</sup>C]MPC-6827 in white male mice by ex vivo biodistribution experiments at 5, 15, 30, and 60 min after tracer tail vein administration in triplicate. [<sup>11</sup>C]MPC-6827 penetrated the BBB and was retained in the brain (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A).</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.8b00028/20180302/images/medium/jm-2018-00028q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.8b00028/20180302/images/large/jm-2018-00028q_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Baseline biodistribition of [<sup>11</sup>C]MPC-6827 in male white mice (<i>n</i> = 3). (B) Blocking biodistriution of [<sup>11</sup>C]MPC-6827 in mice at 30 min (<i>n</i> = 3)</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.8b00028/20180302/images/large/jm-2018-00028q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00028&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The time course of [<sup>11</sup>C]MPC-6827 in brain indicated a peak at 5 min followed by a gradual washout (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A). We elected to perform blocking experiments at 30 min based on timeâactivity curves of [<sup>11</sup>C]MPC-6827 in baseline experiments (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A). At 30 min of the biodistribution experiments, 70% specific binding is observed in brain after the administration of MPC-6827 (5 mg/kg, iv) 20 min prior to the radioligand administration (<i>n</i> = 3, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B). Apart from the brain, muscles, spleen, and lungs showed 60%, 42%, and 30% specific binding, respectively. Pancreas and heart show 20% and 16% specific binding, and no significant specific binding was found in the rest of the tested regions. Therefore, binding in liver and kidney may be attributed to nonspecific binding of [<sup>11</sup>C]MPC-6827 or its metabolites.</div><div class="NLM_p">Next, we examined the in vivo binding of [<sup>11</sup>C]MPC-6827 in athymic nude male mice (<i>n</i> = 3) using microPET. As evident from microPET images (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), [<sup>11</sup>C]MPC-6827 penetrates the BBB and shows excellent retention in mouse brain. Brain activity was substantially blocked by the iv administration of 5 mg/kg unlabeled MPC-6827, indicating specific binding of [<sup>11</sup>C]MPC-6827 to brain MT (<i>n</i> = 3). Of note, radioligand binding in thyroid or salivary gland is also displaced during the blocking experiments (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). MicroPET experiments in male SpragueâDawley rats indicate BBB penetration and excellent retention of [<sup>11</sup>C]MPC-6827 in brain (<i>n</i> = 2) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.8b00028/20180302/images/medium/jm-2018-00028q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.8b00028/20180302/images/large/jm-2018-00028q_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Sum of 0â60 min microPET sagittal images of [<sup>11</sup>C]MPC-6827 in a representative mouse brain (left, baseline; right, blocking with 5 mg/kg MPC-6827; cross lines represent center of brain).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.8b00028/20180302/images/large/jm-2018-00028q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00028&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.8b00028/20180302/images/medium/jm-2018-00028q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.8b00028/20180302/images/large/jm-2018-00028q_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Sum of 0â60 min microPET sagittal images of [<sup>11</sup>C]MPC-6827 in rat brain (left, transverse; middle, coronal; right, sagittal; cross lines represent center of brain).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.8b00028/20180302/images/large/jm-2018-00028q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00028&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26404" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26404" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">MPC-6827 is a high affinity, selective MTA (IC<sub>50</sub> = 1.5 nM) that demonstrated suppression of tumor growth in a variety of cancer animal models, proven safe to use in human subjects, and underwent multiple clinical trials for treatment of glioblastoma (GBM) and a variety of advanced cancers.<a onclick="showRef(event, 'ref31 ref32 ref33 ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33 ref34 ref35 ref36">(31â36)</a> MPC-6827 is proven to be safe in over 100 cancer patients including GBM.<a onclick="showRef(event, 'ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36">(34â36)</a> Although clinical outcome suggests that the drug as a single agent or combination may have limited success in cancer therapy, the BBB penetration, lack of MDR resistance, selective on-target specific binding, facile labeling site, and lack of possible radioactive metabolite and safe use in human subjects are the merits of [<sup>11</sup>C]MPC-6827 as a potential CNS PET imaging agent for the MT target. Reliability of the automated radiosynthesis of [<sup>11</sup>C]MPC-6827 was demonstrated by a 100% success rate. Synthesis of MPC-6827 and desmethyl-6827 were accomplished in one step from commercially available precursor chemicals in good yield. The radioligand exhibited BBB penetration in mice and rats and was retained in brain consistent with higher affinity specific binding. The brain uptake of [<sup>11</sup>C]MPC-6827 was blocked with cold ligand MPC-6827, confirming specific binding. Abundant specific binding of [<sup>11</sup>C]MP-6827 was also observed in muscle, however, the ratio of specific to nonspecific binding in brain is 10 times higher than in muscle (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B). [<sup>11</sup>C]MPC-6827 activity in brain was peaked at 5 min, followed by a gradual washout indicating favorable kinetics for tracer quantification in mouse brain (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A). We did not find blockade of radioligand binding in the heart. In blood, there is high plasma binding (98.2%) of the parent ligand in rodents.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Kidney and liver show high accumulation of activity in mice, and the binding was not displaced with cold MPC-6827 in blocking experiments. This uptake may be related to metabolism and excretion of the tracer and its metabolites. Therefore, [<sup>11</sup>C]MPC-6827 may not be a good PET radiotracer for imaging tumors in lower thorax or abdomen in mice. To the best of our knowledge, [<sup>11</sup>C]MPC-6827 is the first MT radioligand that penetrates the BBB and specific binding in vivo in rodents. [<sup>11</sup>C]MPC-6827 may be a viable radiotracer for the in vivo imaging of normal MT functions and animal models with altered brain functions with MT pathology due to its specific binding and favorable kinetics.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45605" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45605" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we developed an automated synthesis of [<sup>11</sup>C]MPC-6827, a high affinity and selective MT ligand, in high yield, purity, and specific activity. In vivo studies in rodents indicated BBB penetration and binding of the radiotracer in brain and other organs or tissues. Specificity of [<sup>11</sup>C]MPC-6827 binding was demonstrated by blocking studies with cold ligand MPC-6827. Combination of rapid washout and robust specific binding with excellent brain uptake may make [<sup>11</sup>C]MPC-6827 a suitable PET ligand for the in vivo quantification of MT inside and outside of the brain.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06107" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06107" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> General Considerations</h3><div class="NLM_p last">Solvents are of reagent grade or higher purity. All reagents were purchased from commercial vendors in >95% purity and used as received. <sup>1</sup>H NMR spectra were recorded on a Bruker PPX 400-MHz spectrometer. Spectra were recorded in CD<sub>3</sub>OD, and chemical shifts (Î´) are reported in parts per million (ppm) relative to tetramethylsilane. The mass spectra were recorded on a JKS-HX 11UHF/HX110 HF tandem mass spectrometer in the fast atom bombardment (EI+) mode. Thin-layer chromatography was performed using silica gel 60 F254 plates from E. Merck (Aston, PA). High-performance liquid chromatography (HPLC) analyses were performed using a Waters 1525 HPLC system (Milford, MA), and flash column chromatography was performed on silica gel (Fisher 200â400 mesh) using the solvent system indicated in the experimental procedure for each compound. Chemical purities of biologically tested compounds MPC-6827 and desmethyl-MPC-6827 were >95% based on reverse phase HPLC (RP-HPC) analyses using UV detector at 254 nM. The purities (chemical and radiochemical) and stability of [<sup>11</sup>C]MPC-6827 were determined by RP-HPLC (Torrance, CA) with photodiode array and sodium iodide detectors. Lipophilicity (expressed as log <i>P</i><sub>oct/water</sub>) of [<sup>11</sup>C]MPC-6827 was estimated by determining the partition coefficient between 1-octanol and freshly prepared phosphate buffer using a standard shake flask method as described elsewhere.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Biodistribution studies were performed in male white mice, and radioactivity counts were measured using a Wallac 1480 Wizard gamma counter, PerkinElmer, Turku, Finland.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> microPET studies were performed in SpragueâDawley rats and athymic male nude mice Trifoil PET/CT scanner under anesthetic condition.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> All animal experiments were carried out with the approval of the Institutional Animal Care and Use Committee of Wake Forest University Medical Center.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Desmethyl-MPC-6827 (<b>4</b>)</h3><div class="NLM_p last">First, 2 mL of anhydrous dichloromethane (DCM) was added to an argon charged reaction vessel containing MPC-6827 (85 mg, 0.3 mmol) at 0 Â°C. Then 1 M solution of BBr<sub>3</sub> in DCM (1 mL) was added dropwise to it at 0 Â°C. The solution was stirred for 1 h at room temperature. An aliquot of reaction mixture was quenched with methanol, analytical HPLC performed, and complete conversion of MPC-6827 conformed. The reaction was quenched by dropwise addition of methanol (1 mL) at 0 Â°C, diluted with water (5 mL), extracted with 50 mL of DCM (2 Ã 25 mL), followed by 50 mL of ethyl acetate (2 Ã 25 mL). The combined organic extracts were washed with brine and dried over anhydrous MgSO<sub>4</sub>. Solvent was evaporated under reduced pressure, and the residue obtained was washed with ice-cold hexane to obtain compound <b>4</b> (70 mg, 85%) as a yellow solid. <b>4</b>: <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´: 2.7 (s, 3H), 3.7 (s, 3H), 6.8 (m, 3H), 7.1 (m, 3H), 7.6 (m, 2H). HRMS (EI+): calculated for C<sub>16</sub>H<sub>16</sub>N<sub>3</sub>O 266.1293, found 266.1294.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Alternative Synthesis of Compound <b>4</b></h3><div class="NLM_p last">To a solution of 4-chloro-2-methylquinazoline (<b>1</b>, 90 mg, 0.5 mmol) and 4-(methylamino)-phenol (<b>5</b>, 70 mg, 5.75 mmol) in 2 mL of anhydrous 2-propanol (IPA) added 2 drops of concentrated HCl, and the reaction mixture was stirred at room temperature overnight. The yellow precipitate was collected by filtration, washed with cold 2-propanol, and dried under vacuum to afford compound <b>4</b> (105 mg, 80%) as a yellow solid. Analytical data of compound <b>4</b> is identical with the product obtained using previous method.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Radiosynthesis of [<sup>11</sup>C]MPC-6827</h3><div class="NLM_p last">[<sup>11</sup>C]MeI from FX2MeI module was bubbled to the reaction vial placed in FX2M module containing precursor <b>4</b> (â¼0.5â0.8 mg) in anhydrous DMF (0.6 mL) and 5 N NaOH aqueous solution (10.0 Î¼L) for â¼5 min at room temperature. After the complete transfer of radioactivity, the sealed reaction vial was then heated at 80 Â°C for 5 min. The reaction mixture was quenched with HPLC mobile phase (1.0 mL) and injected onto a reverse-phase semipreparative C18 Phenomenex ODS (250 mm Ã 10 mm, 10 Î¼) HPLC column to purify [<sup>11</sup>C]MPC-6827. The isocratic HPLC mobile phase solution consisted of 60% acetonitrile, 40% 0.1 M aqueous ammonium formate buffer solution (pH 6.0â6.5) with UV Î» @ 254 nm and a flow rate of 7.0 mL/min. The product [<sup>11</sup>C]MPC-6827 (<i>R</i><sub>t</sub> = 9.0â11.0 min) was collected and diluted with 100 mL of deionized water and passed through C18 SepPak cartridge (WAT036800, Waters, Milford, MA) to trap the radioactive product. [<sup>11</sup>C]MPC-6827 was then directly eluted from the cartridge with absolute ethanol (1.0 mL) and formulated with saline (10% ethanol in saline) into a sterile vial through a sterile 0.22 Î¼m pyrogen-free filter for further animal studies and quality control analysis. [<sup>11</sup>C]MPC-6827 purity was assessed using an analytical Phenomenex C18 HPLC column (250 mm Ã 4.6 mm, 5 Î¼) and with UV Î» @ 254 nm. The mobile phase (1.0 mL/min) consisted of 60% acetonitrile and 40% 0.1 M aqueous ammonium formate pH 6.0â6.5 solution. [<sup>11</sup>C]MPC-6827 showed a retention at 7.1 min, and authentication of the product was performed with coinjection of the nonradioactive standard MPC-6827, which demonstrated a similar retention times.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Biodistribution of [<sup>11</sup>C]MPC-6827 in Mice</h3><div class="NLM_p last">Biodistribution experiments were performed as described previously.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Briefly, 100 Â± 20 Î¼Ci of [<sup>11</sup>C]MPC-6827 were administered to male white mice in 10% ethanolâsaline (100 Î¼L per 100 g body weight) through tail vein injection without anesthesia. Uptake of radiotracer in different organs such as brain, heart, lungs, liver, kidney, spleen, pancreas, muscles, and blood were calculated as percentages of injected dose per gram of tissue (%ID/g tissue). Tracer uptakes in the tissues were measured using a Î³-counter and expressed in %ID/g tissue. Specific binding were demonstrated by performing blocking studies of cold-ligand MPC-6827 (5 mg/kg, iv) 20 min prior to radiotracer administration, and dissections were performed at 30 min post radiotracer injection. All experiments were performed in triplicate.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> microPET Imaging of [<sup>11</sup>C]MPC-6827 in Mice and Rats</h3><div class="NLM_p last">microPET imaging of [<sup>11</sup>C]MPC-6827 was performed as described previously.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> In brief, microPET experiments were performed in anesthetized white male mice (<i>n</i> = 3) or Sprague-Dawey rats (<i>n</i> = 2) using Trifoil PET/CT scanner. After the transmission scans, [<sup>11</sup>C]MPC-6827 (50 Â± 10 Î¼Ci for mice and 100 Â± 20 Î¼Ci for rats) was injected into the tail vein and initiated camera acquisition for 60 min and reconstructed using attenuation correction and Fourier rebinning. Blocking microPET imaging were performed in white male mice (<i>n</i> = 3) 20 prior to the injection of MPC-6827 (5 mg/kg, iv). The dynamic images were reconstructed using a filtered back-projection algorithm (microPET Manager).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00028" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20063" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20063" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00028" class="ext-link">10.1021/acs.jmedchem.8b00028</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings of key chemicals (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00028/suppl_file/jm8b00028_si_002.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings of key chemicals (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00028/suppl_file/jm8b00028_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00028/suppl_file/jm8b00028_si_001.csv">jm8b00028_si_001.csv (0.14 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00028/suppl_file/jm8b00028_si_002.pdf">jm8b00028_si_002.pdf (71.84 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00028" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14253" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14253" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">J. S. Dileep Kumar</span> - <span class="hlFld-Affiliation affiliation">Molecular
Imaging and Neuropathology Division, New
York State Psychiatric Institute, 1051 Riverside Drive, New
York, New York 10032, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6688-3991" title="Orcid link">http://orcid.org/0000-0001-6688-3991</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#462d332b2734222f06283f35362f6825292a332b242f2768232233"><span class="__cf_email__" data-cfemail="6b001e060a190f022b0512181b02450804071e0609020a450e0f1e">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kiran Kumar Solingapuram Sai</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology, Wake Forest Medical Center, Winston Salem, North Carolina 27157, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jaya Prabhakaran</span> - <span class="hlFld-Affiliation affiliation">Molecular
Imaging and Neuropathology Division, New
York State Psychiatric Institute, 1051 Riverside Drive, New
York, New York 10032, United States</span>;Â 
    <span class="hlFld-Affiliation affiliation">Department
of Psychiatry, Columbia University Medical
Center, New York, New York 10032, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hakeem R. Oufkir</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology, Wake Forest Medical Center, Winston Salem, North Carolina 27157, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gayathri Ramanathan</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology, Wake Forest Medical Center, Winston Salem, North Carolina 27157, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher T. Whitlow</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology, Wake Forest Medical Center, Winston Salem, North Carolina 27157, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hima Dileep</span> - <span class="hlFld-Affiliation affiliation">Molecular
Imaging and Neuropathology Division, New
York State Psychiatric Institute, 1051 Riverside Drive, New
York, New York 10032, United States</span>;Â 
    <span class="hlFld-Affiliation affiliation">Department
of Psychiatry, Columbia University Medical
Center, New York, New York 10032, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Akiva Mintz</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology, Wake Forest Medical Center, Winston Salem, North Carolina 27157, United States</span>;Â 
    <span>Present Address:
                        For A.K.: Department of Radiology, Columbia University Medical Center, New York, New York 10032, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">J. John Mann</span> - <span class="hlFld-Affiliation affiliation">Molecular
Imaging and Neuropathology Division, New
York State Psychiatric Institute, 1051 Riverside Drive, New
York, New York 10032, United States</span>;Â 
    <span class="hlFld-Affiliation affiliation">Department
of Psychiatry, Columbia University Medical
Center, New York, New York 10032, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>J.S.D.K. and K.K.S.S. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13535" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13535" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank NIMH-PDSP for competitive binding assay of MPC-6827. This work was supported by Diane Goldberg Foundation (CUMC/NYSPI) and Translational Imaging Program (TIP) of the Wake Forest CTSA (UL1TR001420).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimerâs Disease</p></td></tr><tr><td class="NLM_term">ALS</td><td class="NLM_def"><p class="first last">amyotrophic lateral sclerosis</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">bloodâbrain barrier</p></td></tr><tr><td class="NLM_term">BCRP</td><td class="NLM_def"><p class="first last">breast cancer resistance protein</p></td></tr><tr><td class="NLM_term">CTE</td><td class="NLM_def"><p class="first last">chronic traumatic encephalopathy</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CBD</td><td class="NLM_def"><p class="first last">corticobasal degeneration</p></td></tr><tr><td class="NLM_term">EOS</td><td class="NLM_def"><p class="first last">end of synthesis</p></td></tr><tr><td class="NLM_term">GBM</td><td class="NLM_def"><p class="first last">glioblastoma multiform</p></td></tr><tr><td class="NLM_term">GPER</td><td class="NLM_def"><p class="first last">G-protein coupled estrogen receptor:</p></td></tr><tr><td class="NLM_term">HSP</td><td class="NLM_def"><p class="first last">hereditary spastic paraplegia</p></td></tr><tr><td class="NLM_term">H4R</td><td class="NLM_def"><p class="first last">histamine-4 receptor</p></td></tr><tr><td class="NLM_term">HD</td><td class="NLM_def"><p class="first last">Huntingtonâs disease:</p></td></tr><tr><td class="NLM_term">HIF-1</td><td class="NLM_def"><p class="first last">hypoxia inducible factor 1</p></td></tr><tr><td class="NLM_term">MT</td><td class="NLM_def"><p class="first last">microtubule</p></td></tr><tr><td class="NLM_term">MTA</td><td class="NLM_def"><p class="first last">microtubule targeting agent</p></td></tr><tr><td class="NLM_term">MDR1</td><td class="NLM_def"><p class="first last">multidrug resistance protein 1</p></td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">multiple sclerosis</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">Parkinsonâs disease</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">permeability glycoprotein</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron emission tomography</p></td></tr><tr><td class="NLM_term">PSP</td><td class="NLM_def"><p class="first last">progressive supranuclear palsy</p></td></tr><tr><td class="NLM_term">RCY</td><td class="NLM_def"><p class="first last">radiochemical yield</p></td></tr><tr><td class="NLM_term">Ï1R</td><td class="NLM_def"><p class="first last">sigma 1 receptor</p></td></tr><tr><td class="NLM_term">SCI</td><td class="NLM_def"><p class="first last">spinal cord injury</p></td></tr><tr><td class="NLM_term">TBI</td><td class="NLM_def"><p class="first last">traumatic brain injury</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53026" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53026" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 40 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janke, C.</span></span> <span> </span><span class="NLM_article-title">The tubulin code: molecular components, readout mechanisms, and functions</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>206</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">461</span>â <span class="NLM_lpage">472</span>, <span class="refDoi">Â DOI: 10.1083/jcb.201406055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1083%2Fjcb.201406055" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2014&pages=461-472&issue=4&author=C.+Janke&title=The+tubulin+code%3A+molecular+components%2C+readout+mechanisms%2C+and+functions&doi=10.1083%2Fjcb.201406055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1083%2Fjcb.201406055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.201406055%26sid%3Dliteratum%253Aachs%26aulast%3DJanke%26aufirst%3DC.%26atitle%3DThe%2520tubulin%2520code%253A%2520molecular%2520components%252C%2520readout%2520mechanisms%252C%2520and%2520functions%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2014%26volume%3D206%26issue%3D4%26spage%3D461%26epage%3D472%26doi%3D10.1083%2Fjcb.201406055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nogales, E.</span></span> <span> </span><span class="NLM_article-title">Structural insights into microtubule function</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">277</span>â <span class="NLM_lpage">302</span>, <span class="refDoi">Â DOI: 10.1146/annurev.biochem.69.1.277</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1146%2Fannurev.biochem.69.1.277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10966460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1ajtb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2000&pages=277-302&author=E.+Nogales&title=Structural+insights+into+microtubule+function&doi=10.1146%2Fannurev.biochem.69.1.277"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into microtubule function</span></div><div class="casAuthors">Nogales, Eva</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">277-302</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 144 refs.  Microtubules are polymers that are essential for, among other functions, cell transport and cell division in all eukaryotes.  The regulation of the microtubule system includes transcription of different tubulin isotypes, folding of Î±/Î²-tubulin heterodimers, post-translation modification of tubulin, and nucleotide-based microtubule dynamics, as well as interaction with numerous microtubule-assocd. proteins that are themselves regulated.  The result is the precise temporal and spatial pattern of microtubules that is obsd. throughout the cell cycle.  The recent high-resoln. anal. of the structure of tubulin and the microtubule has brought new insight to the study of microtubule function and regulation, as well as the mode of action of antimitotic drugs that disrupt normal microtubule behavior.  The combination of structural, genetic, biochem., and biophys. data should soon provide a fuller understanding of the exquisite details in the regulation of the microtubule cytoskeleton.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMOwnZFGcGIbVg90H21EOLACvtfcHk0lgONu3k2i74XA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1ajtb4%253D&md5=2bba64a3fa1a9e3eb9f4b9517793f7b1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.69.1.277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.69.1.277%26sid%3Dliteratum%253Aachs%26aulast%3DNogales%26aufirst%3DE.%26atitle%3DStructural%2520insights%2520into%2520microtubule%2520function%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2000%26volume%3D69%26spage%3D277%26epage%3D302%26doi%3D10.1146%2Fannurev.biochem.69.1.277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hur, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, B. D.</span></span> <span> </span><span class="NLM_article-title">Microtubule-targeting agents enter the central nervous system (CNS): double-edged swords for treating CNS injury and disease</span>. <i>Int. Neurourol J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">171</span>â <span class="NLM_lpage">178</span>, <span class="refDoi">Â DOI: 10.5213/inj.2014.18.4.171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.5213%2Finj.2014.18.4.171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=25558415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A280%3ADC%252BC2MvjsFyrsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2014&pages=171-178&issue=4&author=E.+M.+Hurauthor=B.+D.+Lee&title=Microtubule-targeting+agents+enter+the+central+nervous+system+%28CNS%29%3A+double-edged+swords+for+treating+CNS+injury+and+disease&doi=10.5213%2Finj.2014.18.4.171"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule-Targeting Agents Enter the Central Nervous System (CNS): Double-edged Swords for Treating CNS Injury and Disease</span></div><div class="casAuthors">Hur Eun-Mi; Lee Byoung Dae</div><div class="citationInfo"><span class="NLM_cas:title">International neurourology journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">171-8</span>
        ISSN:<span class="NLM_cas:issn">2093-4777</span>.
    </div><div class="casAbstract">Microtubules have been among the most successful targets in anticancer therapy and a large number of microtubule-targeting agents (MTAs) are in various stages of clinical development for the treatment of several malignancies.  Given that injury and diseases in the central nervous system (CNS) are accompanied by acute or chronic disruption of the structural integrity of neurons and that microtubules provide structural support for the nervous system at cellular and intracellular levels, microtubules are emerging as potential therapeutic targets for treating CNS disorders.  It has been postulated that exogenous application of MTAs might prevent the breakdown or degradation of microtubules after injury or during neurodegeneration, which will thereby aid in preserving the structural integrity and function of the nervous system.  Here we review recent evidence that supports this notion and also discuss potential risks of targeting microtubules as a therapy for treating nerve injury and neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtRxlOi8BO8r0AGQpJZWpJfW6udTcc2eaqUvKxuYVq0Lntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MvjsFyrsw%253D%253D&md5=f66e8464d4838d2bb1f8f408cb999e64</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.5213%2Finj.2014.18.4.171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5213%252Finj.2014.18.4.171%26sid%3Dliteratum%253Aachs%26aulast%3DHur%26aufirst%3DE.%2BM.%26aulast%3DLee%26aufirst%3DB.%2BD.%26atitle%3DMicrotubule-targeting%2520agents%2520enter%2520the%2520central%2520nervous%2520system%2520%2528CNS%2529%253A%2520double-edged%2520swords%2520for%2520treating%2520CNS%2520injury%2520and%2520disease%26jtitle%3DInt.%2520Neurourol%2520J.%26date%3D2014%26volume%3D18%26issue%3D4%26spage%3D171%26epage%3D178%26doi%3D10.5213%2Finj.2014.18.4.171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eira, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sousa, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liz, M. A.</span></span> <span> </span><span class="NLM_article-title">The cytoskeleton as a novel therapeutic target for old neurodegenerative disorders</span>. <i>Prog. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">61</span>â <span class="NLM_lpage">82</span>, <span class="refDoi">Â DOI: 10.1016/j.pneurobio.2016.04.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1016%2Fj.pneurobio.2016.04.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=27095262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC28XntVCltLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2016&pages=61-82&author=J.+Eiraauthor=C.+S.+Silvaauthor=M.+M.+Sousaauthor=M.+A.+Liz&title=The+cytoskeleton+as+a+novel+therapeutic+target+for+old+neurodegenerative+disorders&doi=10.1016%2Fj.pneurobio.2016.04.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The cytoskeleton as a novel therapeutic target for old neurodegenerative disorders</span></div><div class="casAuthors">Eira, Jessica; Silva, Catarina Santos; Sousa, Monica Mendes; Liz, Marcia Almeida</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">61-82</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Cytoskeleton defects, including alterations in microtubule stability, in axonal transport as well as in actin dynamics, have been characterized in several unrelated neurodegenerative conditions.  These observations suggest that defects of cytoskeleton organization may be a common feature contributing to neurodegeneration.  In line with this hypothesis, drugs targeting the cytoskeleton are currently being tested in animal models and in human clin. trials, showing promising effects.  Drugs that modulate microtubule stability, inhibitors of posttranslational modifications of cytoskeletal components, specifically compds. affecting the levels of tubulin acetylation, and compds. targeting signaling mols. which regulate cytoskeleton dynamics, constitute the mostly addressed therapeutic interventions aiming at preventing cytoskeleton damage in neurodegenerative disorders.  In this review, we will discuss in a crit. perspective the current knowledge on cytoskeleton damage pathways as well as therapeutic strategies designed to revert cytoskeleton-related defects mainly focusing on the following neurodegenerative disorders: Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, Amyotrophic Lateral Sclerosis and Charcot-Marie-Tooth Disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOe7GHwM31HrVg90H21EOLACvtfcHk0lgONu3k2i74XA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntVCltLk%253D&md5=8385b1ac087937579849fc4f30233cf3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2016.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2016.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DEira%26aufirst%3DJ.%26aulast%3DSilva%26aufirst%3DC.%2BS.%26aulast%3DSousa%26aufirst%3DM.%2BM.%26aulast%3DLiz%26aufirst%3DM.%2BA.%26atitle%3DThe%2520cytoskeleton%2520as%2520a%2520novel%2520therapeutic%2520target%2520for%2520old%2520neurodegenerative%2520disorders%26jtitle%3DProg.%2520Neurobiol.%26date%3D2016%26volume%3D141%26spage%3D61%26epage%3D82%26doi%3D10.1016%2Fj.pneurobio.2016.04.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brunden, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. B.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojanowski, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballatore, C.</span></span> <span> </span><span class="NLM_article-title">Altered microtubule dynamics in neurodegenerative disease: Therapeutic potential of microtubule-stabilizing drugs</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">328</span>â <span class="NLM_lpage">335</span>, <span class="refDoi">Â DOI: 10.1016/j.nbd.2016.12.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1016%2Fj.nbd.2016.12.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=28012891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvFejuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2017&pages=328-335&author=K.+R.+Brundenauthor=V.+M.+Leeauthor=A.+B.+Smithauthor=J.+Q.+Trojanowskiauthor=C.+Ballatore&title=Altered+microtubule+dynamics+in+neurodegenerative+disease%3A+Therapeutic+potential+of+microtubule-stabilizing+drugs&doi=10.1016%2Fj.nbd.2016.12.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Altered microtubule dynamics in neurodegenerative disease: Therapeutic potential of microtubule-stabilizing drugs</span></div><div class="casAuthors">Brunden, Kurt R.; Lee, Virginia M.-Y.; Smith, Amos B., III; Trojanowski, John Q.; Ballatore, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">328-335</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Many neurodegenerative diseases are characterized by deficiencies in neuronal axonal transport, a process in which cellular cargo is shuttled with the aid of mol. motors from the cell body to axonal termini and back along microtubules (MTs).  Proper axonal transport is crit. to the normal functioning of neurons, and impairments in this process could contribute to the neuronal damage and death that is characteristic of neurodegenerative disease.  Although the causes of axonal transport abnormalities may vary among the various neurodegenerative conditions, in many cases it appears that the transport deficiencies result from a diminution of axonal MT stability.  Here we review the evidence of MT abnormalities in a no. of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis and traumatic brain injury, and highlight the potential benefit of MT-stabilizing agents in improving axonal transport and nerve function in these diseases.  Moreover, we discuss the challenges assocd. with the utilization of MT-stabilizing drugs as therapeutic candidates for neurodegenerative conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoinJoFYGRgj7Vg90H21EOLACvtfcHk0ljKmQR2pJi7Ww"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvFejuw%253D%253D&md5=dedda09d9cae4dd4ed06b37fcbadd805</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2016.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2016.12.021%26sid%3Dliteratum%253Aachs%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DBallatore%26aufirst%3DC.%26atitle%3DAltered%2520microtubule%2520dynamics%2520in%2520neurodegenerative%2520disease%253A%2520Therapeutic%2520potential%2520of%2520microtubule-stabilizing%2520drugs%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2017%26volume%3D105%26spage%3D328%26epage%3D335%26doi%3D10.1016%2Fj.nbd.2016.12.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Florian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchison, T. J.</span></span> <span> </span><span class="NLM_article-title">Anti-microtubule drugs</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1413</i></span>,  <span class="NLM_fpage">403</span>â <span class="NLM_lpage">421</span>, <span class="refDoi">Â DOI: 10.1007/978-1-4939-3542-0_25</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1007%2F978-1-4939-3542-0_25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=27193863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpsFantrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1413&publication_year=2016&pages=403-421&author=S.+Florianauthor=T.+J.+Mitchison&title=Anti-microtubule+drugs&doi=10.1007%2F978-1-4939-3542-0_25"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-Microtubule Drugs</span></div><div class="casAuthors">Florian, Stefan; Mitchison, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1413</span>
        (<span class="NLM_cas:issue">Mitotic Spindle</span>),
    <span class="NLM_cas:pages">403-421</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Small mol. drugs that target microtubules (MTs), many of them natural products, have long been important tools in the MT field.  Indeed, tubulin (Tb) was discovered, in part, as the protein binding partner of colchicine.  Several anti-MT drug classes also have important medical uses, notably colchicine, which is used to treat gout, familial Mediterranean fever (FMF), and pericarditis, and the vinca alkaloids and taxanes, which are used to treat cancer.  Anti-MT drugs have in common that they bind specifically to Tb in the dimer, MT or some other form.  However, their effects on polymn. dynamics and on the human body differ markedly.  Here we briefly review the most-studied mols., and comment on their uses in basic research and medicine.  Our focus is on practical applications of different anti-MT drugs in the lab., and key points that users should be aware of when designing expts.  We also touch on interesting unsolved problems, particularly in the area of medical applications.  In our opinion, the mechanism by which any MT drug cures or treats any disease is still unsolved, despite decades of research.  Solving this problem for particular drug-disease combinations might open new uses for old drugs, or provide insights into novel routes for treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3CX77S6H9irVg90H21EOLACvtfcHk0ljKmQR2pJi7Ww"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpsFantrs%253D&md5=1de6eebc227d50a8939b79e779ca8114</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-3542-0_25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-3542-0_25%26sid%3Dliteratum%253Aachs%26aulast%3DFlorian%26aufirst%3DS.%26aulast%3DMitchison%26aufirst%3DT.%2BJ.%26atitle%3DAnti-microtubule%2520drugs%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2016%26volume%3D1413%26spage%3D403%26epage%3D421%26doi%3D10.1007%2F978-1-4939-3542-0_25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, M. A.</span></span> <span> </span><span class="NLM_article-title">New microtubule/tubulin-targeted anticancer drugs and novel chemotherapeutic strategies</span>. <i>J. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">83</span>â <span class="NLM_lpage">85</span>, <span class="refDoi">Â DOI: 10.1179/joc.2004.16.Supplement-1.83</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1179%2Fjoc.2004.16.Supplement-1.83" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=15688618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsFantbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2004&pages=83-85&issue=4&author=L.+Wilsonauthor=M.+A.+Jordan&title=New+microtubule%2Ftubulin-targeted+anticancer+drugs+and+novel+chemotherapeutic+strategies&doi=10.1179%2Fjoc.2004.16.Supplement-1.83"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">New microtubule / tubulin-targeted anticancer drugs and novel chemotherapeutic strategies</span></div><div class="casAuthors">Wilson, L.; Jordan, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemotherapy (Firenze, Italy)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">Suppl. 4</span>),
    <span class="NLM_cas:pages">83-85</span>CODEN:
                <span class="NLM_cas:coden">JCHEEU</span>;
        ISSN:<span class="NLM_cas:issn">1120-009X</span>.
    
            (<span class="NLM_cas:orgname">E.S.I.F.T. srl</span>)
        </div><div class="casAbstract">A review.  The clin. success of the taxanes and the vinca alkaloids has sparked a major search for new drugs that perturb mitotic spindle microtubule dynamics and function, yielding a large no. of promising compds.  A potential valuable strategy would be to use core microtubule-targeted drugs along with novel targeted drug therapies as they are developed, where the antitumor activity of a targeted drug can be combined with the power of low dose microtubule-targeted therapy.  The goal of such combination therapy is to achieve high efficacy, reduced toxicity, and reduced emergence of drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1Ixb7nJ08ZbVg90H21EOLACvtfcHk0ljKmQR2pJi7Ww"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsFantbc%253D&md5=6e08b5ae6312226e56e2f867cf3ab3ae</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1179%2Fjoc.2004.16.Supplement-1.83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1179%252Fjoc.2004.16.Supplement-1.83%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DL.%26aulast%3DJordan%26aufirst%3DM.%2BA.%26atitle%3DNew%2520microtubule%252Ftubulin-targeted%2520anticancer%2520drugs%2520and%2520novel%2520chemotherapeutic%2520strategies%26jtitle%3DJ.%2520Chemother.%26date%3D2004%26volume%3D16%26issue%3D4%26spage%3D83%26epage%3D85%26doi%3D10.1179%2Fjoc.2004.16.Supplement-1.83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DostÃ¡l, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LibusovÃ¡, L.</span></span> <span> </span><span class="NLM_article-title">Microtubule drugs: action, selectivity, and resistance across the kingdoms of life</span>. <i>Protoplasma</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>251</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">991</span>â <span class="NLM_lpage">1005</span>, <span class="refDoi">Â DOI: 10.1007/s00709-014-0633-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1007%2Fs00709-014-0633-0" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=2014&pages=991-1005&issue=5&author=V.+Dost%C3%A1lauthor=L.+Libusov%C3%A1&title=Microtubule+drugs%3A+action%2C+selectivity%2C+and+resistance+across+the+kingdoms+of+life&doi=10.1007%2Fs00709-014-0633-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs00709-014-0633-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00709-014-0633-0%26sid%3Dliteratum%253Aachs%26aulast%3DDost%25C3%25A1l%26aufirst%3DV.%26aulast%3DLibusov%25C3%25A1%26aufirst%3DL.%26atitle%3DMicrotubule%2520drugs%253A%2520action%252C%2520selectivity%252C%2520and%2520resistance%2520across%2520the%2520kingdoms%2520of%2520life%26jtitle%3DProtoplasma%26date%3D2014%26volume%3D251%26issue%3D5%26spage%3D991%26epage%3D1005%26doi%3D10.1007%2Fs00709-014-0633-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergendahl, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashikaga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeSarno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraveka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eslin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werff, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanna, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sholler, G. L.</span></span> <span> </span><span class="NLM_article-title">A Phase 1 trial of TPI 287 as a single agent and in combination with Temozolomide in patients with refractory or recurrent neuroblastoma or medulloblastoma</span>. <i>Pediatr. Blood Cancer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">39</span>â <span class="NLM_lpage">46</span>, <span class="refDoi">Â DOI: 10.1002/pbc.25687</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1002%2Fpbc.25687" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=26235333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFCqtr7K" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2016&pages=39-46&issue=1&author=D.+Mitchellauthor=G.+Bergendahlauthor=W.+Fergusonauthor=W.+Robertsauthor=T.+Higginsauthor=T.+Ashikagaauthor=M.+DeSarnoauthor=J.+Kaplanauthor=J.+Kravekaauthor=D.+Eslinauthor=A.+V.+Werffauthor=G.+K.+Hannaauthor=G.+L.+Sholler&title=A+Phase+1+trial+of+TPI+287+as+a+single+agent+and+in+combination+with+Temozolomide+in+patients+with+refractory+or+recurrent+neuroblastoma+or+medulloblastoma&doi=10.1002%2Fpbc.25687"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma</span></div><div class="casAuthors">Mitchell, Deanna; Bergendahl, Genevieve; Ferguson, William; Roberts, William; Higgins, Timothy; Ashikaga, Takamaru; DeSarno, Mike; Kaplan, Joel; Kraveka, Jacqueline; Eslin, Don; Werff, Alyssa Vander; Hanna, Gina K.; Sholler, Giselle L. Saulnier</div><div class="citationInfo"><span class="NLM_cas:title">Pediatric Blood & Cancer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-46</span>CODEN:
                <span class="NLM_cas:coden">PBCEAQ</span>;
        ISSN:<span class="NLM_cas:issn">1545-5017</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Background : The primary aim of this Phase I study was to det. the max. tolerated dose (MTD) of TPI 287 and the safety and tolerability of TPI 287 alone and in combination with temozolomide (TMZ) in pediatric patients with refractory or recurrent neuroblastoma or medulloblastoma.  The secondary aims were to evaluate the pharmacokinetics of TPI 287 and the treatment responses.  Procedure : Eighteen patients were enrolled to a phase I dose escalation trial of weekly i.v. infusion of TPI 287 for two 28-day cycles with toxicity monitoring to det. the MTD, followed by two cycles of TPI 287 in combination with TMZ.  Samples were collected to det. the pharmacokinetic parameters Cmax, AUC0-24, t1/2, CL, and Vd on day 1 of cycles 1 (TPI 287 alone) and 3 (TPI 287 + TMZ) following TPI 287 infusion.  Treatment response was evaluated by radiog. (CT or MRI) and radionuclide (MIBG) imaging for neuroblastoma.  Results : We detd. the MTD of TPI 287 alone and in combination with temozolomide to be 125 mg/m2.  The non-dose-limiting toxicities at this dose were mainly anorexia and pain.  The dose-limiting toxicities (DLTs) of two patients at 135 mg/m2 were grade 3 hemorrhagic cystitis and grade 3 sensory neuropathy.  Conclusions : Overall, TPI 287 was well tolerated by pediatric patients with refractory and relapsed neuroblastoma and medulloblastoma at a dose of 125 mg/m2 IV on days 1, 8, and 15 of a 28 day cycle.  Pediatr Blood Cancer 2015; 9999:1-8 Â© 2015 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJoqa9ycMw9LVg90H21EOLACvtfcHk0li-WwxsnTX7Kw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFCqtr7K&md5=730dc6798b055ec12e5c7d2dea1630c3</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fpbc.25687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpbc.25687%26sid%3Dliteratum%253Aachs%26aulast%3DMitchell%26aufirst%3DD.%26aulast%3DBergendahl%26aufirst%3DG.%26aulast%3DFerguson%26aufirst%3DW.%26aulast%3DRoberts%26aufirst%3DW.%26aulast%3DHiggins%26aufirst%3DT.%26aulast%3DAshikaga%26aufirst%3DT.%26aulast%3DDeSarno%26aufirst%3DM.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DKraveka%26aufirst%3DJ.%26aulast%3DEslin%26aufirst%3DD.%26aulast%3DWerff%26aufirst%3DA.%2BV.%26aulast%3DHanna%26aufirst%3DG.%2BK.%26aulast%3DSholler%26aufirst%3DG.%2BL.%26atitle%3DA%2520Phase%25201%2520trial%2520of%2520TPI%2520287%2520as%2520a%2520single%2520agent%2520and%2520in%2520combination%2520with%2520Temozolomide%2520in%2520patients%2520with%2520refractory%2520or%2520recurrent%2520neuroblastoma%2520or%2520medulloblastoma%26jtitle%3DPediatr.%2520Blood%2520Cancer%26date%3D2016%26volume%3D63%26issue%3D1%26spage%3D39%26epage%3D46%26doi%3D10.1002%2Fpbc.25687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Penazzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakota, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, R.</span></span> <span> </span><span class="NLM_article-title">Microtubule dynamics in neuronal development, plasticity, and neurode- generation</span>. <i>Int. Rev. Cell Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>321</i></span>,  <span class="NLM_fpage">89</span>â <span class="NLM_lpage">169</span>, <span class="refDoi">Â DOI: 10.1016/bs.ircmb.2015.09.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1016%2Fbs.ircmb.2015.09.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=26811287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A280%3ADC%252BC28nksVKjtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2016&pages=89-169&author=L.+Penazziauthor=L.+Bakotaauthor=R.+Brandt&title=Microtubule+dynamics+in+neuronal+development%2C+plasticity%2C+and+neurode-+generation&doi=10.1016%2Fbs.ircmb.2015.09.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule Dynamics in Neuronal Development, Plasticity, and Neurodegeneration</span></div><div class="casAuthors">Penazzi Lorene; Bakota Lidia; Brandt Roland</div><div class="citationInfo"><span class="NLM_cas:title">International review of cell and molecular biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89-169</span>
        ISSN:<span class="NLM_cas:issn">1937-6448</span>.
    </div><div class="casAbstract">Neurons are the basic information-processing units of the nervous system.  In fulfilling their task, they establish a structural polarity with an axon that can be over a meter long and dendrites with a complex arbor, which can harbor ten-thousands of spines.  Microtubules and their associated proteins play important roles during the development of neuronal morphology, the plasticity of neurons, and neurodegenerative processes.  They are dynamic structures, which can quickly adapt to changes in the environment and establish a structural scaffold with high local variations in composition and stability.  This review presents a comprehensive overview about the role of microtubules and their dynamic behavior during the formation and maturation of processes and spines in the healthy brain, during aging and under neurodegenerative conditions.  The review ends with a discussion of microtubule-targeted therapies as a perspective for the supportive treatment of neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTpx2wh-aVG0z0SWnHPWbmmfW6udTcc2eaavmNwqHuWmLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28nksVKjtw%253D%253D&md5=0eb845a4c17dcf9df9f0145b512aa946</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fbs.ircmb.2015.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fbs.ircmb.2015.09.004%26sid%3Dliteratum%253Aachs%26aulast%3DPenazzi%26aufirst%3DL.%26aulast%3DBakota%26aufirst%3DL.%26aulast%3DBrandt%26aufirst%3DR.%26atitle%3DMicrotubule%2520dynamics%2520in%2520neuronal%2520development%252C%2520plasticity%252C%2520and%2520neurode-%2520generation%26jtitle%3DInt.%2520Rev.%2520Cell%2520Mol.%2520Biol.%26date%3D2016%26volume%3D321%26spage%3D89%26epage%3D169%26doi%3D10.1016%2Fbs.ircmb.2015.09.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kovalevich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornec, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojanowski, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. B.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballatore, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunden, K. R.</span></span> <span> </span><span class="NLM_article-title">Characterization of brain-penetrant pyrimidine-containing molecules with differential microtubule-stabilizing activities dveloped as potential therapeutic agents for Alzheimerâs Disease and related tauopathies</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>357</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">432</span>â <span class="NLM_lpage">450</span>, <span class="refDoi">Â DOI: 10.1124/jpet.115.231175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1124%2Fjpet.115.231175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=26980057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFGjt7zK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2016&pages=432-450&issue=2&author=J.+Kovalevichauthor=A.+S.+Cornecauthor=Y.+Yaoauthor=M.+Jamesauthor=A.+Croweauthor=V.+M.+Leeauthor=J.+Q.+Trojanowskiauthor=A.+B.+Smithauthor=C.+Ballatoreauthor=K.+R.+Brunden&title=Characterization+of+brain-penetrant+pyrimidine-containing+molecules+with+differential+microtubule-stabilizing+activities+dveloped+as+potential+therapeutic+agents+for+Alzheimer%E2%80%99s+Disease+and+related+tauopathies&doi=10.1124%2Fjpet.115.231175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of brain-penetrant pyrimidine-containing molecules with differential microtubule-stabilizing activities developed as potential therapeutic agents for Alzheimer's disease and related tauopathies</span></div><div class="casAuthors">Kovalevich, Jane; Cornec, Anne-Sophie; Yao, Yuemang; James, Michael; Crowe, Alexander; Lee, Virginia M.-Y.; Trojanowski, John Q.; Smith, Amos B., III; Ballatore, Carlo; Brunden, Kurt R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">432-450</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The microtubule (MT)-stabilizing protein tau disengages from MTs and forms intracellular inclusions known as neurofibrillary tangles in Alzheimer's disease and related tauopathies.  Reduced tau binding to MTs in tauopathies may contribute to neuronal dysfunction through decreased MT stabilization and disrupted axonal transport.  Thus, the introduction of brain-penetrant MT-stabilizing compds. might normalize MT dynamics and axonal deficits in these disorders.  We previously described a no. of phenylpyrimidines and triazolopyrimidines (TPDs) that induce tubulin post-translational modifications indicative of MT stabilization.  We now further characterize the biol. properties of these small mols., and our results reveal that these compds. can be divided into two general classes based on the cellular response they evoke.  One group composed of the phenylpyrimidines and several TPD examples showed a bell-shaped concn.-response effect on markers of MT stabilization in cellular assays.  Moreover, these compds. induced proteasome-dependent degrdn. of Î±- and Î²-tubulin and caused altered MT morphol. in both dividing cells and neuron cultures.  In contrast, a second group comprising a subset of TPD mols. (TPD+) increased markers of stable MTs in a concn.-dependent manner in dividing cells and in neurons without affecting total tubulin levels or disrupting MT architecture.  Moreover, an example TPD+ compd. was shown to increase MTs in a neuron culture model with induced tau hyperphosphorylation and assocd. MT deficits.  Several TPD+ compds. were shown to be both brain penetrant and orally bioavailable, and a TPD+ example increased MT stabilization in the mouse brain, making these compds. potential candidate therapeutics for neurodegenerative tauopathies such as Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCEADXoI6tlbVg90H21EOLACvtfcHk0li-WwxsnTX7Kw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFGjt7zK&md5=14cc76d21739ed6b63ba6f2754287b51</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.231175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.231175%26sid%3Dliteratum%253Aachs%26aulast%3DKovalevich%26aufirst%3DJ.%26aulast%3DCornec%26aufirst%3DA.%2BS.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DJames%26aufirst%3DM.%26aulast%3DCrowe%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26atitle%3DCharacterization%2520of%2520brain-penetrant%2520pyrimidine-containing%2520molecules%2520with%2520differential%2520microtubule-stabilizing%2520activities%2520dveloped%2520as%2520potential%2520therapeutic%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%2520and%2520related%2520tauopathies%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D357%26issue%3D2%26spage%3D432%26epage%3D450%26doi%3D10.1124%2Fjpet.115.231175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dent, E. W.</span></span> <span> </span><span class="NLM_article-title">Of microtubules and memory: implications for microtubule dynamics in dendrites and spines</span>. <i>Mol. Biol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">8</span>, <span class="refDoi">Â DOI: 10.1091/mbc.E15-11-0769</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1091%2Fmbc.E15-11-0769" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=28035040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC2sXptVOhs7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2017&pages=1-8&issue=1&author=E.+W.+Dent&title=Of+microtubules+and+memory%3A+implications+for+microtubule+dynamics+in+dendrites+and+spines&doi=10.1091%2Fmbc.E15-11-0769"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Of microtubules and memory: implications for microtubule dynamics in dendrites and spines</span></div><div class="casAuthors">Dent, Erik W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1939-4586</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">Microtubules (MTs) are cytoskeletal polymers composed of repeating subunits of tubulin that are ubiquitously expressed in eukaryotic cells.  They undergo a stochastic process of polymn. and depolymn. from their plus ends termed dynamic instability.  MT dynamics is an ongoing process in all cell types and has been the target for the development of several useful anticancer drugs, which compromise rapidly dividing cells.  Recent studies also suggest that MT dynamics may be particularly important in neurons, which develop a highly polarized morphol., consisting of a single axon and multiple dendrites that persist throughout adulthood.  MTs are esp. dynamic in dendrites and have recently been shown to polymerize directly into dendritic spines, the postsynaptic compartment of excitatory neurons in the CNS.  These transient polymn. events into dendritic spines have been demonstrated to play important roles in synaptic plasticity in cultured neurons.  Recent studies also suggest that MT dynamics in the adult brain function in the essential process of learning and memory and may be compromised in degenerative diseases, such as Alzheimer's disease.  This raises the possibility of targeting MT dynamics in the design of new therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZxuF-_ccHSrVg90H21EOLACvtfcHk0ljD4XGhqT64kg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXptVOhs7s%253D&md5=3ee0bbdb3cb02e77be372274622849a7</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1091%2Fmbc.E15-11-0769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.E15-11-0769%26sid%3Dliteratum%253Aachs%26aulast%3DDent%26aufirst%3DE.%2BW.%26atitle%3DOf%2520microtubules%2520and%2520memory%253A%2520implications%2520for%2520microtubule%2520dynamics%2520in%2520dendrites%2520and%2520spines%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2017%26volume%3D28%26issue%3D1%26spage%3D1%26epage%3D8%26doi%3D10.1091%2Fmbc.E15-11-0769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cappelletti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casagrande, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calogero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Gregorio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezzoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartelli, D.</span></span> <span> </span><span class="NLM_article-title">Linking microtubules to Parkinsonâs disease: the case of parkin</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">292</span>â <span class="NLM_lpage">296</span>, <span class="refDoi">Â DOI: 10.1042/BST20150007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1042%2FBST20150007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=25849932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvFSjurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=292-296&issue=2&author=G.+Cappellettiauthor=F.+Casagrandeauthor=A.+Calogeroauthor=C.+De+Gregorioauthor=G.+Pezzoliauthor=D.+Cartelli&title=Linking+microtubules+to+Parkinson%E2%80%99s+disease%3A+the+case+of+parkin&doi=10.1042%2FBST20150007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Linking microtubules to Parkinson's disease- the case of parkin</span></div><div class="casAuthors">Cappelletti, Graziella; Casagrande, Francesca; Calogero, Alessandra; De Gregorio, Carmelita; Pezzoli, Gianni; Cartelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">292-296</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Microtubules (MTs) are dynamic polymers consisting of Î±/Î² tubulin dimers and playing a plethora of roles in eukaryotic cells.  Looking at neurons, they are key determinants of neuronal polarity, axonal transport and synaptic plasticity.  The concept that MT dysfunction can participate in, and perhaps lead to, Parkinson's disease (PD) progression has been suggested by studies using toxin-based and genetic exptl. models of the disease.  Here, we first learn lessons from MPTP and rotenone as well as from the PD related genes, including SNCA and LRRK2, and then look at old and new evidence regarding the interplay between parkin and MTs.  Data from exptl. models and human cells point out that parkin regulates MT stability and strengthen the link between MTs and PD paving the way to a viable strategy for the management of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpXLJOcj9WvrVg90H21EOLACvtfcHk0ljD4XGhqT64kg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvFSjurs%253D&md5=5f7cf7e604aaec2504c60428dcfe4618</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1042%2FBST20150007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20150007%26sid%3Dliteratum%253Aachs%26aulast%3DCappelletti%26aufirst%3DG.%26aulast%3DCasagrande%26aufirst%3DF.%26aulast%3DCalogero%26aufirst%3DA.%26aulast%3DDe%2BGregorio%26aufirst%3DC.%26aulast%3DPezzoli%26aufirst%3DG.%26aulast%3DCartelli%26aufirst%3DD.%26atitle%3DLinking%2520microtubules%2520to%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520the%2520case%2520of%2520parkin%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2015%26volume%3D43%26issue%3D2%26spage%3D292%26epage%3D296%26doi%3D10.1042%2FBST20150007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeaman, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blizzard, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuckowree, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickson, T. C.</span></span> <span> </span><span class="NLM_article-title">A case for microtubule vulnerability in Amyotrophic Lateral Sclerosis: altered dynamics during disease</span>. <i>Front. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">204</span>, <span class="refDoi">Â DOI: 10.3389/fncel.2016.00204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.3389%2Ffncel.2016.00204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=27679561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotFyisrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&pages=204&author=J.+A.+Clarkauthor=E.+J.+Yeamanauthor=C.+A.+Blizzardauthor=J.+A.+Chuckowreeauthor=T.+C.+Dickson&title=A+case+for+microtubule+vulnerability+in+Amyotrophic+Lateral+Sclerosis%3A+altered+dynamics+during+disease&doi=10.3389%2Ffncel.2016.00204"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A case for microtubule vulnerability in amyotrophic lateral sclerosis: altered dynamics during disease</span></div><div class="casAuthors">Clark, Jayden A.; Yeaman, Elise J.; Blizzard, Catherine A.; Chuckowree, Jyoti A.; Dickson, Tracey C.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">204/1-204/16</span>CODEN:
                <span class="NLM_cas:coden">FCNRAH</span>;
        ISSN:<span class="NLM_cas:issn">1662-5102</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Amyotrophic lateral sclerosis (ALS) is an aggressive multifactorial disease converging on a common pathol.: the degeneration of motor neurons (MNs), their axons and neuromuscular synapses.  This vulnerability and dysfunction of MNs highlights the dependency of these large cells on their intracellular machinery.  Neuronal microtubules (MTs) are intracellular structures that facilitate a myriad of vital neuronal functions, including activity dependent axonal transport.  In ALS, it is becoming increasingly apparent that MTs are likely to be a crit. component of this disease.  Not only are disruptions in this intracellular machinery present in the vast majority of seemingly sporadic cases, recent research has revealed that mutation to a microtubule protein, the tubulin isoform TUBA4A, is sufficient to cause a familial, albeit rare, form of disease.  In both sporadic and familial disease, studies have provided evidence that microtubule mediated deficits in axonal transport are the tipping point for MN survivability.  Axonal transport deficits would lead to abnormal mitochondrial recycling, decreased vesicle and mRNA transport and limited signaling of key survival factors from the neurons peripheral synapses, causing the characteristic peripheral "die back".  This disruption to microtubule dependant transport in ALS has been shown to result from alterations in the phenomenon of microtubule dynamic instability: the rapid growth and shrinkage of microtubule polymers.  This is accomplished primarily due to aberrant alterations to microtubule assocd. proteins (MAPs) that regulate microtubule stability.  Indeed, the current literature would argue that microtubule stability, particularly alterations in their dynamics, may be the initial driving force behind many familial and sporadic insults in ALS.  Pharmacol. stabilization of the microtubule network offers an attractive therapeutic strategy in ALS; indeed it has shown promise in many neurol. disorders, ALS included.  However, the pathophysiol. involvement of MTs and their functions is still poorly understood in ALS.  Future investigations will hopefully uncover further therapeutic targets that may aid in combating this awful disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA5zGQXu-v1rVg90H21EOLACvtfcHk0ljD4XGhqT64kg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotFyisrc%253D&md5=af459cae22b01548a150b0a15a0ac507</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.3389%2Ffncel.2016.00204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffncel.2016.00204%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DJ.%2BA.%26aulast%3DYeaman%26aufirst%3DE.%2BJ.%26aulast%3DBlizzard%26aufirst%3DC.%2BA.%26aulast%3DChuckowree%26aufirst%3DJ.%2BA.%26aulast%3DDickson%26aufirst%3DT.%2BC.%26atitle%3DA%2520case%2520for%2520microtubule%2520vulnerability%2520in%2520Amyotrophic%2520Lateral%2520Sclerosis%253A%2520altered%2520dynamics%2520during%2520disease%26jtitle%3DFront.%2520Cell.%2520Neurosci.%26date%3D2016%26volume%3D10%26spage%3D204%26doi%3D10.3389%2Ffncel.2016.00204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zempel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandelkow, E. M.</span></span> <span> </span><span class="NLM_article-title">Tau missorting and spastin-induced microtubule disruption in neurodege-neration: Alzheimer Disease and Hereditary Spastic Paraplegia</span>. <i>Mol. Neurodegener.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">68</span>, <span class="refDoi">Â DOI: 10.1186/s13024-015-0064-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1186%2Fs13024-015-0064-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=26691836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivVaqtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=68&author=H.+Zempelauthor=E.+M.+Mandelkow&title=Tau+missorting+and+spastin-induced+microtubule+disruption+in+neurodege-neration%3A+Alzheimer+Disease+and+Hereditary+Spastic+Paraplegia&doi=10.1186%2Fs13024-015-0064-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Tau missorting and spastin-induced microtubule disruption in neurodegeneration: Alzheimer Disease and Hereditary Spastic Paraplegia</span></div><div class="casAuthors">Zempel, Hans; Mandelkow, Eva-Maria</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">68/1-68/12</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">In Alzheimer Disease (AD), the mechanistic connection of the two major pathol. hallmarks, namely deposition of Amyloid-beta (AÎ²) in the form of extracellular plaques, and the pathol. changes of the intracellular protein Tau (such as phosphorylation, missorting, aggregation), is not well understood.  Genetic evidence from AD and Down Syndrome (Trisomy 21), and animal models thereof, suggests that aberrant prodn. of AÎ² is upstream of Tau aggregation, but also points to Tau as a crit. effector in the pathol. process.  Yet, the cascade of events leading from increased levels of AÎ² to Tau-dependent toxicity remains a matter of debate.  Using primary neurons exposed to oligomeric forms of AÎ², we have found that Tau becomes mislocalized (missorted) into the somatodendritic compartment.  Missorting of Tau correlates with loss of microtubules and downstream consequences such as loss of mature spines, loss of synaptic activity, and mislocalization of mitochondria.  In this cascade, missorting of Tau induces mislocalization of TTLL6 (Tubulin-Tyrosine-Ligase-Like 6) into the dendrites.  TTLL6 induces polyglutamylation of microtubules, which acts as a trigger for spastin mediated severing of dendritic microtubules.  Loss of microtubules makes cells unable to maintain transport of mitochondria, which in turn results in synaptic dysfunction and loss of mature spines.  These pathol. changes are absent in TauKO derived primary neurons.  Thus, Tau mediated mislocalization of TTLL6 and spastin activation reveals a pathol. gain of function for Tau and spastin in this cellular model system of AD.  In contrast, in hereditary spastic paraplegia (HSP) caused by mutations of the gene encoding spastin (spg4 alias SPAST), spastin function in terms of microtubule severing is decreased at least for the gene product of the mutated allele, resulting in overstable microtubules in disease model systems.  Whether total spastin severing activity or microtubule stability in human disease is also affected is not yet clear.  No human disease has been assocd. so far with the longchain polyglutamylation enzyme TTLL6, or the other TTLLs (1,5,11) possibly involved.  Here we review the findings supporting a role for Tau, spastin and TTLL6 in AD and other tauopathies, HSP and neurodegeneration, and summarize possible therapeutic approaches for AD and HSP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC0nYhPwoKurVg90H21EOLACvtfcHk0liYB46LyguX3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivVaqtQ%253D%253D&md5=cceb873889c43ad6e3fe53f77a53857b</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1186%2Fs13024-015-0064-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13024-015-0064-1%26sid%3Dliteratum%253Aachs%26aulast%3DZempel%26aufirst%3DH.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26atitle%3DTau%2520missorting%2520and%2520spastin-induced%2520microtubule%2520disruption%2520in%2520neurodege-neration%253A%2520Alzheimer%2520Disease%2520and%2520Hereditary%2520Spastic%2520Paraplegia%26jtitle%3DMol.%2520Neurodegener.%26date%3D2015%26volume%3D10%26spage%3D68%26doi%3D10.1186%2Fs13024-015-0064-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mastronardi, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscarello, M. A.</span></span> <span> </span><span class="NLM_article-title">Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis</span>. <i>J. Neurosci. Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>80</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">301</span>â <span class="NLM_lpage">308</span>, <span class="refDoi">Â DOI: 10.1002/jnr.20420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1002%2Fjnr.20420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=15704220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvFaktr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2005&pages=301-308&issue=3&author=F.+G.+Mastronardiauthor=M.+A.+Moscarello&title=Molecules+affecting+myelin+stability%3A+a+novel+hypothesis+regarding+the+pathogenesis+of+multiple+sclerosis&doi=10.1002%2Fjnr.20420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Molecules affecting myelin stability: A novel hypothesis regarding the pathogenesis of multiple sclerosis</span></div><div class="casAuthors">Mastronardi, Fabrizio G.; Moscarello, Mario A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">301-308</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  In this Mini-Review the authors present a new hypothesis in support of the neurodegenerative theory as a mechanism for the pathogenesis of multiple sclerosis (MS).  The pathogenesis of MS results from changes in 2 distinct CNS compartments.  These are the "myelin" and "nonmyelin" compartments.  The myelin compartment is where primary demyelination, amidst attempts at remyelination, is superseded in the CNS by ongoing disease.  Recent evidence obtained via magnetic resonance imaging and spectroscopy techniques supports the view that the normal-appearing white matter (NAWM) in the MS brain is altered.  Several biochem. changes in NAWM were detd.  These include the cationicity of myelin basic protein (MBP) as a result of the action of peptidyl argininedeiminase (PAD) activity converting arginyl residues to citrulline.  The accompanying loss of pos. charge makes myelin susceptible to vesiculation and MBP more susceptible to proteolytic activity.  An increase of MBP autocatalysis in the MS brain might also contribute to the generation of immunodominant epitopes.  Accompanying the destruction of myelin in the myelin compartment is the activation of astrocytes and microglia.  These contribute to the inflammatory response and T-cell activation leading to autoimmunity.  The complex environment that exists in the demyelinating brain also affects the "nonmyelin" compartment.  The inappropriate upregulation of mols., including those of the Jagged-1-Notch-1 signal transduction pathway, affects oligodendrocyte precursor cell (OPC) differentiation.  Other effectors of oligodendrocyte maturation include stathmin, a microtubule-destabilizing protein, which prevents healing in the demyelinating brain.  The hypothesis the authors present suggests a therapeutic strategy that should (1) target the effectors within the myelin compartment and (2) enable resident OPC maturation in the nonmyelin compartment, allowing for effective repair of myelin loss.  The net effect of this new therapeutic strategy is the modification of the disease environment and the stimulation of healing and repair.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhmwhRMQNourVg90H21EOLACvtfcHk0liYB46LyguX3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvFaktr4%253D&md5=8e97a68d991f175e71e9be99efb3189e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fjnr.20420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.20420%26sid%3Dliteratum%253Aachs%26aulast%3DMastronardi%26aufirst%3DF.%2BG.%26aulast%3DMoscarello%26aufirst%3DM.%2BA.%26atitle%3DMolecules%2520affecting%2520myelin%2520stability%253A%2520a%2520novel%2520hypothesis%2520regarding%2520the%2520pathogenesis%2520of%2520multiple%2520sclerosis%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2005%26volume%3D80%26issue%3D3%26spage%3D301%26epage%3D308%26doi%3D10.1002%2Fjnr.20420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">FernÃ¡ndez-Nogales, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos-Galindo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">HernÃ¡ndez, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrera, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, J. J.</span></span> <span> </span><span class="NLM_article-title">Faulty splicing and cytoskeleton abnormalities in Huntingtonâs disease</span>. <i>Brain Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">772</span>â <span class="NLM_lpage">778</span>, <span class="refDoi">Â DOI: 10.1111/bpa.12430</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1111%2Fbpa.12430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=27529534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFKns7vI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=772-778&issue=6&author=M.+Fern%C3%A1ndez-Nogalesauthor=M.+Santos-Galindoauthor=I.+H.+Hern%C3%A1ndezauthor=J.+R.+Cabreraauthor=J.+J.+Lucas&title=Faulty+splicing+and+cytoskeleton+abnormalities+in+Huntington%E2%80%99s+disease&doi=10.1111%2Fbpa.12430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Faulty splicing and cytoskeleton abnormalities in Huntington's disease</span></div><div class="casAuthors">Fernandez-Nogales, Marta; Santos-Galindo, Maria; Hernandez, Ivo H.; Cabrera, Jorge R.; Lucas, Jose J.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Pathology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">772-778</span>CODEN:
                <span class="NLM_cas:coden">BRPAE7</span>;
        ISSN:<span class="NLM_cas:issn">1015-6305</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Huntington's disease (HD) is caused by a CAG-repeat encoding a polyglutamine (polyQ) tract in the huntingtin protein.  There is plenty of evidence of polyQ-driven toxicity.  However, CAG repeat RNA-driven alteration of splicing has recently been proposed in analogy to CUG-repeat diseases.  Here we review the reported alteration of the CAG-repeat assocd. splicing factor SRSF6 in brains of HD patients and mouse models and how this correlates with altered splicing of, at least, two microtubule-assocd. proteins in HD, namely MAPT (tau) and MAP2.  Regarding tau, altered splicing of exon 10 has been reported, along with increased levels and 4R/3R-tau ratio and detection of tau in a new nuclear rod-shaped histopathol. hallmark termed tau nuclear rod (TNR) or tau nuclear indentation (TNI).  These findings, together with an attenuation of HD phenotype in R6/1 mice with tau deficiency and subsequent studies showing increased phosphorylation in mouse models and increased levels in CSF of patients, has led to proposing HD as a tauopathy.  Regarding MAP2, an increase in its juvenile form and a decrease in total MAP2 together with redistribution from dendrites to soma is obsd. in HD patients, which may contribute to the dendritic atrophy in HD.  Furthermore, MAP2 pos. structures filling nuclear indentations have occasionally been found and co-localized with tau.  Therefore, altered MAP function with imbalance in tau/MAP2 content could contribute to HD striatal atrophy and dysfunction.  Besides, TNIs might be indicative of such MAP abnormalities.  TNIs are also found in early pathol. Alzheimer's disease and in tauopathy mice over-expressing mutant 4R-tau.  This indicates that tau alteration is sufficient for TNI detection, which becomes a marker of increased total tau and/or altered 4R/3R-tau ratio and reporter of pathol.-assocd. nuclear indentations.  Altogether, these recent studies suggest that correcting the SRSF6-driven missplicing and/or microtubule-assocd. imbalance might be of therapeutic value in HD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq51-1WKghTN7Vg90H21EOLACvtfcHk0liYB46LyguX3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFKns7vI&md5=68fe7991f3314a3cb9cc3504848495e3</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fbpa.12430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbpa.12430%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Nogales%26aufirst%3DM.%26aulast%3DSantos-Galindo%26aufirst%3DM.%26aulast%3DHern%25C3%25A1ndez%26aufirst%3DI.%2BH.%26aulast%3DCabrera%26aufirst%3DJ.%2BR.%26aulast%3DLucas%26aufirst%3DJ.%2BJ.%26atitle%3DFaulty%2520splicing%2520and%2520cytoskeleton%2520abnormalities%2520in%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DBrain%2520Pathol.%26date%3D2016%26volume%3D26%26issue%3D6%26spage%3D772%26epage%3D778%26doi%3D10.1111%2Fbpa.12430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paula-Barbosa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavares, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadete-Leite, A.</span></span> <span> </span><span class="NLM_article-title">A quantitative study of frontal cortex dendritic microtubules in patients with Alzheimer disease</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>417</i></span>,  <span class="NLM_fpage">139</span>â <span class="NLM_lpage">142</span>, <span class="refDoi">Â DOI: 10.1016/0006-8993(87)90188-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1016%2F0006-8993%2887%2990188-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=3620973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A280%3ADyaL2szgtVyisw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=417&publication_year=1987&pages=139-142&author=M.+Paula-Barbosaauthor=M.+A.+Tavaresauthor=A.+Cadete-Leite&title=A+quantitative+study+of+frontal+cortex+dendritic+microtubules+in+patients+with+Alzheimer+disease&doi=10.1016%2F0006-8993%2887%2990188-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative study of frontal cortex dendritic microtubules in patients with Alzheimer's disease</span></div><div class="casAuthors">Paula-Barbosa M; Tavares M A; Cadete-Leite A</div><div class="citationInfo"><span class="NLM_cas:title">Brain research</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">417</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-42</span>
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">The dendritic microtubules (MT) of the frontal cortex layers II and III were studied in 9 patients with Alzheimer's disease (AD) and the results compared with 9 case controls.  Dendrites with abnormally oriented MTs and others depleted of these structures were seen.  A significant reduction in the number of MTs per unit area was found in AD.  It is suggested that microtubular changes in AD can interfere with neuroplasmic transport and thus, be implicated with the dendritic degeneration present in this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRnvM5iSt7HV2LFM_lbR1VmfW6udTcc2eZvoRfSELdRpLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2szgtVyisw%253D%253D&md5=1ae3f0742de253235860c81347331d00</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2887%2990188-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252887%252990188-0%26sid%3Dliteratum%253Aachs%26aulast%3DPaula-Barbosa%26aufirst%3DM.%26aulast%3DTavares%26aufirst%3DM.%2BA.%26aulast%3DCadete-Leite%26aufirst%3DA.%26atitle%3DA%2520quantitative%2520study%2520of%2520frontal%2520cortex%2520dendritic%2520microtubules%2520in%2520patients%2520with%2520Alzheimer%2520disease%26jtitle%3DBrain%2520Res.%26date%3D1987%26volume%3D417%26spage%3D139%26epage%3D142%26doi%3D10.1016%2F0006-8993%2887%2990188-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rustan, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frey, W. H.</span></span> <span> </span><span class="NLM_article-title">Human brain tubulin purification: decrease in soluble tubulin with age</span>. <i>Neurochem. Res.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">18</span>, <span class="refDoi">Â DOI: 10.1007/BF00964768</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1007%2FBF00964768" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=3982586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADyaL2MXhs1egsrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1985&pages=1-18&author=S.+B.+Yanauthor=S.+Hwangauthor=T.+D.+Rustanauthor=W.+H.+Frey&title=Human+brain+tubulin+purification%3A+decrease+in+soluble+tubulin+with+age&doi=10.1007%2FBF00964768"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Human brain tubulin purification:  decrease in soluble tubulin with age</span></div><div class="casAuthors">Yan, Sau Chi B.; Hwang, Sutaeg; Rustan, Timothy D.; Frey, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-18</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    </div><div class="casAbstract">The sol. tubulin of human cerebral cortex, as assessed by [3H]colchicine binding of the 100,000 g supernatant fraction, decreases drastically with age, 75% from age 0 to age 90.  There is also a considerably lower concn. of high-mol.-wt. proteins in the sol. fraction of postmortem human cerebral cortex than in that of nonhuman species.  Human brain tubulin can be polymd. into microtubules with DEAE-dextran.  The DEAE-dextran-induced microtubules are stable to cold temp. (4Â°) and Ca.  However, in the presence of 1M glutamate, the microtubules become cold labile and depolymerize at 4Â°.  The polymn.-depolymn. steps provided a novel method for purifying polymn.-competent tubulin from fresh or frozen human cerebral cortex.  Human brain tubulin purified by this method is very similar to tubulin from the brains of other mammals in mol. wt., amino acid compn., polymn.-depolymn. parameters, and structural dimensions of the microtubules formed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-DSAkSEpDk7Vg90H21EOLACvtfcHk0ljNJPltxq7emw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXhs1egsrk%253D&md5=2b8b75661ab4f80f959d9beb14995841</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2FBF00964768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00964768%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DS.%2BB.%26aulast%3DHwang%26aufirst%3DS.%26aulast%3DRustan%26aufirst%3DT.%2BD.%26aulast%3DFrey%26aufirst%3DW.%2BH.%26atitle%3DHuman%2520brain%2520tubulin%2520purification%253A%2520decrease%2520in%2520soluble%2520tubulin%2520with%2520age%26jtitle%3DNeurochem.%2520Res.%26date%3D1985%26volume%3D10%26spage%3D1%26epage%3D18%26doi%3D10.1007%2FBF00964768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katsetos, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DrÃ¡ber, P.</span></span> <span> </span><span class="NLM_article-title">Tubulins as therapeutic targets in cancer: from bench to bedside</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">2778</span>â <span class="NLM_lpage">2792</span>, <span class="refDoi">Â DOI: 10.2174/138161212800626193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.2174%2F138161212800626193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=22390762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC38XoslCrs7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=2778-2792&issue=19&author=C.+D.+Katsetosauthor=P.+Dr%C3%A1ber&title=Tubulins+as+therapeutic+targets+in+cancer%3A+from+bench+to+bedside&doi=10.2174%2F138161212800626193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Tubulins as therapeutic targets in cancer: from bench to bedside</span></div><div class="casAuthors">Katsetos, Christos D.; Draber, Pavel</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2778-2792</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Tubulin is the target of some of the most widely used and time-honored anticancer tubulin-binding agents (TBAs).  The clin. usefulness of many TBAs has been held back as a result of tumor cell drug-resistance.  The elucidation of the three-dimensional structure of Î±Î²-tubulin dimer has provided an opportunity for rational drug design aimed at generating compds. that will target tubulin in therapeutically more efficacious ways compared to presently available drugs.  An issue to be addressed is which one(s) of the tubulin species, their isotypes, or their posttranslationally modified forms, should be specifically targeted in cancer chemotherapy.  This review offers a crit. appraisal of current knowledge on tubulins in cancer and an update on new anti-neoplastic microtubule-targeted treatment strategies.  Specifically, it examines, across disciplines, cellular/mol., biochem., clin./pathol., and pharmacol. aspects of Î²-tubulin isotypes, posttranslational modifications of tubulin dimers, Î³-tubulin and microtubule nucleation, and microtubule regulatory proteins.  Emphasis is placed on the overexpression of (i) the Î²III isotypes, which functions as a survival factor assocd. with dynamic instability of microtubules; (ii) Î³-tubulin, a key microtubule nucleating protein; and (iii) the microtubule severing enzyme spastin, involved in cell motility and proliferation of glioblastoma cells.  The role of Î²III-tubulin in resistance of cancer cells to taxanes is examd.  Attention is called to the novel concept that Î²III-tubulin functions as a "gateway" for prosurvival signals in partnership with GTPases, such as GBP1.  Appraisal is also offered on epothilones and the concept of hypersensitization to TBAs as promising therapeutic strategies in taxane resistant epithelial cancers and in high-grade gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxdmReNG2Qw7Vg90H21EOLACvtfcHk0ljNJPltxq7emw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XoslCrs7k%253D&md5=cc9638610d51334759aa081a624f7abe</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2174%2F138161212800626193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161212800626193%26sid%3Dliteratum%253Aachs%26aulast%3DKatsetos%26aufirst%3DC.%2BD.%26aulast%3DDr%25C3%25A1ber%26aufirst%3DP.%26atitle%3DTubulins%2520as%2520therapeutic%2520targets%2520in%2520cancer%253A%2520from%2520bench%2520to%2520bedside%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2012%26volume%3D18%26issue%3D19%26spage%3D2778%26epage%3D2792%26doi%3D10.2174%2F138161212800626193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laggner, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pipp, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hainfellner, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preusser, M.</span></span> <span> </span><span class="NLM_article-title">Immunohistochemical detection of class III beta-tubulin in primary brain tumours: variable expression in most tumour types limits utility as a differential diagnostic marker</span>. <i>Histopathology</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">949</span>â <span class="NLM_lpage">952</span>, <span class="refDoi">Â DOI: 10.1111/j.1365-2559.2007.02696.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1111%2Fj.1365-2559.2007.02696.x" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=949-952&issue=7&author=U.+Laggnerauthor=I.+Pippauthor=H.+Budkaauthor=J.+A.+Hainfellnerauthor=M.+Preusser&title=Immunohistochemical+detection+of+class+III+beta-tubulin+in+primary+brain+tumours%3A+variable+expression+in+most+tumour+types+limits+utility+as+a+differential+diagnostic+marker&doi=10.1111%2Fj.1365-2559.2007.02696.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2559.2007.02696.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2559.2007.02696.x%26sid%3Dliteratum%253Aachs%26aulast%3DLaggner%26aufirst%3DU.%26aulast%3DPipp%26aufirst%3DI.%26aulast%3DBudka%26aufirst%3DH.%26aulast%3DHainfellner%26aufirst%3DJ.%2BA.%26aulast%3DPreusser%26aufirst%3DM.%26atitle%3DImmunohistochemical%2520detection%2520of%2520class%2520III%2520beta-tubulin%2520in%2520primary%2520brain%2520tumours%253A%2520variable%2520expression%2520in%2520most%2520tumour%2520types%2520limits%2520utility%2520as%2520a%2520differential%2520diagnostic%2520marker%26jtitle%3DHistopathology%26date%3D2007%26volume%3D50%26issue%3D7%26spage%3D949%26epage%3D952%26doi%3D10.1111%2Fj.1365-2559.2007.02696.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katsetos, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DrÃ¡berovÃ¡, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legido, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumontet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DrÃ¡ber, P.</span></span> <span> </span><span class="NLM_article-title">Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. Class III beta-tubulin</span>. <i>J. Cell. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>221</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">505</span>â <span class="NLM_lpage">513</span>, <span class="refDoi">Â DOI: 10.1002/jcp.21870</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1002%2Fjcp.21870" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=19650075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtF2qtb7L" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=221&publication_year=2009&pages=505-513&issue=3&author=C.+D.+Katsetosauthor=E.+Dr%C3%A1berov%C3%A1author=A.+Legidoauthor=C.+Dumontetauthor=P.+Dr%C3%A1ber&title=Tubulin+targets+in+the+pathobiology+and+therapy+of+glioblastoma+multiforme.+I.+Class+III+beta-tubulin&doi=10.1002%2Fjcp.21870"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. class III Î²-tubulin</span></div><div class="casAuthors">Katsetos, Christos D.; Draberova, Eduarda; Legido, Agustin; Dumontet, Charles; Draber, Pavel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">221</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">505-513</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Glioblastoma multiforme (GBM) is the most common and deadliest form of primary brain cancer in adults.  Despite advances in mol. biol. and genetics of gliomas currently there is no effective treatment or promising molecularly targeted exptl. therapeutic strategies for these tumors.  In previous studies we have shown aberrant overexpression of the class III Î²-tubulin isotype (Î²III-tubulin) in GBM and have proposed that this change may reflect perturbations in microtubule dynamics assocd. with glioma tumorigenesis, tumor progression and malignant transformation into GBM.  This minireview focuses on microtubules and tubulin as emerging targets in potential therapy of GBM using a new class of Î²III-tubulin-targeted drugs in the light of recent developments concerning the function and potential role of this isotype in clin. aggressive tumor behavior, cancer stem cells, tumor hypoxia and chemoresistance to tubulin binding agents, principally taxanes.  J. Cell. Physiol. 221: 505-513, 2009. Â© 2009 Wiley-Liss, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN1Htsz4QeQrVg90H21EOLACvtfcHk0lhcf9nzoto1gQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtF2qtb7L&md5=b56543debf63e7fd09431d84e3ffccb8</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fjcp.21870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.21870%26sid%3Dliteratum%253Aachs%26aulast%3DKatsetos%26aufirst%3DC.%2BD.%26aulast%3DDr%25C3%25A1berov%25C3%25A1%26aufirst%3DE.%26aulast%3DLegido%26aufirst%3DA.%26aulast%3DDumontet%26aufirst%3DC.%26aulast%3DDr%25C3%25A1ber%26aufirst%3DP.%26atitle%3DTubulin%2520targets%2520in%2520the%2520pathobiology%2520and%2520therapy%2520of%2520glioblastoma%2520multiforme.%2520I.%2520Class%2520III%2520beta-tubulin%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2009%26volume%3D221%26issue%3D3%26spage%3D505%26epage%3D513%26doi%3D10.1002%2Fjcp.21870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
der Veldt, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lammertsma, A. A.</span></span> <span> </span><span class="NLM_article-title">In vivo imaging as a pharmacodynamic marker</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2569</span>â <span class="NLM_lpage">2577</span>, <span class="refDoi">Â DOI: 10.1158/1078-0432.CCR-13-2666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1158%2F1078-0432.CCR-13-2666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=24831279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvF2gt7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=2569-2577&issue=10&author=A.+A.+van%0Ader+Veldtauthor=A.+A.+Lammertsma&title=In+vivo+imaging+as+a+pharmacodynamic+marker&doi=10.1158%2F1078-0432.CCR-13-2666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">In Vivo Imaging as a Pharmacodynamic Marker</span></div><div class="casAuthors">van der Veldt, Astrid A. M.; Lammertsma, Adriaan A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2569-2577</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Although numerous anticancer drugs are widely used in the clinic, many questions remain about pharmacokinetics, biodistribution, toxicities, and efficacy.  Positron emission tomog. (PET) using radiolabeled drugs is a promising method to further understand the clin. behavior of anticancer agents.  In addn., it may contribute to better guided treatment planning in individual patients with cancer.  Among the available anticancer drugs, considerable experience has been gained with radiolabeling taxanes.  At present, two radiolabeled taxanes, paclitaxel and docetaxel, are available as PET tracers.  In the present review, data available for the labeled taxanes [18F]paclitaxel and [11C]docetaxel are discussed and linked to clin. observations following paclitaxel and docetaxel therapy, resp.  In addn., the review discusses the applications and the future of PET using radiolabeled drugs.  Experience gained with [18F]paclitaxel and [11C]docetaxel may be extrapolated to other taxanes and may provide a framework for the development and clin. implementation of other radiolabeled anticancer drugs, even outside the taxane era.  See all articles in this section, "Progress in Pharmacodynamic Endpoints.  " Clin Cancer Res; 20(10); 2569-77. Â©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV0cv7pkx3XLVg90H21EOLACvtfcHk0lhcf9nzoto1gQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvF2gt7g%253D&md5=231d9ed92ef93cba49526922df849a68</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-2666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-2666%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BVeldt%26aufirst%3DA.%2BA.%26aulast%3DLammertsma%26aufirst%3DA.%2BA.%26atitle%3DIn%2520vivo%2520imaging%2520as%2520a%2520pharmacodynamic%2520marker%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2014%26volume%3D20%26issue%3D10%26spage%3D2569%26epage%3D2577%26doi%3D10.1158%2F1078-0432.CCR-13-2666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horwitz, S. B.</span></span> <span> </span><span class="NLM_article-title">TaxolÂ®: The first microtubule stabilizing agent</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1733</span>â <span class="NLM_lpage">1744</span>, <span class="refDoi">Â DOI: 10.3390/ijms18081733</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.3390%2Fijms18081733" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=1733-1744&issue=8&author=C.+H.+Yangauthor=S.+B.+Horwitz&title=Taxol%C2%AE%3A+The+first+microtubule+stabilizing+agent&doi=10.3390%2Fijms18081733"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.3390%2Fijms18081733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms18081733%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DC.%2BH.%26aulast%3DHorwitz%26aufirst%3DS.%2BB.%26atitle%3DTaxol%25C2%25AE%253A%2520The%2520first%2520microtubule%2520stabilizing%2520agent%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2017%26volume%3D18%26issue%3D8%26spage%3D1733%26epage%3D1744%26doi%3D10.3390%2Fijms18081733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. D.</span></span> <span> </span><span class="NLM_article-title">Current advances of tubulin inhibitors in nanoparticle drug delivery and vascular disruption/angiogenesis</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1468</span>â <span class="NLM_lpage">1487</span>, <span class="refDoi">Â DOI: 10.3390/molecules21111468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.3390%2Fmolecules21111468" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=1468-1487&issue=11&author=S.+Banerjeeauthor=D.+J.+Hwangauthor=W.+Liauthor=D.+D.+Miller&title=Current+advances+of+tubulin+inhibitors+in+nanoparticle+drug+delivery+and+vascular+disruption%2Fangiogenesis&doi=10.3390%2Fmolecules21111468"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21111468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21111468%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DHwang%26aufirst%3DD.%2BJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26atitle%3DCurrent%2520advances%2520of%2520tubulin%2520inhibitors%2520in%2520nanoparticle%2520drug%2520delivery%2520and%2520vascular%2520disruption%252Fangiogenesis%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26issue%3D11%26spage%3D1468%26epage%3D1487%26doi%3D10.3390%2Fmolecules21111468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hendrikse, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franssen, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Graaf, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaalburg, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vries, E. G.</span></span> <span> </span><span class="NLM_article-title">Visualization of multidrug resistance in vivo</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">283</span>â <span class="NLM_lpage">293</span>, <span class="refDoi">Â DOI: 10.1007/s002590050390</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1007%2Fs002590050390" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1999&pages=283-293&issue=3&author=N.+H.+Hendrikseauthor=E.+J.+Franssenauthor=W.+T.+van+der%0AGraafauthor=W.+Vaalburgauthor=E.+G.+de+Vries&title=Visualization+of+multidrug+resistance+in+vivo&doi=10.1007%2Fs002590050390"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs002590050390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002590050390%26sid%3Dliteratum%253Aachs%26aulast%3DHendrikse%26aufirst%3DN.%2BH.%26aulast%3DFranssen%26aufirst%3DE.%2BJ.%26aulast%3Dvan%2Bder%2BGraaf%26aufirst%3DW.%2BT.%26aulast%3DVaalburg%26aufirst%3DW.%26aulast%3Dde%2BVries%26aufirst%3DE.%2BG.%26atitle%3DVisualization%2520of%2520multidrug%2520resistance%2520in%2520vivo%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D1999%26volume%3D26%26issue%3D3%26spage%3D283%26epage%3D293%26doi%3D10.1007%2Fs002590050390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Levchenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humm, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augensen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Squire, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kothari, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finn, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, S. M.</span></span> <span> </span><span class="NLM_article-title">Evaluation of 11C-colchicine for PET imaging of multiple drug resistance</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">493</span>â <span class="NLM_lpage">501</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=493-501&issue=3&author=A.+Levchenkoauthor=B.+M.+Mehtaauthor=J.+B.+Leeauthor=J.+L.+Hummauthor=F.+Augensenauthor=O.+Squireauthor=P.+J.+Kothariauthor=R.+D.+Finnauthor=E.+F.+Leonardauthor=S.+M.+Larson&title=Evaluation+of+11C-colchicine+for+PET+imaging+of+multiple+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevchenko%26aufirst%3DA.%26aulast%3DMehta%26aufirst%3DB.%2BM.%26aulast%3DLee%26aufirst%3DJ.%2BB.%26aulast%3DHumm%26aufirst%3DJ.%2BL.%26aulast%3DAugensen%26aufirst%3DF.%26aulast%3DSquire%26aufirst%3DO.%26aulast%3DKothari%26aufirst%3DP.%2BJ.%26aulast%3DFinn%26aufirst%3DR.%2BD.%26aulast%3DLeonard%26aufirst%3DE.%2BF.%26aulast%3DLarson%26aufirst%3DS.%2BM.%26atitle%3DEvaluation%2520of%252011C-colchicine%2520for%2520PET%2520imaging%2520of%2520multiple%2520drug%2520resistance%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2000%26volume%3D41%26issue%3D3%26spage%3D493%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voll, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 2-[11C]methoxy-3,17Î²- estradiol to measure the pharmacokinetics of an antitumor drug candidate, 2-methoxy-3,17Î²-estradiol</span>. <i>J. Labelled Compd. Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1117</span>â <span class="NLM_lpage">1124</span>, <span class="refDoi">Â DOI: 10.1002/jlcr.1131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1002%2Fjlcr.1131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12hu73N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1117-1124&author=J.+Munauthor=R.+J.+Vollauthor=M.+M.+Goodman&title=Synthesis+of+2-%5B11C%5Dmethoxy-3%2C17%CE%B2-+estradiol+to+measure+the+pharmacokinetics+of+an+antitumor+drug+candidate%2C+2-methoxy-3%2C17%CE%B2-estradiol&doi=10.1002%2Fjlcr.1131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 2-[11C]methoxy-3,17Î²-estradiol to measure the pharmacokinetics of an antitumor drug candidate, 2-methoxy-3,17Î²-estradiol</span></div><div class="casAuthors">Mun, Jiyoung; Voll, Ronald J.; Goodman, Mark M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1117-1124</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">2-Methoxy-3,17Î²-estradiol, an endogenous estrogen metabolite, showed cytotoxicity in various cancer cell lines and also has antiangiogenic and proapoptotic activities.  Clin. I and II trials of 2-methoxy-3,17Î²-estradiol for multiple myeloma, advanced solid tumors, metastatic breast and prostate cancer are underway.  We prepd. 2-[11C]methoxy-3,17Î²-estradiol to measure the pharmacokinetics and organ distribution of 2-methoxy-3,17Î²-estradiol in clin. trials.  2-[11C]Methoxy-3,17Î²-estradiol was synthesized from a precursor, 2-hydroxy-3,17Î²-O-bis(methoxymethyl)estradiol, in two steps with over 99% radiochem. purity.  The overall reaction time was 45 min and the decay-cor. radiochem. yield was 32.9%.  The distribution coeff. (logP7.4) of 2-[11C]methoxy-3,17Î²-estradiol at pH 7.4 was measured as 2.95.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-PkUkUO5Jx7Vg90H21EOLACvtfcHk0lhjpN_ae4R5Og"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12hu73N&md5=c8dad2ff26817cbb257c9ffbc42b698a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.1131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.1131%26sid%3Dliteratum%253Aachs%26aulast%3DMun%26aufirst%3DJ.%26aulast%3DVoll%26aufirst%3DR.%2BJ.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26atitle%3DSynthesis%2520of%25202-%255B11C%255Dmethoxy-3%252C17%25CE%25B2-%2520estradiol%2520to%2520measure%2520the%2520pharmacokinetics%2520of%2520an%2520antitumor%2520drug%2520candidate%252C%25202-methoxy-3%252C17%25CE%25B2-estradiol%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2006%26volume%3D49%26spage%3D1117%26epage%3D1124%26doi%3D10.1002%2Fjlcr.1131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voll, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escuin-Borras, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannakakou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span> <span> </span><span class="NLM_article-title">Syntheses and biological activities of novel 2-methoxyestradiol analogs, 2-fluoroethoxyestradiol and 2-fluoropropanoxyestradiol, and a radiosynthesis of 2-[(18)F]fluoroethoxyestradiol for positron emission tomography</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">615</span>â <span class="NLM_lpage">622</span>, <span class="refDoi">Â DOI: 10.1016/j.nucmedbio.2008.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1016%2Fj.nucmedbio.2008.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=18589306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVKnsbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=615-622&issue=5&author=J.+Munauthor=Y.+Wangauthor=R.+J.+Vollauthor=D.+Escuin-Borrasauthor=P.+Giannakakouauthor=M.+M.+Goodman&title=Syntheses+and+biological+activities+of+novel+2-methoxyestradiol+analogs%2C+2-fluoroethoxyestradiol+and+2-fluoropropanoxyestradiol%2C+and+a+radiosynthesis+of+2-%5B%2818%29F%5Dfluoroethoxyestradiol+for+positron+emission+tomography&doi=10.1016%2Fj.nucmedbio.2008.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Syntheses and biological activities of novel 2-methoxyestradiol analogs, 2-fluoroethoxyestradiol and 2-fluoropropanoxyestradiol, and a radiosynthesis of 2-[18F]fluoroethoxyestradiol for positron emission tomography</span></div><div class="casAuthors">Mun, Jiyoung; Wang, Yuefang; Voll, Ronald J.; Escuin-Borras, Daniel; Giannakakou, Paraskevi; Goodman, Mark M.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">615-622</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Introduction: 2-Methoxyestradiol (2ME2) is an endogenous metabolite of the human hormone, estrogen, which has been shown to possess antitumor activity.  2-Fluoroethoxyestradiol (2FEE2) and 2-fluoropropanoxyestradiol (2FPE2), novel analogs of 2-methoxyestradiol, were designed and synthesized to be utilized as F-18 radiotracers for positron emission tomog. (PET), with which the biodistribution and intratumoral accumulations of 2ME2 could be measured in vivo for potential translation to human use.  Methods: 2FEE2 and 2FPE2 were synthesized from 3,17Î²-estradiol in five steps resp.  Drug-induced microtubule depolymn., antiproliferative activity against human cancer cell lines and HIF-1Î± down-regulation by 2FEE2 and 2FPE2 were investigated to examine whether these mols. possess similar antitumor activities as 2-methoxyestradiol.  2-[18F]Fluoroethoxyestradiol was synthesized for PET.  Results: Novel 2ME2 analogs, 2FEE2 and 2FPE2, were synthesized in 29% and 22% overall yield, resp.  2FEE2 and 2FPE2 showed microtubule depolymn. and cytotoxicities against the human ovarian carcinoma cell line, 1A9, and the human glioma cell line, LN229.  HIF-1Î± was down-regulated by 2FEE2 and 2FPE2 under hypoxic conditions.  2-[18F]Fluoroethoxyestradiol (2[18F]FEE2) was prepd. in 8.3% decay-cor. yield in 90 min, based on a prodn. of H[18F]F with more than 98% radiochem. purity.  2FEE2 was chosen as an F-18 radiotracer candidate, since it showed stronger antiproliferative activity than 2ME2 and 2FPE2.  Conclusions: 2FEE2 and 2FPE2 showed similar activity as 2ME2.  2[18F]FEE2 was synthesized to be utilized as a PET radiotracer to measure the biol. efficacy of 2ME2 and its analogs in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotNF4CS9v9_bVg90H21EOLACvtfcHk0lhjpN_ae4R5Og"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVKnsbo%253D&md5=0c5dfd7cf1a36448225fb95ec242ba7a</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2008.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2008.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DMun%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DVoll%26aufirst%3DR.%2BJ.%26aulast%3DEscuin-Borras%26aufirst%3DD.%26aulast%3DGiannakakou%26aufirst%3DP.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26atitle%3DSyntheses%2520and%2520biological%2520activities%2520of%2520novel%25202-methoxyestradiol%2520analogs%252C%25202-fluoroethoxyestradiol%2520and%25202-fluoropropanoxyestradiol%252C%2520and%2520a%2520radiosynthesis%2520of%25202-%255B%252818%2529F%255Dfluoroethoxyestradiol%2520for%2520positron%2520emission%2520tomography%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2008%26volume%3D35%26issue%3D5%26spage%3D615%26epage%3D622%26doi%3D10.1016%2Fj.nucmedbio.2008.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jalilian, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seyfi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afarideh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shafiee, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a [18F]labeled chelidonine derivative as a possible antitumor agent</span>. <i>Appl. Radiat. Isot.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">407</span>â <span class="NLM_lpage">411</span>, <span class="refDoi">Â DOI: 10.1016/S0969-8043(00)00270-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1016%2FS0969-8043%2800%2900270-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=11214874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtVWlu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2001&pages=407-411&issue=3&author=A.+R.+Jalilianauthor=P.+Seyfiauthor=H.+Afaridehauthor=A.+Shafiee&title=Synthesis+of+a+%5B18F%5Dlabeled+chelidonine+derivative+as+a+possible+antitumor+agent&doi=10.1016%2FS0969-8043%2800%2900270-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a [18F]labeled chelidonine derivative as a possible antitumor agent</span></div><div class="casAuthors">Jalilian, A. R.; Seyfi, P.; Afarideh, H.; Shafiee, A.</div><div class="citationInfo"><span class="NLM_cas:title">Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">407-411</span>CODEN:
                <span class="NLM_cas:coden">ARISEF</span>;
        ISSN:<span class="NLM_cas:issn">0969-8043</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">{(Â±)-[5BRS-(5bÎ±,6Î²,12bÎ±)]-5b,6,7,12b,13,14-hexahydro-13-methyl[1,3]benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridin-6-yl}-4-[18F]-fluorobenzoate (I) an arom. ester of (Â±)-chelidonine was prepd. as a possible PET radiotracer.  I was prepd. in no-carrier-added (n.c.a) form from the 4-N,N,N-trimethylanilinium triflate deriv. in one step.  The best results were obtained using Kryptofix2.2.2/[18F] and DMSO as the solvent at 90Â°C.  Column chromatog. afforded the desired compd. in overall radiochem. yield of 65-70% (EOS) with a specific activity of about 3000 Ci/mmole and radiochem. purity greater than 95% in 15 min.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGRK7LzWWDwbVg90H21EOLACvtfcHk0lhjpN_ae4R5Og"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtVWlu7c%253D&md5=ef6ff1fc16f3623541bf8fcc8aa2fbf5</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0969-8043%2800%2900270-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8043%252800%252900270-0%26sid%3Dliteratum%253Aachs%26aulast%3DJalilian%26aufirst%3DA.%2BR.%26aulast%3DSeyfi%26aufirst%3DP.%26aulast%3DAfarideh%26aufirst%3DH.%26aulast%3DShafiee%26aufirst%3DA.%26atitle%3DSynthesis%2520of%2520a%2520%255B18F%255Dlabeled%2520chelidonine%2520derivative%2520as%2520a%2520possible%2520antitumor%2520agent%26jtitle%3DAppl.%2520Radiat.%2520Isot.%26date%3D2001%26volume%3D54%26issue%3D3%26spage%3D407%26epage%3D411%26doi%3D10.1016%2FS0969-8043%2800%2900270-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kasibhatla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baichwal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skvortsova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skvortsov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">English, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirisoma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pervin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pleiman, C. M.</span></span> <span> </span><span class="NLM_article-title">MPC-6827: a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5865</span>â <span class="NLM_lpage">5871</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-07-0127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1158%2F0008-5472.CAN-07-0127" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=5865-5871&issue=12&author=S.+Kasibhatlaauthor=V.+Baichwalauthor=S.+X.+Caiauthor=B.+Rothauthor=I.+Skvortsovaauthor=S.+Skvortsovauthor=P.+Lukasauthor=N.+M.+Englishauthor=N.+Sirisomaauthor=J.+Dreweauthor=A.+Pervinauthor=B.+Tsengauthor=R.+O.+Carlsonauthor=C.+M.+Pleiman&title=MPC-6827%3A+a+small-molecule+inhibitor+of+microtubule+formation+that+is+not+a+substrate+for+multidrug+resistance+pumps&doi=10.1158%2F0008-5472.CAN-07-0127"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-0127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-0127%26sid%3Dliteratum%253Aachs%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DBaichwal%26aufirst%3DV.%26aulast%3DCai%26aufirst%3DS.%2BX.%26aulast%3DRoth%26aufirst%3DB.%26aulast%3DSkvortsova%26aufirst%3DI.%26aulast%3DSkvortsov%26aufirst%3DS.%26aulast%3DLukas%26aufirst%3DP.%26aulast%3DEnglish%26aufirst%3DN.%2BM.%26aulast%3DSirisoma%26aufirst%3DN.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DPervin%26aufirst%3DA.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DCarlson%26aufirst%3DR.%2BO.%26aulast%3DPleiman%26aufirst%3DC.%2BM.%26atitle%3DMPC-6827%253A%2520a%2520small-molecule%2520inhibitor%2520of%2520microtubule%2520formation%2520that%2520is%2520not%2520a%2520substrate%2520for%2520multidrug%2520resistance%2520pumps%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26issue%3D12%26spage%3D5865%26epage%3D5871%26doi%3D10.1158%2F0008-5472.CAN-07-0127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sirisoma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pervin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willardsen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mather, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pleiman, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasibhatla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, S. X.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-(4-methoxyphenyl)-N,2-dimethylquina- zolin-4-amine, a potent apoptosis inducer and efficacious anticancer agent with high blood brain barrier penetration</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2341</span>â <span class="NLM_lpage">2351</span>, <span class="refDoi">Â DOI: 10.1021/jm801315b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801315b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2341-2351&issue=8&author=N.+Sirisomaauthor=A.+Pervinauthor=H.+Zhangauthor=S.+Jiangauthor=J.+A.+Willardsenauthor=M.+B.+Andersonauthor=G.+Matherauthor=C.+M.+Pleimanauthor=S.+Kasibhatlaauthor=B.+Tsengauthor=J.+Dreweauthor=S.+X.+Cai&title=Discovery+of+N-%284-methoxyphenyl%29-N%2C2-dimethylquina-+zolin-4-amine%2C+a+potent+apoptosis+inducer+and+efficacious+anticancer+agent+with+high+blood+brain+barrier+penetration&doi=10.1021%2Fjm801315b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm801315b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801315b%26sid%3Dliteratum%253Aachs%26aulast%3DSirisoma%26aufirst%3DN.%26aulast%3DPervin%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26aulast%3DAnderson%26aufirst%3DM.%2BB.%26aulast%3DMather%26aufirst%3DG.%26aulast%3DPleiman%26aufirst%3DC.%2BM.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%2520N-%25284-methoxyphenyl%2529-N%252C2-dimethylquina-%2520zolin-4-amine%252C%2520a%2520potent%2520apoptosis%2520inducer%2520and%2520efficacious%2520anticancer%2520agent%2520with%2520high%2520blood%2520brain%2520barrier%2520penetration%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D8%26spage%3D2341%26epage%3D2351%26doi%3D10.1021%2Fjm801315b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Resch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ficner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schobert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biersack, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, T.</span></span> <span> </span><span class="NLM_article-title">Effects of the tumor-vasculature-disrupting agent verubulin and two heteroaryl analogues on cancer cells, endothelial cells, and blood vessels</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">847</span>â <span class="NLM_lpage">854</span>, <span class="refDoi">Â DOI: 10.1002/cmdc.201300531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1002%2Fcmdc.201300531" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=847-854&issue=4&author=K.+Mahalauthor=M.+Reschauthor=R.+Ficnerauthor=R.+Schobertauthor=B.+Biersackauthor=T.+Mueller&title=Effects+of+the+tumor-vasculature-disrupting+agent+verubulin+and+two+heteroaryl+analogues+on+cancer+cells%2C+endothelial+cells%2C+and+blood+vessels&doi=10.1002%2Fcmdc.201300531"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300531%26sid%3Dliteratum%253Aachs%26aulast%3DMahal%26aufirst%3DK.%26aulast%3DResch%26aufirst%3DM.%26aulast%3DFicner%26aufirst%3DR.%26aulast%3DSchobert%26aufirst%3DR.%26aulast%3DBiersack%26aufirst%3DB.%26aulast%3DMueller%26aufirst%3DT.%26atitle%3DEffects%2520of%2520the%2520tumor-vasculature-disrupting%2520agent%2520verubulin%2520and%2520two%2520heteroaryl%2520analogues%2520on%2520cancer%2520cells%252C%2520endothelial%2520cells%252C%2520and%2520blood%2520vessels%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26issue%3D4%26spage%3D847%26epage%3D854%26doi%3D10.1002%2Fcmdc.201300531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chamberlain, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phuphanich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Recht, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenfeld, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadul, C. E.</span></span> <span> </span><span class="NLM_article-title">Brain tumor investigational consortium. A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the Brain Tumor Investigational Consortium (BTIC)</span>. <i>J. Neuro-Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>118</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">335</span>â <span class="NLM_lpage">343</span>, <span class="refDoi">Â DOI: 10.1007/s11060-014-1437-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1007%2Fs11060-014-1437-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=24740196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpt1Oit7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2014&pages=335-343&issue=2&author=M.+C.+Chamberlainauthor=S.+Grimmauthor=S.+Phuphanichauthor=L.+Rechtauthor=J.+Z.+Zhuauthor=L.+Kimauthor=S.+Rosenfeldauthor=C.+E.+Fadul&title=Brain+tumor+investigational+consortium.+A+phase+2+trial+of+verubulin+for+recurrent+glioblastoma%3A+a+prospective+study+by+the+Brain+Tumor+Investigational+Consortium+%28BTIC%29&doi=10.1007%2Fs11060-014-1437-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the brain tumor investigational consortium (BTIC)</span></div><div class="casAuthors">Chamberlain, Marc C.; Grimm, Sean; Phuphanich, Surasak; Recht, Larry; Zhu, Jay Z.; Kim, Lyndon; Rosenfeld, Steve; Fadul, Camilo E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuro-Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">335-343</span>CODEN:
                <span class="NLM_cas:coden">JNODD2</span>;
        ISSN:<span class="NLM_cas:issn">0167-594X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Treatment options are limited for recurrent glioblastoma (GBM).  Verubulin is a microtubule destabilizer and vascular disrupting agent that achieve high brain concn. relative to plasma in animals.  Adults with recurrent GBM who failed prior std. therapy were eligible.  The primary endpoint was 1-mo progression-free survival (PFS-1) for bevacizumab refractory (Group 2) and 6-mo progression-free survival (PFS-6) for bevacizumab naive patients (Group 1).  Verubulin was administered at 3.3 mg/m2 as a 2-h i.v. infusion once weekly for 3 consecutive weeks in a 4-wk cycle.  The planned sample size was 34 subjects per cohort. 56 patients (37 men, 19 women) were enrolled, 31 in Group 1 and 25 in Group 2.  The PFS-6 for Group 1 was 14 % and the PFS-1 for Group 2 was 20 %.  Median survival from onset of treatment was 9.5 mo in Group 1 and 3.4 mo in Group 2.  Best overall response was partial response (n = 3; 10 % in Group 1; n = 1; 4.2 % in Group 2) and stable disease (n = 7; 23 % in Group 1; n = 5; 21 % in Group 2).  In Group 1, 38.7 % of patients experienced a serious adverse event; however only 3.2 % were potentially attributable to study drug.  In Group 2, 44 % of patients experienced a serious adverse event although none were attributable to study drug.  Accrual was terminated early for futility.  Single agent verubulin, in this dose and schedule, is well tolerated, assocd. with moderate but tolerable toxicity but has limited activity in either bevacizumab naive or refractory recurrent GBM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomdh3oV1Ivk7Vg90H21EOLACvtfcHk0lioTtTt6SNgIw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpt1Oit7Y%253D&md5=9d0edc9a438512b437c0b661fadfe84d</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1007%2Fs11060-014-1437-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11060-014-1437-y%26sid%3Dliteratum%253Aachs%26aulast%3DChamberlain%26aufirst%3DM.%2BC.%26aulast%3DGrimm%26aufirst%3DS.%26aulast%3DPhuphanich%26aufirst%3DS.%26aulast%3DRecht%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DJ.%2BZ.%26aulast%3DKim%26aufirst%3DL.%26aulast%3DRosenfeld%26aufirst%3DS.%26aulast%3DFadul%26aufirst%3DC.%2BE.%26atitle%3DBrain%2520tumor%2520investigational%2520consortium.%2520A%2520phase%25202%2520trial%2520of%2520verubulin%2520for%2520recurrent%2520glioblastoma%253A%2520a%2520prospective%2520study%2520by%2520the%2520Brain%2520Tumor%2520Investigational%2520Consortium%2520%2528BTIC%2529%26jtitle%3DJ.%2520Neuro-Oncol.%26date%3D2014%26volume%3D118%26issue%3D2%26spage%3D335%26epage%3D343%26doi%3D10.1007%2Fs11060-014-1437-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grossmann, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akerley, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glantz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beelen, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Groot, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aiken, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, R. L.</span></span> <span> </span><span class="NLM_article-title">Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme</span>. <i>J. Neuro-Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>110</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">257</span>â <span class="NLM_lpage">264</span>, <span class="refDoi">Â DOI: 10.1007/s11060-012-0964-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1007%2Fs11060-012-0964-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=22932984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFagsrrI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2012&pages=257-264&issue=2&author=K.+F.+Grossmannauthor=H.+Colmanauthor=W.+A.+Akerleyauthor=M.+Glantzauthor=Y.+Matsuokoauthor=A.+P.+Beelenauthor=M.+Yuauthor=J.+F.+De+Grootauthor=R.+D.+Aikenauthor=J.+J.+Olsenauthor=B.+A.+Evansauthor=R.+L.+Jensen&title=Phase+I+trial+of+verubulin+%28MPC-6827%29+plus+carboplatin+in+patients+with+relapsed+glioblastoma+multiforme&doi=10.1007%2Fs11060-012-0964-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme</span></div><div class="casAuthors">Grossmann, Kenneth F.; Colman, Howard; Akerley, Wallace A.; Glantz, Michael; Matsuoko, Yuko; Beelen, Andrew P.; Yu, Margaret; Groot, John F.; Aiken, Robert D.; Olsen, Jeffery J.; Evans, Brent A.; Jensen, Randy L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuro-Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">257-264</span>CODEN:
                <span class="NLM_cas:coden">JNODD2</span>;
        ISSN:<span class="NLM_cas:issn">0167-594X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Verubulin (MPC-6827) is a microtubule-destabilizing agent that achieves high concns. in the brain.  Verubulin disrupts newly formed blood vessels in xenografts.  We detd. the safety and tolerability of verubulin administered in combination with carboplatin in patients with relapsed glioblastoma multiforme (GBM).  Three pre-selected doses of verubulin were tested: 2.1, 2.7, and 3.3 mg/m2 in a std. "3+3" design.  Verubulin was given every second week of a 6-wk cycle in the 2.1 mg/m2 cohort or weekly for 3 wk of a 4-wk cycle in subsequent cohorts.  Carboplatin was administered i.v. at an area under the curve (AUC) dosage 4 every 2 wk for the 2.1 mg/m2 cohort or on day 1 of each 4-wk cycle in subsequent cohorts.  Nineteen patients with GBM in first or second relapse were enrolled.  Four patients (21 %) experienced a grade 3 or greater verubulin- or carboplatin-related adverse event, including hypesthesia, cerebral ischemia, anemia, and thrombocytopenia.  The mean plasma half life of verubulin was 3.2 h (SD = 0.82).  Two patients achieved at least a partial response by Macdonald criteria.  One of these patients remains progression free and off treatment more than 24 mo beyond his initiation of verubulin.  Five patients had stable disease.  Median progression-free survival (PFS) across all patients was 8 wk, and the 6-mo PFS rate was 21 %.  The combination of verubulin at the previously detd. single-agent max. tolerated dose of 3.3 mg/m2 with carboplatin in patients with recurrent/refractory GBM is safe and well tolerated.  In this patient population with a highly vascularized tumor, no cerebral hemorrhage was obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzTGKu9Dd7kLVg90H21EOLACvtfcHk0ljMod7rOOY8lg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFagsrrI&md5=460e95d82078c2bff2334cac6eda0f9c</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1007%2Fs11060-012-0964-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11060-012-0964-7%26sid%3Dliteratum%253Aachs%26aulast%3DGrossmann%26aufirst%3DK.%2BF.%26aulast%3DColman%26aufirst%3DH.%26aulast%3DAkerley%26aufirst%3DW.%2BA.%26aulast%3DGlantz%26aufirst%3DM.%26aulast%3DMatsuoko%26aufirst%3DY.%26aulast%3DBeelen%26aufirst%3DA.%2BP.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DDe%2BGroot%26aufirst%3DJ.%2BF.%26aulast%3DAiken%26aufirst%3DR.%2BD.%26aulast%3DOlsen%26aufirst%3DJ.%2BJ.%26aulast%3DEvans%26aufirst%3DB.%2BA.%26aulast%3DJensen%26aufirst%3DR.%2BL.%26atitle%3DPhase%2520I%2520trial%2520of%2520verubulin%2520%2528MPC-6827%2529%2520plus%2520carboplatin%2520in%2520patients%2520with%2520relapsed%2520glioblastoma%2520multiforme%26jtitle%3DJ.%2520Neuro-Oncol.%26date%3D2012%26volume%3D110%26issue%3D2%26spage%3D257%26epage%3D264%26doi%3D10.1007%2Fs11060-012-0964-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsimberidou, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akerley, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schabel, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uehara, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chhabra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mather, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodland, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swabb, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurzrock, R.</span></span> <span> </span><span class="NLM_article-title">Phase I clinical trial of MPC-6827 (Azixa), a microtubule destabilizing agent, in patients with advanced cancer</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">3410</span>â <span class="NLM_lpage">3419</span>, <span class="refDoi">Â DOI: 10.1158/1535-7163.MCT-10-0516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1158%2F1535-7163.MCT-10-0516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=21159616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGrsLjN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=3410-3419&issue=12&author=A.+M.+Tsimberidouauthor=W.+Akerleyauthor=M.+C.+Schabelauthor=D.+S.+Hongauthor=C.+Ueharaauthor=A.+Chhabraauthor=T.+Warrenauthor=G.+G.+Matherauthor=B.+A.+Evansauthor=D.+P.+Woodlandauthor=E.+A.+Swabbauthor=R.+Kurzrock&title=Phase+I+clinical+trial+of+MPC-6827+%28Azixa%29%2C+a+microtubule+destabilizing+agent%2C+in+patients+with+advanced+cancer&doi=10.1158%2F1535-7163.MCT-10-0516"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I Clinical Trial of MPC-6827 (Azixa), a Microtubule Destabilizing Agent, in Patients with Advanced Cancer</span></div><div class="casAuthors">Tsimberidou, Apostolia-Maria; Akerley, Wallace; Schabel, Matthias C.; Hong, David S.; Uehara, Cynthia; Chhabra, Anil; Warren, Terri; Mather, Gary G.; Evans, Brent A.; Woodland, Deane P.; Swabb, Edward A.; Kurzrock, Razelle</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3410-3419</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">MPC-6827 (Azixa) is a small-mol. microtubule-destabilizing agent that binds to the same (or nearby) sites on Î²-tubulin as colchicine.  This phase I study was designed to det. the dose-limiting toxicities (DLT), max. tolerated dose (MTD), and pharmacokinetics (PK) of MPC-6827 in patients with solid tumors.  Patients with advanced/metastatic cancer were treated with once-weekly, 1- to 2-h i.v. administration of MPC-6827 for 3 consecutive weeks every 28 days (1 cycle).  Dose escalation began with 0.3, 0.6, 1, and 1.5 mg/m2, with subsequent increments of 0.6 mg/m2 until the MTD was detd.  A 3 + 3 design was used.  Pharmacokinetics of MPC-6827 and its metabolite MPI-0440627 were evaluated.  Forty-eight patients received therapy; 79 cycles were completed (median, 1; range, 1-10).  The most common adverse events were nausea, fatigue, flushing, and hyperglycemia.  The DLT was nonfatal grade 3 myocardial infarction at 3.9 mg/m2 (1/6 patients) and at 4.5 mg/m2 (1/7 patients).  The MTD was detd. to be 3.3 mg/m2 (0/13 patients had a DLT).  Five (10.4%) of the 48 patients achieved stable disease (Response Evaluation Criteria in Solid Tumors) for 4 mo or greater.  MPC-6827 has a high vol. of distribution and clearance.  Half-life ranged from 3.8 to 7.5 h.  In conclusion, MPC-6827 administered i.v. over 2 h at a dose of 3.3 mg/m2 once weekly for 3 wk every 28 days was safe in patients with heavily pretreated cancer.  Clin. trials with MPC-6827 and chemotherapy are ongoing.  Mol Cancer Ther; 9(12); 3410-9.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQxB3bYYYZ1rVg90H21EOLACvtfcHk0ljMod7rOOY8lg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGrsLjN&md5=97b0a255d67eec98f8bd7c3709cdcf6c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-0516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-0516%26sid%3Dliteratum%253Aachs%26aulast%3DTsimberidou%26aufirst%3DA.%2BM.%26aulast%3DAkerley%26aufirst%3DW.%26aulast%3DSchabel%26aufirst%3DM.%2BC.%26aulast%3DHong%26aufirst%3DD.%2BS.%26aulast%3DUehara%26aufirst%3DC.%26aulast%3DChhabra%26aufirst%3DA.%26aulast%3DWarren%26aufirst%3DT.%26aulast%3DMather%26aufirst%3DG.%2BG.%26aulast%3DEvans%26aufirst%3DB.%2BA.%26aulast%3DWoodland%26aufirst%3DD.%2BP.%26aulast%3DSwabb%26aufirst%3DE.%2BA.%26aulast%3DKurzrock%26aufirst%3DR.%26atitle%3DPhase%2520I%2520clinical%2520trial%2520of%2520MPC-6827%2520%2528Azixa%2529%252C%2520a%2520microtubule%2520destabilizing%2520agent%252C%2520in%2520patients%2520with%2520advanced%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26issue%3D12%26spage%3D3410%26epage%3D3419%26doi%3D10.1158%2F1535-7163.MCT-10-0516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lockman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klimova, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willardsen, J. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of substituted quinazolines: Application to the synthesis of verubulin</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1715</span>â <span class="NLM_lpage">1723</span>, <span class="refDoi">Â DOI: 10.1080/00397911.2010.529730</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1080%2F00397911.2010.529730" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVGhsb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2012&pages=1715-1723&issue=12&author=J.+W.+Lockmanauthor=Y.+Klimovaauthor=M.+B.+Andersonauthor=J.+A.+Willardsen&title=Synthesis+of+substituted+quinazolines%3A+Application+to+the+synthesis+of+verubulin&doi=10.1080%2F00397911.2010.529730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of substituted quinazolines: application to the synthesis of verubulin</span></div><div class="casAuthors">Lockman, Jeffrey W.; Klimova, Yevgeniya; Anderson, Mark B.; Willardsen, J. Adam</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1715-1723</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Through newly adapted methodol., 2-methyl-3H-quinazolin-4-one was activated using a no. of methods followed by displacement to afford 4-aminoquinazolines.  The most useful of these processes utilize the p-toluenesulfonate ester or I2/PPh3 activation.  Using this methodol., the anticancer vascular targeting clin. candidate verubulin (I) was synthesized in a highly efficient manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJpMEOVLXHuLVg90H21EOLACvtfcHk0ljMod7rOOY8lg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVGhsb8%253D&md5=a1563ba9daffe1f09b571718867cbd20</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1080%2F00397911.2010.529730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397911.2010.529730%26sid%3Dliteratum%253Aachs%26aulast%3DLockman%26aufirst%3DJ.%2BW.%26aulast%3DKlimova%26aufirst%3DY.%26aulast%3DAnderson%26aufirst%3DM.%2BB.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26atitle%3DSynthesis%2520of%2520substituted%2520quinazolines%253A%2520Application%2520to%2520the%2520synthesis%2520of%2520verubulin%26jtitle%3DSynth.%2520Commun.%26date%3D2012%26volume%3D42%26issue%3D12%26spage%3D1715%26epage%3D1723%26doi%3D10.1080%2F00397911.2010.529730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houle, S.</span></span> <span> </span><span class="NLM_article-title">An admonition when measuring the lipophilicity of radiotracers using counting techniques</span>. <i>Appl. Radiat. Isot.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">203</span>â <span class="NLM_lpage">208</span>, <span class="refDoi">Â DOI: 10.1016/S0969-8043(00)00269-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1016%2FS0969-8043%2800%2900269-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=11200881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovFSrtLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2001&pages=203-208&issue=2&author=A.+A.+Wilsonauthor=L.+Jinauthor=A.+Garciaauthor=J.+N.+DaSilvaauthor=S.+Houle&title=An+admonition+when+measuring+the+lipophilicity+of+radiotracers+using+counting+techniques&doi=10.1016%2FS0969-8043%2800%2900269-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">An admonition when measuring the lipophilicity of radiotracers using counting techniques</span></div><div class="casAuthors">Wilson, A. A.; Jin, L.; Garcia, A.; DaSilva, J. N.; Houle, S.</div><div class="citationInfo"><span class="NLM_cas:title">Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">203-208</span>CODEN:
                <span class="NLM_cas:coden">ARISEF</span>;
        ISSN:<span class="NLM_cas:issn">0969-8043</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Log P measurements are a fundamental physico-chem. parameter and one of the cornerstones of structure-activity relationships in medicinal chem.  Despite the attractiveness of the method, the use of counting techniques to measure the log P of lipophilic radiotracers is fraught with pitfalls due to the amplifying effects of small quantities of radioactive impurities.  For example, a radiotracer with a log P of 4 contg. only 0.1% of a radioactive impurity with a log P of -1 will have an apparent log P of 3 if measured using conventional shake-flask partition techniques, counting the radioactivity in each phase.  However, pre-washing the radiotracer-contg. org. phase with aq. phase can, in many cases, allay doubts about the validity of such measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr80UKR8GWYeLVg90H21EOLACvtfcHk0liptd4qiGAKTw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovFSrtLc%253D&md5=452528ce86fd39c9bb6368f83f24df07</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0969-8043%2800%2900269-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8043%252800%252900269-4%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DA.%2BA.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DGarcia%26aufirst%3DA.%26aulast%3DDaSilva%26aufirst%3DJ.%2BN.%26aulast%3DHoule%26aufirst%3DS.%26atitle%3DAn%2520admonition%2520when%2520measuring%2520the%2520lipophilicity%2520of%2520radiotracers%2520using%2520counting%2520techniques%26jtitle%3DAppl.%2520Radiat.%2520Isot.%26date%3D2001%26volume%3D54%26issue%3D2%26spage%3D203%26epage%3D208%26doi%3D10.1016%2FS0969-8043%2800%2900269-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solingapuram
Sai, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattiraju, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almaguel, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craft, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mintz, A.</span></span> <span> </span><span class="NLM_article-title">Radiolabeling and initial biological evaluation of [18F]KBM-1 for imaging RAR-a receptors in neuroblastoma</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1425</span>â <span class="NLM_lpage">1427</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2017.01.093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1016%2Fj.bmcl.2017.01.093" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=1425-1427&issue=6&author=K.+K.+Solingapuram%0ASaiauthor=B.+C.+Dasauthor=A.+Sattirajuauthor=F.+G.+Almaguelauthor=S.+Craftauthor=A.+Mintz&title=Radiolabeling+and+initial+biological+evaluation+of+%5B18F%5DKBM-1+for+imaging+RAR-a+receptors+in+neuroblastoma&doi=10.1016%2Fj.bmcl.2017.01.093"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.01.093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.01.093%26sid%3Dliteratum%253Aachs%26aulast%3DSolingapuram%2BSai%26aufirst%3DK.%2BK.%26aulast%3DDas%26aufirst%3DB.%2BC.%26aulast%3DSattiraju%26aufirst%3DA.%26aulast%3DAlmaguel%26aufirst%3DF.%2BG.%26aulast%3DCraft%26aufirst%3DS.%26aulast%3DMintz%26aufirst%3DA.%26atitle%3DRadiolabeling%2520and%2520initial%2520biological%2520evaluation%2520of%2520%255B18F%255DKBM-1%2520for%2520imaging%2520RAR-a%2520receptors%2520in%2520neuroblastoma%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26issue%3D6%26spage%3D1425%26epage%3D1427%26doi%3D10.1016%2Fj.bmcl.2017.01.093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solingapuram
Sai, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabhakaran, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattiraju, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mintz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, J. S. D.</span></span> <span> </span><span class="NLM_article-title">Radiosynthesis and evaluation of IGF1R PET ligand [11C]GSK1838705A, Bioorg</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">2895</span>â <span class="NLM_lpage">2897</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2017.04.085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1016%2Fj.bmcl.2017.04.085" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2895-2897&issue=13&author=K.+K.+Solingapuram%0ASaiauthor=J.+Prabhakaranauthor=A.+Sattirajuauthor=J.+J.+Mannauthor=A.+Mintzauthor=J.+S.+D.+Kumar&title=Radiosynthesis+and+evaluation+of+IGF1R+PET+ligand+%5B11C%5DGSK1838705A%2C+Bioorg&doi=10.1016%2Fj.bmcl.2017.04.085"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.04.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.04.085%26sid%3Dliteratum%253Aachs%26aulast%3DSolingapuram%2BSai%26aufirst%3DK.%2BK.%26aulast%3DPrabhakaran%26aufirst%3DJ.%26aulast%3DSattiraju%26aufirst%3DA.%26aulast%3DMann%26aufirst%3DJ.%2BJ.%26aulast%3DMintz%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DJ.%2BS.%2BD.%26atitle%3DRadiosynthesis%2520and%2520evaluation%2520of%2520IGF1R%2520PET%2520ligand%2520%255B11C%255DGSK1838705A%252C%2520Bioorg%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26issue%3D13%26spage%3D2895%26epage%3D2897%26doi%3D10.1016%2Fj.bmcl.2017.04.085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 8 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Kiran
Kumar Solingapuram Sai, Jaya Prabhakaran, Gayathri Ramanathan, Stephanie Rideout, Christopher Whitlow, Akiva Mintz, J. John Mann, <span class="NLM_string-name hlFld-ContribAuthor">J. S. Dileep Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Radiosynthesis and Evaluation of [11C]HD-800, a High Affinity Brain Penetrant PET Tracer for Imaging Microtubules. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (5)
                                     , 452-456. <a href="https://doi.org/10.1021/acsmedchemlett.8b00060" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00060%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DRadiosynthesis%252Band%252BEvaluation%252Bof%252B%25255B11C%25255DHD-800%25252C%252Ba%252BHigh%252BAffinity%252BBrain%252BPenetrant%252BPET%252BTracer%252Bfor%252BImaging%252BMicrotubules%26aulast%3DSolingapuram%2BSai%26aufirst%3DKiran%2BKumar%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D07022018%26date%3D30042018%26date%3D03052018%26date%3D30042018%26volume%3D9%26issue%3D5%26spage%3D452%26epage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naresh  Damuka</span>, <span class="hlFld-ContribAuthor ">Miranda  Orr</span>, <span class="hlFld-ContribAuthor ">Paul W.  Czoty</span>, <span class="hlFld-ContribAuthor ">Jeffrey L.  Weiner</span>, <span class="hlFld-ContribAuthor ">Thomas J.  Martin</span>, <span class="hlFld-ContribAuthor ">Michael A.  Nader</span>, <span class="hlFld-ContribAuthor ">Avinash H.  Bansode</span>, <span class="hlFld-ContribAuthor ">Buddhika S.  Liyana Pathirannahel</span>, <span class="hlFld-ContribAuthor ">Akiva  Mintz</span>, <span class="hlFld-ContribAuthor ">Shannon L.  Macauley</span>, <span class="hlFld-ContribAuthor ">Suzanne  Craft</span>, <span class="hlFld-ContribAuthor ">Kiran Kumar  Solingapuram Sai</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of ethanol and cocaine on [11C]MPC-6827 uptake in SH-SY5Y cells. </span><span class="cited-content_cbyCitation_journal-name">Molecular Biology Reports</span><span> <strong>2021,</strong> <em>48 </em>
                                    (4)
                                     , 3871-3876. <a href="https://doi.org/10.1007/s11033-021-06336-7" title="DOI URL">https://doi.org/10.1007/s11033-021-06336-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11033-021-06336-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11033-021-06336-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Biology%2520Reports%26atitle%3DEffect%252Bof%252Bethanol%252Band%252Bcocaine%252Bon%252B%25255B11C%25255DMPC-6827%252Buptake%252Bin%252BSH-SY5Y%252Bcells%26aulast%3DDamuka%26aufirst%3DNaresh%26date%3D2021%26date%3D2021%26volume%3D48%26issue%3D4%26spage%3D3871%26epage%3D3876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kiran Kumar Solingapuram  Sai</span>, <span class="hlFld-ContribAuthor ">Jaya  Prabhakaran</span>, <span class="hlFld-ContribAuthor ">Naresh  Damuka</span>, <span class="hlFld-ContribAuthor ">Suzanne  Craft</span>, <span class="hlFld-ContribAuthor ">Shamyaa A.  Rajagopal</span>, <span class="hlFld-ContribAuthor ">Akiva  Mintz</span>, <span class="hlFld-ContribAuthor ">John  Mann</span>, <span class="hlFld-ContribAuthor ">Dileep  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Initial In Vivo Evaluations of [
              11
              C]WXâ132â18B, a Microtubule PET Imaging Agent. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2020,</strong> <em>5 </em>
                                    (31)
                                     , 9623-9625. <a href="https://doi.org/10.1002/slct.202001827" title="DOI URL">https://doi.org/10.1002/slct.202001827</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202001827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202001827%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSynthesis%252Band%252BInitial%252BIn%252BVivo%252BEvaluations%252Bof%252B%25255B%252B11%252BC%25255DWX%2525E2%252580%252590132%2525E2%252580%25259018B%25252C%252Ba%252BMicrotubule%252BPET%252BImaging%252BAgent%26aulast%3DSai%26aufirst%3DKiran%2BKumar%2BSolingapuram%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D31%26spage%3D9623%26epage%3D9625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bi-Yun  Lin</span>, <span class="hlFld-ContribAuthor ">Wen-Lin  Liu</span>, <span class="hlFld-ContribAuthor ">Hui  Huang</span>, <span class="hlFld-ContribAuthor ">Ya-Guang  Hu</span>, <span class="hlFld-ContribAuthor ">Sha  Gong</span>, <span class="hlFld-ContribAuthor ">Yu-Hua  Meng</span>, <span class="hlFld-ContribAuthor ">Jun  Yan</span>, <span class="hlFld-ContribAuthor ">Yuan-Zhi  Lu</span>, <span class="hlFld-ContribAuthor ">Hua-Lin  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">AQ-4, a deuterium-containing molecule, acts as a microtubule-targeting agent for cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2020,</strong> <em>877 </em>, 173093. <a href="https://doi.org/10.1016/j.ejphar.2020.173093" title="DOI URL">https://doi.org/10.1016/j.ejphar.2020.173093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2020.173093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2020.173093%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DAQ-4%25252C%252Ba%252Bdeuterium-containing%252Bmolecule%25252C%252Bacts%252Bas%252Ba%252Bmicrotubule-targeting%252Bagent%252Bfor%252Bcancer%252Btreatment%26aulast%3DLin%26aufirst%3DBi-Yun%26date%3D2020%26volume%3D877%26spage%3D173093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naresh  Damuka</span>, <span class="hlFld-ContribAuthor ">Paul W.  Czoty</span>, <span class="hlFld-ContribAuthor ">Ashley T.  Davis</span>, <span class="hlFld-ContribAuthor ">Michael A.  Nader</span>, <span class="hlFld-ContribAuthor ">Susan H.  Nader</span>, <span class="hlFld-ContribAuthor ">Suzanne  Craft</span>, <span class="hlFld-ContribAuthor ">Shannon L.  Macauley</span>, <span class="hlFld-ContribAuthor ">Lindsey K.  Galbo</span>, <span class="hlFld-ContribAuthor ">Phillip M.  Epperly</span>, <span class="hlFld-ContribAuthor ">Christopher T.  Whitlow</span>, <span class="hlFld-ContribAuthor ">April T.  Davenport</span>, <span class="hlFld-ContribAuthor ">Thomas J.  Martin</span>, <span class="hlFld-ContribAuthor ">James B.  Daunais</span>, <span class="hlFld-ContribAuthor ">Akiva  Mintz</span>, <span class="hlFld-ContribAuthor ">Kiran Kumar  Solingapuram Sai</span>. </span><span class="cited-content_cbyCitation_article-title">PET Imaging of [11C]MPC-6827, a Microtubule-Based Radiotracer in Non-Human Primate Brains. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (10)
                                     , 2289. <a href="https://doi.org/10.3390/molecules25102289" title="DOI URL">https://doi.org/10.3390/molecules25102289</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25102289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25102289%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DPET%252BImaging%252Bof%252B%25255B11C%25255DMPC-6827%25252C%252Ba%252BMicrotubule-Based%252BRadiotracer%252Bin%252BNon-Human%252BPrimate%252BBrains%26aulast%3DDamuka%26aufirst%3DNaresh%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D10%26spage%3D2289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J.S.  Dileep Kumar</span>, <span class="hlFld-ContribAuthor ">Jaya  Prabhakaran</span>, <span class="hlFld-ContribAuthor ">Naresh  Damuka</span>, <span class="hlFld-ContribAuthor ">Justin Wayne  Hines</span>, <span class="hlFld-ContribAuthor ">Skylar  Norman</span>, <span class="hlFld-ContribAuthor ">Meghana  Dodda</span>, <span class="hlFld-ContribAuthor ">J.  John Mann</span>, <span class="hlFld-ContribAuthor ">Akiva  Mintz</span>, <span class="hlFld-ContribAuthor ">Kiran Kumar Solingapuram  Sai</span>. </span><span class="cited-content_cbyCitation_article-title">In vivo comparison of N-11CH3 vs O-11CH3 radiolabeled microtubule targeted PET ligands. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (2)
                                     , 126785. <a href="https://doi.org/10.1016/j.bmcl.2019.126785" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126785</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126785%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIn%252Bvivo%252Bcomparison%252Bof%252BN-11CH3%252Bvs%252BO-11CH3%252Bradiolabeled%252Bmicrotubule%252Btargeted%252BPET%252Bligands%26aulast%3DDileep%2BKumar%26aufirst%3DJ.S.%26date%3D2020%26volume%3D30%26issue%3D2%26spage%3D126785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kiran Kumar  Solingapuram Sai</span>, <span class="hlFld-ContribAuthor ">Nagaraju  Bashetti</span>, <span class="hlFld-ContribAuthor ">Xiaofei  Chen</span>, <span class="hlFld-ContribAuthor ">Skylar  Norman</span>, <span class="hlFld-ContribAuthor ">Justin W.  Hines</span>, <span class="hlFld-ContribAuthor ">Omsai  Meka</span>, <span class="hlFld-ContribAuthor ">J. V. Shanmukha  Kumar</span>, <span class="hlFld-ContribAuthor ">Sriram  Devanathan</span>, <span class="hlFld-ContribAuthor ">Gagan  Deep</span>, <span class="hlFld-ContribAuthor ">Cristina M.  Furdui</span>, <span class="hlFld-ContribAuthor ">Akiva  Mintz</span>. </span><span class="cited-content_cbyCitation_article-title">Initial biological evaluations of 18F-KS1, a novel ascorbate derivative to image oxidative stress in cancer. </span><span class="cited-content_cbyCitation_journal-name">EJNMMI Research</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13550-019-0513-x" title="DOI URL">https://doi.org/10.1186/s13550-019-0513-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13550-019-0513-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13550-019-0513-x%26sid%3Dliteratum%253Aachs%26jtitle%3DEJNMMI%2520Research%26atitle%3DInitial%252Bbiological%252Bevaluations%252Bof%252B18F-KS1%25252C%252Ba%252Bnovel%252Bascorbate%252Bderivative%252Bto%252Bimage%252Boxidative%252Bstress%252Bin%252Bcancer%26aulast%3DSolingapuram%2BSai%26aufirst%3DKiran%2BKumar%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jaya  Prabhakaran</span>, <span class="hlFld-ContribAuthor ">Kiran Kumar Solingapuram  Sai</span>, <span class="hlFld-ContribAuthor ">Anirudh  Sattiraju</span>, <span class="hlFld-ContribAuthor ">Akiva  Mintz</span>, <span class="hlFld-ContribAuthor ">J. John  Mann</span>, <span class="hlFld-ContribAuthor ">J.S. Dileep  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Radiosynthesis and evaluation of [11C]CMP, a high affinity GSK3 ligand. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (6)
                                     , 778-781. <a href="https://doi.org/10.1016/j.bmcl.2019.01.033" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.01.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.01.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.01.033%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DRadiosynthesis%252Band%252Bevaluation%252Bof%252B%25255B11C%25255DCMP%25252C%252Ba%252Bhigh%252Baffinity%252BGSK3%252Bligand%26aulast%3DPrabhakaran%26aufirst%3DJaya%26date%3D2019%26volume%3D29%26issue%3D6%26spage%3D778%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.8b00028/20180302/images/medium/jm-2018-00028q_0004.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.8b00028/20180302/images/large/jm-2018-00028q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00028&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.8b00028/20180302/images/medium/jm-2018-00028q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.8b00028/20180302/images/large/jm-2018-00028q_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of MPC-6827 and Radiosynthesis of [<sup>11</sup>C]MPC-6827</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.8b00028/20180302/images/large/jm-2018-00028q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00028&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.8b00028/20180302/images/medium/jm-2018-00028q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.8b00028/20180302/images/large/jm-2018-00028q_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Baseline biodistribition of [<sup>11</sup>C]MPC-6827 in male white mice (<i>n</i> = 3). (B) Blocking biodistriution of [<sup>11</sup>C]MPC-6827 in mice at 30 min (<i>n</i> = 3)</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.8b00028/20180302/images/large/jm-2018-00028q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00028&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.8b00028/20180302/images/medium/jm-2018-00028q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.8b00028/20180302/images/large/jm-2018-00028q_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Sum of 0â60 min microPET sagittal images of [<sup>11</sup>C]MPC-6827 in a representative mouse brain (left, baseline; right, blocking with 5 mg/kg MPC-6827; cross lines represent center of brain).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.8b00028/20180302/images/large/jm-2018-00028q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00028&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.8b00028/20180302/images/medium/jm-2018-00028q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.8b00028/20180302/images/large/jm-2018-00028q_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Sum of 0â60 min microPET sagittal images of [<sup>11</sup>C]MPC-6827 in rat brain (left, transverse; middle, coronal; right, sagittal; cross lines represent center of brain).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.8b00028/20180302/images/large/jm-2018-00028q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00028&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i20">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82522" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82522" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 40 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janke, C.</span></span> <span> </span><span class="NLM_article-title">The tubulin code: molecular components, readout mechanisms, and functions</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>206</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">461</span>â <span class="NLM_lpage">472</span>, <span class="refDoi">Â DOI: 10.1083/jcb.201406055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1083%2Fjcb.201406055" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2014&pages=461-472&issue=4&author=C.+Janke&title=The+tubulin+code%3A+molecular+components%2C+readout+mechanisms%2C+and+functions&doi=10.1083%2Fjcb.201406055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1083%2Fjcb.201406055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.201406055%26sid%3Dliteratum%253Aachs%26aulast%3DJanke%26aufirst%3DC.%26atitle%3DThe%2520tubulin%2520code%253A%2520molecular%2520components%252C%2520readout%2520mechanisms%252C%2520and%2520functions%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2014%26volume%3D206%26issue%3D4%26spage%3D461%26epage%3D472%26doi%3D10.1083%2Fjcb.201406055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nogales, E.</span></span> <span> </span><span class="NLM_article-title">Structural insights into microtubule function</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">277</span>â <span class="NLM_lpage">302</span>, <span class="refDoi">Â DOI: 10.1146/annurev.biochem.69.1.277</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1146%2Fannurev.biochem.69.1.277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10966460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1ajtb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2000&pages=277-302&author=E.+Nogales&title=Structural+insights+into+microtubule+function&doi=10.1146%2Fannurev.biochem.69.1.277"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into microtubule function</span></div><div class="casAuthors">Nogales, Eva</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">277-302</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 144 refs.  Microtubules are polymers that are essential for, among other functions, cell transport and cell division in all eukaryotes.  The regulation of the microtubule system includes transcription of different tubulin isotypes, folding of Î±/Î²-tubulin heterodimers, post-translation modification of tubulin, and nucleotide-based microtubule dynamics, as well as interaction with numerous microtubule-assocd. proteins that are themselves regulated.  The result is the precise temporal and spatial pattern of microtubules that is obsd. throughout the cell cycle.  The recent high-resoln. anal. of the structure of tubulin and the microtubule has brought new insight to the study of microtubule function and regulation, as well as the mode of action of antimitotic drugs that disrupt normal microtubule behavior.  The combination of structural, genetic, biochem., and biophys. data should soon provide a fuller understanding of the exquisite details in the regulation of the microtubule cytoskeleton.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMOwnZFGcGIbVg90H21EOLACvtfcHk0lhhEmaybZoI8A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1ajtb4%253D&md5=2bba64a3fa1a9e3eb9f4b9517793f7b1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.69.1.277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.69.1.277%26sid%3Dliteratum%253Aachs%26aulast%3DNogales%26aufirst%3DE.%26atitle%3DStructural%2520insights%2520into%2520microtubule%2520function%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2000%26volume%3D69%26spage%3D277%26epage%3D302%26doi%3D10.1146%2Fannurev.biochem.69.1.277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hur, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, B. D.</span></span> <span> </span><span class="NLM_article-title">Microtubule-targeting agents enter the central nervous system (CNS): double-edged swords for treating CNS injury and disease</span>. <i>Int. Neurourol J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">171</span>â <span class="NLM_lpage">178</span>, <span class="refDoi">Â DOI: 10.5213/inj.2014.18.4.171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.5213%2Finj.2014.18.4.171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=25558415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A280%3ADC%252BC2MvjsFyrsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2014&pages=171-178&issue=4&author=E.+M.+Hurauthor=B.+D.+Lee&title=Microtubule-targeting+agents+enter+the+central+nervous+system+%28CNS%29%3A+double-edged+swords+for+treating+CNS+injury+and+disease&doi=10.5213%2Finj.2014.18.4.171"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule-Targeting Agents Enter the Central Nervous System (CNS): Double-edged Swords for Treating CNS Injury and Disease</span></div><div class="casAuthors">Hur Eun-Mi; Lee Byoung Dae</div><div class="citationInfo"><span class="NLM_cas:title">International neurourology journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">171-8</span>
        ISSN:<span class="NLM_cas:issn">2093-4777</span>.
    </div><div class="casAbstract">Microtubules have been among the most successful targets in anticancer therapy and a large number of microtubule-targeting agents (MTAs) are in various stages of clinical development for the treatment of several malignancies.  Given that injury and diseases in the central nervous system (CNS) are accompanied by acute or chronic disruption of the structural integrity of neurons and that microtubules provide structural support for the nervous system at cellular and intracellular levels, microtubules are emerging as potential therapeutic targets for treating CNS disorders.  It has been postulated that exogenous application of MTAs might prevent the breakdown or degradation of microtubules after injury or during neurodegeneration, which will thereby aid in preserving the structural integrity and function of the nervous system.  Here we review recent evidence that supports this notion and also discuss potential risks of targeting microtubules as a therapy for treating nerve injury and neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtRxlOi8BO8r0AGQpJZWpJfW6udTcc2eYHSKZovi2ZpLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MvjsFyrsw%253D%253D&md5=f66e8464d4838d2bb1f8f408cb999e64</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.5213%2Finj.2014.18.4.171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5213%252Finj.2014.18.4.171%26sid%3Dliteratum%253Aachs%26aulast%3DHur%26aufirst%3DE.%2BM.%26aulast%3DLee%26aufirst%3DB.%2BD.%26atitle%3DMicrotubule-targeting%2520agents%2520enter%2520the%2520central%2520nervous%2520system%2520%2528CNS%2529%253A%2520double-edged%2520swords%2520for%2520treating%2520CNS%2520injury%2520and%2520disease%26jtitle%3DInt.%2520Neurourol%2520J.%26date%3D2014%26volume%3D18%26issue%3D4%26spage%3D171%26epage%3D178%26doi%3D10.5213%2Finj.2014.18.4.171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eira, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sousa, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liz, M. A.</span></span> <span> </span><span class="NLM_article-title">The cytoskeleton as a novel therapeutic target for old neurodegenerative disorders</span>. <i>Prog. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">61</span>â <span class="NLM_lpage">82</span>, <span class="refDoi">Â DOI: 10.1016/j.pneurobio.2016.04.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1016%2Fj.pneurobio.2016.04.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=27095262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC28XntVCltLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2016&pages=61-82&author=J.+Eiraauthor=C.+S.+Silvaauthor=M.+M.+Sousaauthor=M.+A.+Liz&title=The+cytoskeleton+as+a+novel+therapeutic+target+for+old+neurodegenerative+disorders&doi=10.1016%2Fj.pneurobio.2016.04.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The cytoskeleton as a novel therapeutic target for old neurodegenerative disorders</span></div><div class="casAuthors">Eira, Jessica; Silva, Catarina Santos; Sousa, Monica Mendes; Liz, Marcia Almeida</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">61-82</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Cytoskeleton defects, including alterations in microtubule stability, in axonal transport as well as in actin dynamics, have been characterized in several unrelated neurodegenerative conditions.  These observations suggest that defects of cytoskeleton organization may be a common feature contributing to neurodegeneration.  In line with this hypothesis, drugs targeting the cytoskeleton are currently being tested in animal models and in human clin. trials, showing promising effects.  Drugs that modulate microtubule stability, inhibitors of posttranslational modifications of cytoskeletal components, specifically compds. affecting the levels of tubulin acetylation, and compds. targeting signaling mols. which regulate cytoskeleton dynamics, constitute the mostly addressed therapeutic interventions aiming at preventing cytoskeleton damage in neurodegenerative disorders.  In this review, we will discuss in a crit. perspective the current knowledge on cytoskeleton damage pathways as well as therapeutic strategies designed to revert cytoskeleton-related defects mainly focusing on the following neurodegenerative disorders: Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, Amyotrophic Lateral Sclerosis and Charcot-Marie-Tooth Disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOe7GHwM31HrVg90H21EOLACvtfcHk0liX22inqHKMOg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntVCltLk%253D&md5=8385b1ac087937579849fc4f30233cf3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2016.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2016.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DEira%26aufirst%3DJ.%26aulast%3DSilva%26aufirst%3DC.%2BS.%26aulast%3DSousa%26aufirst%3DM.%2BM.%26aulast%3DLiz%26aufirst%3DM.%2BA.%26atitle%3DThe%2520cytoskeleton%2520as%2520a%2520novel%2520therapeutic%2520target%2520for%2520old%2520neurodegenerative%2520disorders%26jtitle%3DProg.%2520Neurobiol.%26date%3D2016%26volume%3D141%26spage%3D61%26epage%3D82%26doi%3D10.1016%2Fj.pneurobio.2016.04.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brunden, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. B.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojanowski, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballatore, C.</span></span> <span> </span><span class="NLM_article-title">Altered microtubule dynamics in neurodegenerative disease: Therapeutic potential of microtubule-stabilizing drugs</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">328</span>â <span class="NLM_lpage">335</span>, <span class="refDoi">Â DOI: 10.1016/j.nbd.2016.12.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1016%2Fj.nbd.2016.12.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=28012891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvFejuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2017&pages=328-335&author=K.+R.+Brundenauthor=V.+M.+Leeauthor=A.+B.+Smithauthor=J.+Q.+Trojanowskiauthor=C.+Ballatore&title=Altered+microtubule+dynamics+in+neurodegenerative+disease%3A+Therapeutic+potential+of+microtubule-stabilizing+drugs&doi=10.1016%2Fj.nbd.2016.12.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Altered microtubule dynamics in neurodegenerative disease: Therapeutic potential of microtubule-stabilizing drugs</span></div><div class="casAuthors">Brunden, Kurt R.; Lee, Virginia M.-Y.; Smith, Amos B., III; Trojanowski, John Q.; Ballatore, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">328-335</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Many neurodegenerative diseases are characterized by deficiencies in neuronal axonal transport, a process in which cellular cargo is shuttled with the aid of mol. motors from the cell body to axonal termini and back along microtubules (MTs).  Proper axonal transport is crit. to the normal functioning of neurons, and impairments in this process could contribute to the neuronal damage and death that is characteristic of neurodegenerative disease.  Although the causes of axonal transport abnormalities may vary among the various neurodegenerative conditions, in many cases it appears that the transport deficiencies result from a diminution of axonal MT stability.  Here we review the evidence of MT abnormalities in a no. of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis and traumatic brain injury, and highlight the potential benefit of MT-stabilizing agents in improving axonal transport and nerve function in these diseases.  Moreover, we discuss the challenges assocd. with the utilization of MT-stabilizing drugs as therapeutic candidates for neurodegenerative conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoinJoFYGRgj7Vg90H21EOLACvtfcHk0liX22inqHKMOg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvFejuw%253D%253D&md5=dedda09d9cae4dd4ed06b37fcbadd805</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2016.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2016.12.021%26sid%3Dliteratum%253Aachs%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DBallatore%26aufirst%3DC.%26atitle%3DAltered%2520microtubule%2520dynamics%2520in%2520neurodegenerative%2520disease%253A%2520Therapeutic%2520potential%2520of%2520microtubule-stabilizing%2520drugs%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2017%26volume%3D105%26spage%3D328%26epage%3D335%26doi%3D10.1016%2Fj.nbd.2016.12.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Florian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchison, T. J.</span></span> <span> </span><span class="NLM_article-title">Anti-microtubule drugs</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1413</i></span>,  <span class="NLM_fpage">403</span>â <span class="NLM_lpage">421</span>, <span class="refDoi">Â DOI: 10.1007/978-1-4939-3542-0_25</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1007%2F978-1-4939-3542-0_25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=27193863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpsFantrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1413&publication_year=2016&pages=403-421&author=S.+Florianauthor=T.+J.+Mitchison&title=Anti-microtubule+drugs&doi=10.1007%2F978-1-4939-3542-0_25"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-Microtubule Drugs</span></div><div class="casAuthors">Florian, Stefan; Mitchison, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1413</span>
        (<span class="NLM_cas:issue">Mitotic Spindle</span>),
    <span class="NLM_cas:pages">403-421</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Small mol. drugs that target microtubules (MTs), many of them natural products, have long been important tools in the MT field.  Indeed, tubulin (Tb) was discovered, in part, as the protein binding partner of colchicine.  Several anti-MT drug classes also have important medical uses, notably colchicine, which is used to treat gout, familial Mediterranean fever (FMF), and pericarditis, and the vinca alkaloids and taxanes, which are used to treat cancer.  Anti-MT drugs have in common that they bind specifically to Tb in the dimer, MT or some other form.  However, their effects on polymn. dynamics and on the human body differ markedly.  Here we briefly review the most-studied mols., and comment on their uses in basic research and medicine.  Our focus is on practical applications of different anti-MT drugs in the lab., and key points that users should be aware of when designing expts.  We also touch on interesting unsolved problems, particularly in the area of medical applications.  In our opinion, the mechanism by which any MT drug cures or treats any disease is still unsolved, despite decades of research.  Solving this problem for particular drug-disease combinations might open new uses for old drugs, or provide insights into novel routes for treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3CX77S6H9irVg90H21EOLACvtfcHk0ljooJsbbRmr8Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpsFantrs%253D&md5=1de6eebc227d50a8939b79e779ca8114</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-3542-0_25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-3542-0_25%26sid%3Dliteratum%253Aachs%26aulast%3DFlorian%26aufirst%3DS.%26aulast%3DMitchison%26aufirst%3DT.%2BJ.%26atitle%3DAnti-microtubule%2520drugs%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2016%26volume%3D1413%26spage%3D403%26epage%3D421%26doi%3D10.1007%2F978-1-4939-3542-0_25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, M. A.</span></span> <span> </span><span class="NLM_article-title">New microtubule/tubulin-targeted anticancer drugs and novel chemotherapeutic strategies</span>. <i>J. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">83</span>â <span class="NLM_lpage">85</span>, <span class="refDoi">Â DOI: 10.1179/joc.2004.16.Supplement-1.83</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1179%2Fjoc.2004.16.Supplement-1.83" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=15688618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsFantbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2004&pages=83-85&issue=4&author=L.+Wilsonauthor=M.+A.+Jordan&title=New+microtubule%2Ftubulin-targeted+anticancer+drugs+and+novel+chemotherapeutic+strategies&doi=10.1179%2Fjoc.2004.16.Supplement-1.83"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">New microtubule / tubulin-targeted anticancer drugs and novel chemotherapeutic strategies</span></div><div class="casAuthors">Wilson, L.; Jordan, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemotherapy (Firenze, Italy)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">Suppl. 4</span>),
    <span class="NLM_cas:pages">83-85</span>CODEN:
                <span class="NLM_cas:coden">JCHEEU</span>;
        ISSN:<span class="NLM_cas:issn">1120-009X</span>.
    
            (<span class="NLM_cas:orgname">E.S.I.F.T. srl</span>)
        </div><div class="casAbstract">A review.  The clin. success of the taxanes and the vinca alkaloids has sparked a major search for new drugs that perturb mitotic spindle microtubule dynamics and function, yielding a large no. of promising compds.  A potential valuable strategy would be to use core microtubule-targeted drugs along with novel targeted drug therapies as they are developed, where the antitumor activity of a targeted drug can be combined with the power of low dose microtubule-targeted therapy.  The goal of such combination therapy is to achieve high efficacy, reduced toxicity, and reduced emergence of drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1Ixb7nJ08ZbVg90H21EOLACvtfcHk0ljooJsbbRmr8Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsFantbc%253D&md5=6e08b5ae6312226e56e2f867cf3ab3ae</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1179%2Fjoc.2004.16.Supplement-1.83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1179%252Fjoc.2004.16.Supplement-1.83%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DL.%26aulast%3DJordan%26aufirst%3DM.%2BA.%26atitle%3DNew%2520microtubule%252Ftubulin-targeted%2520anticancer%2520drugs%2520and%2520novel%2520chemotherapeutic%2520strategies%26jtitle%3DJ.%2520Chemother.%26date%3D2004%26volume%3D16%26issue%3D4%26spage%3D83%26epage%3D85%26doi%3D10.1179%2Fjoc.2004.16.Supplement-1.83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DostÃ¡l, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LibusovÃ¡, L.</span></span> <span> </span><span class="NLM_article-title">Microtubule drugs: action, selectivity, and resistance across the kingdoms of life</span>. <i>Protoplasma</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>251</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">991</span>â <span class="NLM_lpage">1005</span>, <span class="refDoi">Â DOI: 10.1007/s00709-014-0633-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1007%2Fs00709-014-0633-0" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=2014&pages=991-1005&issue=5&author=V.+Dost%C3%A1lauthor=L.+Libusov%C3%A1&title=Microtubule+drugs%3A+action%2C+selectivity%2C+and+resistance+across+the+kingdoms+of+life&doi=10.1007%2Fs00709-014-0633-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs00709-014-0633-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00709-014-0633-0%26sid%3Dliteratum%253Aachs%26aulast%3DDost%25C3%25A1l%26aufirst%3DV.%26aulast%3DLibusov%25C3%25A1%26aufirst%3DL.%26atitle%3DMicrotubule%2520drugs%253A%2520action%252C%2520selectivity%252C%2520and%2520resistance%2520across%2520the%2520kingdoms%2520of%2520life%26jtitle%3DProtoplasma%26date%3D2014%26volume%3D251%26issue%3D5%26spage%3D991%26epage%3D1005%26doi%3D10.1007%2Fs00709-014-0633-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergendahl, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashikaga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeSarno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraveka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eslin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werff, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanna, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sholler, G. L.</span></span> <span> </span><span class="NLM_article-title">A Phase 1 trial of TPI 287 as a single agent and in combination with Temozolomide in patients with refractory or recurrent neuroblastoma or medulloblastoma</span>. <i>Pediatr. Blood Cancer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">39</span>â <span class="NLM_lpage">46</span>, <span class="refDoi">Â DOI: 10.1002/pbc.25687</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1002%2Fpbc.25687" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=26235333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFCqtr7K" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2016&pages=39-46&issue=1&author=D.+Mitchellauthor=G.+Bergendahlauthor=W.+Fergusonauthor=W.+Robertsauthor=T.+Higginsauthor=T.+Ashikagaauthor=M.+DeSarnoauthor=J.+Kaplanauthor=J.+Kravekaauthor=D.+Eslinauthor=A.+V.+Werffauthor=G.+K.+Hannaauthor=G.+L.+Sholler&title=A+Phase+1+trial+of+TPI+287+as+a+single+agent+and+in+combination+with+Temozolomide+in+patients+with+refractory+or+recurrent+neuroblastoma+or+medulloblastoma&doi=10.1002%2Fpbc.25687"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma</span></div><div class="casAuthors">Mitchell, Deanna; Bergendahl, Genevieve; Ferguson, William; Roberts, William; Higgins, Timothy; Ashikaga, Takamaru; DeSarno, Mike; Kaplan, Joel; Kraveka, Jacqueline; Eslin, Don; Werff, Alyssa Vander; Hanna, Gina K.; Sholler, Giselle L. Saulnier</div><div class="citationInfo"><span class="NLM_cas:title">Pediatric Blood & Cancer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-46</span>CODEN:
                <span class="NLM_cas:coden">PBCEAQ</span>;
        ISSN:<span class="NLM_cas:issn">1545-5017</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Background : The primary aim of this Phase I study was to det. the max. tolerated dose (MTD) of TPI 287 and the safety and tolerability of TPI 287 alone and in combination with temozolomide (TMZ) in pediatric patients with refractory or recurrent neuroblastoma or medulloblastoma.  The secondary aims were to evaluate the pharmacokinetics of TPI 287 and the treatment responses.  Procedure : Eighteen patients were enrolled to a phase I dose escalation trial of weekly i.v. infusion of TPI 287 for two 28-day cycles with toxicity monitoring to det. the MTD, followed by two cycles of TPI 287 in combination with TMZ.  Samples were collected to det. the pharmacokinetic parameters Cmax, AUC0-24, t1/2, CL, and Vd on day 1 of cycles 1 (TPI 287 alone) and 3 (TPI 287 + TMZ) following TPI 287 infusion.  Treatment response was evaluated by radiog. (CT or MRI) and radionuclide (MIBG) imaging for neuroblastoma.  Results : We detd. the MTD of TPI 287 alone and in combination with temozolomide to be 125 mg/m2.  The non-dose-limiting toxicities at this dose were mainly anorexia and pain.  The dose-limiting toxicities (DLTs) of two patients at 135 mg/m2 were grade 3 hemorrhagic cystitis and grade 3 sensory neuropathy.  Conclusions : Overall, TPI 287 was well tolerated by pediatric patients with refractory and relapsed neuroblastoma and medulloblastoma at a dose of 125 mg/m2 IV on days 1, 8, and 15 of a 28 day cycle.  Pediatr Blood Cancer 2015; 9999:1-8 Â© 2015 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJoqa9ycMw9LVg90H21EOLACvtfcHk0ljooJsbbRmr8Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFCqtr7K&md5=730dc6798b055ec12e5c7d2dea1630c3</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fpbc.25687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpbc.25687%26sid%3Dliteratum%253Aachs%26aulast%3DMitchell%26aufirst%3DD.%26aulast%3DBergendahl%26aufirst%3DG.%26aulast%3DFerguson%26aufirst%3DW.%26aulast%3DRoberts%26aufirst%3DW.%26aulast%3DHiggins%26aufirst%3DT.%26aulast%3DAshikaga%26aufirst%3DT.%26aulast%3DDeSarno%26aufirst%3DM.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DKraveka%26aufirst%3DJ.%26aulast%3DEslin%26aufirst%3DD.%26aulast%3DWerff%26aufirst%3DA.%2BV.%26aulast%3DHanna%26aufirst%3DG.%2BK.%26aulast%3DSholler%26aufirst%3DG.%2BL.%26atitle%3DA%2520Phase%25201%2520trial%2520of%2520TPI%2520287%2520as%2520a%2520single%2520agent%2520and%2520in%2520combination%2520with%2520Temozolomide%2520in%2520patients%2520with%2520refractory%2520or%2520recurrent%2520neuroblastoma%2520or%2520medulloblastoma%26jtitle%3DPediatr.%2520Blood%2520Cancer%26date%3D2016%26volume%3D63%26issue%3D1%26spage%3D39%26epage%3D46%26doi%3D10.1002%2Fpbc.25687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Penazzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakota, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, R.</span></span> <span> </span><span class="NLM_article-title">Microtubule dynamics in neuronal development, plasticity, and neurode- generation</span>. <i>Int. Rev. Cell Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>321</i></span>,  <span class="NLM_fpage">89</span>â <span class="NLM_lpage">169</span>, <span class="refDoi">Â DOI: 10.1016/bs.ircmb.2015.09.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1016%2Fbs.ircmb.2015.09.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=26811287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A280%3ADC%252BC28nksVKjtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2016&pages=89-169&author=L.+Penazziauthor=L.+Bakotaauthor=R.+Brandt&title=Microtubule+dynamics+in+neuronal+development%2C+plasticity%2C+and+neurode-+generation&doi=10.1016%2Fbs.ircmb.2015.09.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule Dynamics in Neuronal Development, Plasticity, and Neurodegeneration</span></div><div class="casAuthors">Penazzi Lorene; Bakota Lidia; Brandt Roland</div><div class="citationInfo"><span class="NLM_cas:title">International review of cell and molecular biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89-169</span>
        ISSN:<span class="NLM_cas:issn">1937-6448</span>.
    </div><div class="casAbstract">Neurons are the basic information-processing units of the nervous system.  In fulfilling their task, they establish a structural polarity with an axon that can be over a meter long and dendrites with a complex arbor, which can harbor ten-thousands of spines.  Microtubules and their associated proteins play important roles during the development of neuronal morphology, the plasticity of neurons, and neurodegenerative processes.  They are dynamic structures, which can quickly adapt to changes in the environment and establish a structural scaffold with high local variations in composition and stability.  This review presents a comprehensive overview about the role of microtubules and their dynamic behavior during the formation and maturation of processes and spines in the healthy brain, during aging and under neurodegenerative conditions.  The review ends with a discussion of microtubule-targeted therapies as a perspective for the supportive treatment of neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTpx2wh-aVG0z0SWnHPWbmmfW6udTcc2eYFOCGbS-8g-rntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28nksVKjtw%253D%253D&md5=0eb845a4c17dcf9df9f0145b512aa946</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fbs.ircmb.2015.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fbs.ircmb.2015.09.004%26sid%3Dliteratum%253Aachs%26aulast%3DPenazzi%26aufirst%3DL.%26aulast%3DBakota%26aufirst%3DL.%26aulast%3DBrandt%26aufirst%3DR.%26atitle%3DMicrotubule%2520dynamics%2520in%2520neuronal%2520development%252C%2520plasticity%252C%2520and%2520neurode-%2520generation%26jtitle%3DInt.%2520Rev.%2520Cell%2520Mol.%2520Biol.%26date%3D2016%26volume%3D321%26spage%3D89%26epage%3D169%26doi%3D10.1016%2Fbs.ircmb.2015.09.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kovalevich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornec, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojanowski, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. B.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballatore, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunden, K. R.</span></span> <span> </span><span class="NLM_article-title">Characterization of brain-penetrant pyrimidine-containing molecules with differential microtubule-stabilizing activities dveloped as potential therapeutic agents for Alzheimerâs Disease and related tauopathies</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>357</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">432</span>â <span class="NLM_lpage">450</span>, <span class="refDoi">Â DOI: 10.1124/jpet.115.231175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1124%2Fjpet.115.231175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=26980057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFGjt7zK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2016&pages=432-450&issue=2&author=J.+Kovalevichauthor=A.+S.+Cornecauthor=Y.+Yaoauthor=M.+Jamesauthor=A.+Croweauthor=V.+M.+Leeauthor=J.+Q.+Trojanowskiauthor=A.+B.+Smithauthor=C.+Ballatoreauthor=K.+R.+Brunden&title=Characterization+of+brain-penetrant+pyrimidine-containing+molecules+with+differential+microtubule-stabilizing+activities+dveloped+as+potential+therapeutic+agents+for+Alzheimer%E2%80%99s+Disease+and+related+tauopathies&doi=10.1124%2Fjpet.115.231175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of brain-penetrant pyrimidine-containing molecules with differential microtubule-stabilizing activities developed as potential therapeutic agents for Alzheimer's disease and related tauopathies</span></div><div class="casAuthors">Kovalevich, Jane; Cornec, Anne-Sophie; Yao, Yuemang; James, Michael; Crowe, Alexander; Lee, Virginia M.-Y.; Trojanowski, John Q.; Smith, Amos B., III; Ballatore, Carlo; Brunden, Kurt R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">432-450</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The microtubule (MT)-stabilizing protein tau disengages from MTs and forms intracellular inclusions known as neurofibrillary tangles in Alzheimer's disease and related tauopathies.  Reduced tau binding to MTs in tauopathies may contribute to neuronal dysfunction through decreased MT stabilization and disrupted axonal transport.  Thus, the introduction of brain-penetrant MT-stabilizing compds. might normalize MT dynamics and axonal deficits in these disorders.  We previously described a no. of phenylpyrimidines and triazolopyrimidines (TPDs) that induce tubulin post-translational modifications indicative of MT stabilization.  We now further characterize the biol. properties of these small mols., and our results reveal that these compds. can be divided into two general classes based on the cellular response they evoke.  One group composed of the phenylpyrimidines and several TPD examples showed a bell-shaped concn.-response effect on markers of MT stabilization in cellular assays.  Moreover, these compds. induced proteasome-dependent degrdn. of Î±- and Î²-tubulin and caused altered MT morphol. in both dividing cells and neuron cultures.  In contrast, a second group comprising a subset of TPD mols. (TPD+) increased markers of stable MTs in a concn.-dependent manner in dividing cells and in neurons without affecting total tubulin levels or disrupting MT architecture.  Moreover, an example TPD+ compd. was shown to increase MTs in a neuron culture model with induced tau hyperphosphorylation and assocd. MT deficits.  Several TPD+ compds. were shown to be both brain penetrant and orally bioavailable, and a TPD+ example increased MT stabilization in the mouse brain, making these compds. potential candidate therapeutics for neurodegenerative tauopathies such as Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCEADXoI6tlbVg90H21EOLACvtfcHk0liap4SJFD4OTQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFGjt7zK&md5=14cc76d21739ed6b63ba6f2754287b51</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.231175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.231175%26sid%3Dliteratum%253Aachs%26aulast%3DKovalevich%26aufirst%3DJ.%26aulast%3DCornec%26aufirst%3DA.%2BS.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DJames%26aufirst%3DM.%26aulast%3DCrowe%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26atitle%3DCharacterization%2520of%2520brain-penetrant%2520pyrimidine-containing%2520molecules%2520with%2520differential%2520microtubule-stabilizing%2520activities%2520dveloped%2520as%2520potential%2520therapeutic%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%2520and%2520related%2520tauopathies%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D357%26issue%3D2%26spage%3D432%26epage%3D450%26doi%3D10.1124%2Fjpet.115.231175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dent, E. W.</span></span> <span> </span><span class="NLM_article-title">Of microtubules and memory: implications for microtubule dynamics in dendrites and spines</span>. <i>Mol. Biol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">8</span>, <span class="refDoi">Â DOI: 10.1091/mbc.E15-11-0769</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1091%2Fmbc.E15-11-0769" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=28035040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC2sXptVOhs7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2017&pages=1-8&issue=1&author=E.+W.+Dent&title=Of+microtubules+and+memory%3A+implications+for+microtubule+dynamics+in+dendrites+and+spines&doi=10.1091%2Fmbc.E15-11-0769"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Of microtubules and memory: implications for microtubule dynamics in dendrites and spines</span></div><div class="casAuthors">Dent, Erik W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1939-4586</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">Microtubules (MTs) are cytoskeletal polymers composed of repeating subunits of tubulin that are ubiquitously expressed in eukaryotic cells.  They undergo a stochastic process of polymn. and depolymn. from their plus ends termed dynamic instability.  MT dynamics is an ongoing process in all cell types and has been the target for the development of several useful anticancer drugs, which compromise rapidly dividing cells.  Recent studies also suggest that MT dynamics may be particularly important in neurons, which develop a highly polarized morphol., consisting of a single axon and multiple dendrites that persist throughout adulthood.  MTs are esp. dynamic in dendrites and have recently been shown to polymerize directly into dendritic spines, the postsynaptic compartment of excitatory neurons in the CNS.  These transient polymn. events into dendritic spines have been demonstrated to play important roles in synaptic plasticity in cultured neurons.  Recent studies also suggest that MT dynamics in the adult brain function in the essential process of learning and memory and may be compromised in degenerative diseases, such as Alzheimer's disease.  This raises the possibility of targeting MT dynamics in the design of new therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZxuF-_ccHSrVg90H21EOLACvtfcHk0liap4SJFD4OTQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXptVOhs7s%253D&md5=3ee0bbdb3cb02e77be372274622849a7</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1091%2Fmbc.E15-11-0769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.E15-11-0769%26sid%3Dliteratum%253Aachs%26aulast%3DDent%26aufirst%3DE.%2BW.%26atitle%3DOf%2520microtubules%2520and%2520memory%253A%2520implications%2520for%2520microtubule%2520dynamics%2520in%2520dendrites%2520and%2520spines%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2017%26volume%3D28%26issue%3D1%26spage%3D1%26epage%3D8%26doi%3D10.1091%2Fmbc.E15-11-0769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cappelletti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casagrande, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calogero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Gregorio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezzoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartelli, D.</span></span> <span> </span><span class="NLM_article-title">Linking microtubules to Parkinsonâs disease: the case of parkin</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">292</span>â <span class="NLM_lpage">296</span>, <span class="refDoi">Â DOI: 10.1042/BST20150007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1042%2FBST20150007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=25849932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvFSjurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=292-296&issue=2&author=G.+Cappellettiauthor=F.+Casagrandeauthor=A.+Calogeroauthor=C.+De+Gregorioauthor=G.+Pezzoliauthor=D.+Cartelli&title=Linking+microtubules+to+Parkinson%E2%80%99s+disease%3A+the+case+of+parkin&doi=10.1042%2FBST20150007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Linking microtubules to Parkinson's disease- the case of parkin</span></div><div class="casAuthors">Cappelletti, Graziella; Casagrande, Francesca; Calogero, Alessandra; De Gregorio, Carmelita; Pezzoli, Gianni; Cartelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">292-296</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Microtubules (MTs) are dynamic polymers consisting of Î±/Î² tubulin dimers and playing a plethora of roles in eukaryotic cells.  Looking at neurons, they are key determinants of neuronal polarity, axonal transport and synaptic plasticity.  The concept that MT dysfunction can participate in, and perhaps lead to, Parkinson's disease (PD) progression has been suggested by studies using toxin-based and genetic exptl. models of the disease.  Here, we first learn lessons from MPTP and rotenone as well as from the PD related genes, including SNCA and LRRK2, and then look at old and new evidence regarding the interplay between parkin and MTs.  Data from exptl. models and human cells point out that parkin regulates MT stability and strengthen the link between MTs and PD paving the way to a viable strategy for the management of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpXLJOcj9WvrVg90H21EOLACvtfcHk0liap4SJFD4OTQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvFSjurs%253D&md5=5f7cf7e604aaec2504c60428dcfe4618</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1042%2FBST20150007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20150007%26sid%3Dliteratum%253Aachs%26aulast%3DCappelletti%26aufirst%3DG.%26aulast%3DCasagrande%26aufirst%3DF.%26aulast%3DCalogero%26aufirst%3DA.%26aulast%3DDe%2BGregorio%26aufirst%3DC.%26aulast%3DPezzoli%26aufirst%3DG.%26aulast%3DCartelli%26aufirst%3DD.%26atitle%3DLinking%2520microtubules%2520to%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520the%2520case%2520of%2520parkin%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2015%26volume%3D43%26issue%3D2%26spage%3D292%26epage%3D296%26doi%3D10.1042%2FBST20150007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeaman, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blizzard, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuckowree, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickson, T. C.</span></span> <span> </span><span class="NLM_article-title">A case for microtubule vulnerability in Amyotrophic Lateral Sclerosis: altered dynamics during disease</span>. <i>Front. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">204</span>, <span class="refDoi">Â DOI: 10.3389/fncel.2016.00204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.3389%2Ffncel.2016.00204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=27679561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotFyisrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&pages=204&author=J.+A.+Clarkauthor=E.+J.+Yeamanauthor=C.+A.+Blizzardauthor=J.+A.+Chuckowreeauthor=T.+C.+Dickson&title=A+case+for+microtubule+vulnerability+in+Amyotrophic+Lateral+Sclerosis%3A+altered+dynamics+during+disease&doi=10.3389%2Ffncel.2016.00204"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A case for microtubule vulnerability in amyotrophic lateral sclerosis: altered dynamics during disease</span></div><div class="casAuthors">Clark, Jayden A.; Yeaman, Elise J.; Blizzard, Catherine A.; Chuckowree, Jyoti A.; Dickson, Tracey C.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">204/1-204/16</span>CODEN:
                <span class="NLM_cas:coden">FCNRAH</span>;
        ISSN:<span class="NLM_cas:issn">1662-5102</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Amyotrophic lateral sclerosis (ALS) is an aggressive multifactorial disease converging on a common pathol.: the degeneration of motor neurons (MNs), their axons and neuromuscular synapses.  This vulnerability and dysfunction of MNs highlights the dependency of these large cells on their intracellular machinery.  Neuronal microtubules (MTs) are intracellular structures that facilitate a myriad of vital neuronal functions, including activity dependent axonal transport.  In ALS, it is becoming increasingly apparent that MTs are likely to be a crit. component of this disease.  Not only are disruptions in this intracellular machinery present in the vast majority of seemingly sporadic cases, recent research has revealed that mutation to a microtubule protein, the tubulin isoform TUBA4A, is sufficient to cause a familial, albeit rare, form of disease.  In both sporadic and familial disease, studies have provided evidence that microtubule mediated deficits in axonal transport are the tipping point for MN survivability.  Axonal transport deficits would lead to abnormal mitochondrial recycling, decreased vesicle and mRNA transport and limited signaling of key survival factors from the neurons peripheral synapses, causing the characteristic peripheral "die back".  This disruption to microtubule dependant transport in ALS has been shown to result from alterations in the phenomenon of microtubule dynamic instability: the rapid growth and shrinkage of microtubule polymers.  This is accomplished primarily due to aberrant alterations to microtubule assocd. proteins (MAPs) that regulate microtubule stability.  Indeed, the current literature would argue that microtubule stability, particularly alterations in their dynamics, may be the initial driving force behind many familial and sporadic insults in ALS.  Pharmacol. stabilization of the microtubule network offers an attractive therapeutic strategy in ALS; indeed it has shown promise in many neurol. disorders, ALS included.  However, the pathophysiol. involvement of MTs and their functions is still poorly understood in ALS.  Future investigations will hopefully uncover further therapeutic targets that may aid in combating this awful disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA5zGQXu-v1rVg90H21EOLACvtfcHk0lih1pviEVu-HQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotFyisrc%253D&md5=af459cae22b01548a150b0a15a0ac507</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.3389%2Ffncel.2016.00204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffncel.2016.00204%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DJ.%2BA.%26aulast%3DYeaman%26aufirst%3DE.%2BJ.%26aulast%3DBlizzard%26aufirst%3DC.%2BA.%26aulast%3DChuckowree%26aufirst%3DJ.%2BA.%26aulast%3DDickson%26aufirst%3DT.%2BC.%26atitle%3DA%2520case%2520for%2520microtubule%2520vulnerability%2520in%2520Amyotrophic%2520Lateral%2520Sclerosis%253A%2520altered%2520dynamics%2520during%2520disease%26jtitle%3DFront.%2520Cell.%2520Neurosci.%26date%3D2016%26volume%3D10%26spage%3D204%26doi%3D10.3389%2Ffncel.2016.00204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zempel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandelkow, E. M.</span></span> <span> </span><span class="NLM_article-title">Tau missorting and spastin-induced microtubule disruption in neurodege-neration: Alzheimer Disease and Hereditary Spastic Paraplegia</span>. <i>Mol. Neurodegener.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">68</span>, <span class="refDoi">Â DOI: 10.1186/s13024-015-0064-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1186%2Fs13024-015-0064-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=26691836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivVaqtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=68&author=H.+Zempelauthor=E.+M.+Mandelkow&title=Tau+missorting+and+spastin-induced+microtubule+disruption+in+neurodege-neration%3A+Alzheimer+Disease+and+Hereditary+Spastic+Paraplegia&doi=10.1186%2Fs13024-015-0064-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Tau missorting and spastin-induced microtubule disruption in neurodegeneration: Alzheimer Disease and Hereditary Spastic Paraplegia</span></div><div class="casAuthors">Zempel, Hans; Mandelkow, Eva-Maria</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">68/1-68/12</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">In Alzheimer Disease (AD), the mechanistic connection of the two major pathol. hallmarks, namely deposition of Amyloid-beta (AÎ²) in the form of extracellular plaques, and the pathol. changes of the intracellular protein Tau (such as phosphorylation, missorting, aggregation), is not well understood.  Genetic evidence from AD and Down Syndrome (Trisomy 21), and animal models thereof, suggests that aberrant prodn. of AÎ² is upstream of Tau aggregation, but also points to Tau as a crit. effector in the pathol. process.  Yet, the cascade of events leading from increased levels of AÎ² to Tau-dependent toxicity remains a matter of debate.  Using primary neurons exposed to oligomeric forms of AÎ², we have found that Tau becomes mislocalized (missorted) into the somatodendritic compartment.  Missorting of Tau correlates with loss of microtubules and downstream consequences such as loss of mature spines, loss of synaptic activity, and mislocalization of mitochondria.  In this cascade, missorting of Tau induces mislocalization of TTLL6 (Tubulin-Tyrosine-Ligase-Like 6) into the dendrites.  TTLL6 induces polyglutamylation of microtubules, which acts as a trigger for spastin mediated severing of dendritic microtubules.  Loss of microtubules makes cells unable to maintain transport of mitochondria, which in turn results in synaptic dysfunction and loss of mature spines.  These pathol. changes are absent in TauKO derived primary neurons.  Thus, Tau mediated mislocalization of TTLL6 and spastin activation reveals a pathol. gain of function for Tau and spastin in this cellular model system of AD.  In contrast, in hereditary spastic paraplegia (HSP) caused by mutations of the gene encoding spastin (spg4 alias SPAST), spastin function in terms of microtubule severing is decreased at least for the gene product of the mutated allele, resulting in overstable microtubules in disease model systems.  Whether total spastin severing activity or microtubule stability in human disease is also affected is not yet clear.  No human disease has been assocd. so far with the longchain polyglutamylation enzyme TTLL6, or the other TTLLs (1,5,11) possibly involved.  Here we review the findings supporting a role for Tau, spastin and TTLL6 in AD and other tauopathies, HSP and neurodegeneration, and summarize possible therapeutic approaches for AD and HSP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC0nYhPwoKurVg90H21EOLACvtfcHk0lih1pviEVu-HQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivVaqtQ%253D%253D&md5=cceb873889c43ad6e3fe53f77a53857b</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1186%2Fs13024-015-0064-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13024-015-0064-1%26sid%3Dliteratum%253Aachs%26aulast%3DZempel%26aufirst%3DH.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26atitle%3DTau%2520missorting%2520and%2520spastin-induced%2520microtubule%2520disruption%2520in%2520neurodege-neration%253A%2520Alzheimer%2520Disease%2520and%2520Hereditary%2520Spastic%2520Paraplegia%26jtitle%3DMol.%2520Neurodegener.%26date%3D2015%26volume%3D10%26spage%3D68%26doi%3D10.1186%2Fs13024-015-0064-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mastronardi, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscarello, M. A.</span></span> <span> </span><span class="NLM_article-title">Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis</span>. <i>J. Neurosci. Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>80</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">301</span>â <span class="NLM_lpage">308</span>, <span class="refDoi">Â DOI: 10.1002/jnr.20420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1002%2Fjnr.20420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=15704220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvFaktr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2005&pages=301-308&issue=3&author=F.+G.+Mastronardiauthor=M.+A.+Moscarello&title=Molecules+affecting+myelin+stability%3A+a+novel+hypothesis+regarding+the+pathogenesis+of+multiple+sclerosis&doi=10.1002%2Fjnr.20420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Molecules affecting myelin stability: A novel hypothesis regarding the pathogenesis of multiple sclerosis</span></div><div class="casAuthors">Mastronardi, Fabrizio G.; Moscarello, Mario A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">301-308</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  In this Mini-Review the authors present a new hypothesis in support of the neurodegenerative theory as a mechanism for the pathogenesis of multiple sclerosis (MS).  The pathogenesis of MS results from changes in 2 distinct CNS compartments.  These are the "myelin" and "nonmyelin" compartments.  The myelin compartment is where primary demyelination, amidst attempts at remyelination, is superseded in the CNS by ongoing disease.  Recent evidence obtained via magnetic resonance imaging and spectroscopy techniques supports the view that the normal-appearing white matter (NAWM) in the MS brain is altered.  Several biochem. changes in NAWM were detd.  These include the cationicity of myelin basic protein (MBP) as a result of the action of peptidyl argininedeiminase (PAD) activity converting arginyl residues to citrulline.  The accompanying loss of pos. charge makes myelin susceptible to vesiculation and MBP more susceptible to proteolytic activity.  An increase of MBP autocatalysis in the MS brain might also contribute to the generation of immunodominant epitopes.  Accompanying the destruction of myelin in the myelin compartment is the activation of astrocytes and microglia.  These contribute to the inflammatory response and T-cell activation leading to autoimmunity.  The complex environment that exists in the demyelinating brain also affects the "nonmyelin" compartment.  The inappropriate upregulation of mols., including those of the Jagged-1-Notch-1 signal transduction pathway, affects oligodendrocyte precursor cell (OPC) differentiation.  Other effectors of oligodendrocyte maturation include stathmin, a microtubule-destabilizing protein, which prevents healing in the demyelinating brain.  The hypothesis the authors present suggests a therapeutic strategy that should (1) target the effectors within the myelin compartment and (2) enable resident OPC maturation in the nonmyelin compartment, allowing for effective repair of myelin loss.  The net effect of this new therapeutic strategy is the modification of the disease environment and the stimulation of healing and repair.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhmwhRMQNourVg90H21EOLACvtfcHk0lih1pviEVu-HQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvFaktr4%253D&md5=8e97a68d991f175e71e9be99efb3189e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fjnr.20420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.20420%26sid%3Dliteratum%253Aachs%26aulast%3DMastronardi%26aufirst%3DF.%2BG.%26aulast%3DMoscarello%26aufirst%3DM.%2BA.%26atitle%3DMolecules%2520affecting%2520myelin%2520stability%253A%2520a%2520novel%2520hypothesis%2520regarding%2520the%2520pathogenesis%2520of%2520multiple%2520sclerosis%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2005%26volume%3D80%26issue%3D3%26spage%3D301%26epage%3D308%26doi%3D10.1002%2Fjnr.20420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">FernÃ¡ndez-Nogales, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos-Galindo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">HernÃ¡ndez, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrera, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, J. J.</span></span> <span> </span><span class="NLM_article-title">Faulty splicing and cytoskeleton abnormalities in Huntingtonâs disease</span>. <i>Brain Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">772</span>â <span class="NLM_lpage">778</span>, <span class="refDoi">Â DOI: 10.1111/bpa.12430</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1111%2Fbpa.12430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=27529534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFKns7vI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=772-778&issue=6&author=M.+Fern%C3%A1ndez-Nogalesauthor=M.+Santos-Galindoauthor=I.+H.+Hern%C3%A1ndezauthor=J.+R.+Cabreraauthor=J.+J.+Lucas&title=Faulty+splicing+and+cytoskeleton+abnormalities+in+Huntington%E2%80%99s+disease&doi=10.1111%2Fbpa.12430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Faulty splicing and cytoskeleton abnormalities in Huntington's disease</span></div><div class="casAuthors">Fernandez-Nogales, Marta; Santos-Galindo, Maria; Hernandez, Ivo H.; Cabrera, Jorge R.; Lucas, Jose J.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Pathology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">772-778</span>CODEN:
                <span class="NLM_cas:coden">BRPAE7</span>;
        ISSN:<span class="NLM_cas:issn">1015-6305</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Huntington's disease (HD) is caused by a CAG-repeat encoding a polyglutamine (polyQ) tract in the huntingtin protein.  There is plenty of evidence of polyQ-driven toxicity.  However, CAG repeat RNA-driven alteration of splicing has recently been proposed in analogy to CUG-repeat diseases.  Here we review the reported alteration of the CAG-repeat assocd. splicing factor SRSF6 in brains of HD patients and mouse models and how this correlates with altered splicing of, at least, two microtubule-assocd. proteins in HD, namely MAPT (tau) and MAP2.  Regarding tau, altered splicing of exon 10 has been reported, along with increased levels and 4R/3R-tau ratio and detection of tau in a new nuclear rod-shaped histopathol. hallmark termed tau nuclear rod (TNR) or tau nuclear indentation (TNI).  These findings, together with an attenuation of HD phenotype in R6/1 mice with tau deficiency and subsequent studies showing increased phosphorylation in mouse models and increased levels in CSF of patients, has led to proposing HD as a tauopathy.  Regarding MAP2, an increase in its juvenile form and a decrease in total MAP2 together with redistribution from dendrites to soma is obsd. in HD patients, which may contribute to the dendritic atrophy in HD.  Furthermore, MAP2 pos. structures filling nuclear indentations have occasionally been found and co-localized with tau.  Therefore, altered MAP function with imbalance in tau/MAP2 content could contribute to HD striatal atrophy and dysfunction.  Besides, TNIs might be indicative of such MAP abnormalities.  TNIs are also found in early pathol. Alzheimer's disease and in tauopathy mice over-expressing mutant 4R-tau.  This indicates that tau alteration is sufficient for TNI detection, which becomes a marker of increased total tau and/or altered 4R/3R-tau ratio and reporter of pathol.-assocd. nuclear indentations.  Altogether, these recent studies suggest that correcting the SRSF6-driven missplicing and/or microtubule-assocd. imbalance might be of therapeutic value in HD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq51-1WKghTN7Vg90H21EOLACvtfcHk0ljoklDvrwPaMA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFKns7vI&md5=68fe7991f3314a3cb9cc3504848495e3</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fbpa.12430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbpa.12430%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Nogales%26aufirst%3DM.%26aulast%3DSantos-Galindo%26aufirst%3DM.%26aulast%3DHern%25C3%25A1ndez%26aufirst%3DI.%2BH.%26aulast%3DCabrera%26aufirst%3DJ.%2BR.%26aulast%3DLucas%26aufirst%3DJ.%2BJ.%26atitle%3DFaulty%2520splicing%2520and%2520cytoskeleton%2520abnormalities%2520in%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DBrain%2520Pathol.%26date%3D2016%26volume%3D26%26issue%3D6%26spage%3D772%26epage%3D778%26doi%3D10.1111%2Fbpa.12430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paula-Barbosa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavares, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadete-Leite, A.</span></span> <span> </span><span class="NLM_article-title">A quantitative study of frontal cortex dendritic microtubules in patients with Alzheimer disease</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>417</i></span>,  <span class="NLM_fpage">139</span>â <span class="NLM_lpage">142</span>, <span class="refDoi">Â DOI: 10.1016/0006-8993(87)90188-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1016%2F0006-8993%2887%2990188-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=3620973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A280%3ADyaL2szgtVyisw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=417&publication_year=1987&pages=139-142&author=M.+Paula-Barbosaauthor=M.+A.+Tavaresauthor=A.+Cadete-Leite&title=A+quantitative+study+of+frontal+cortex+dendritic+microtubules+in+patients+with+Alzheimer+disease&doi=10.1016%2F0006-8993%2887%2990188-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative study of frontal cortex dendritic microtubules in patients with Alzheimer's disease</span></div><div class="casAuthors">Paula-Barbosa M; Tavares M A; Cadete-Leite A</div><div class="citationInfo"><span class="NLM_cas:title">Brain research</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">417</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-42</span>
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">The dendritic microtubules (MT) of the frontal cortex layers II and III were studied in 9 patients with Alzheimer's disease (AD) and the results compared with 9 case controls.  Dendrites with abnormally oriented MTs and others depleted of these structures were seen.  A significant reduction in the number of MTs per unit area was found in AD.  It is suggested that microtubular changes in AD can interfere with neuroplasmic transport and thus, be implicated with the dendritic degeneration present in this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRnvM5iSt7HV2LFM_lbR1VmfW6udTcc2eZAq5K6vgMiyLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2szgtVyisw%253D%253D&md5=1ae3f0742de253235860c81347331d00</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2887%2990188-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252887%252990188-0%26sid%3Dliteratum%253Aachs%26aulast%3DPaula-Barbosa%26aufirst%3DM.%26aulast%3DTavares%26aufirst%3DM.%2BA.%26aulast%3DCadete-Leite%26aufirst%3DA.%26atitle%3DA%2520quantitative%2520study%2520of%2520frontal%2520cortex%2520dendritic%2520microtubules%2520in%2520patients%2520with%2520Alzheimer%2520disease%26jtitle%3DBrain%2520Res.%26date%3D1987%26volume%3D417%26spage%3D139%26epage%3D142%26doi%3D10.1016%2F0006-8993%2887%2990188-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rustan, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frey, W. H.</span></span> <span> </span><span class="NLM_article-title">Human brain tubulin purification: decrease in soluble tubulin with age</span>. <i>Neurochem. Res.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">18</span>, <span class="refDoi">Â DOI: 10.1007/BF00964768</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1007%2FBF00964768" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=3982586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADyaL2MXhs1egsrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1985&pages=1-18&author=S.+B.+Yanauthor=S.+Hwangauthor=T.+D.+Rustanauthor=W.+H.+Frey&title=Human+brain+tubulin+purification%3A+decrease+in+soluble+tubulin+with+age&doi=10.1007%2FBF00964768"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Human brain tubulin purification:  decrease in soluble tubulin with age</span></div><div class="casAuthors">Yan, Sau Chi B.; Hwang, Sutaeg; Rustan, Timothy D.; Frey, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-18</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    </div><div class="casAbstract">The sol. tubulin of human cerebral cortex, as assessed by [3H]colchicine binding of the 100,000 g supernatant fraction, decreases drastically with age, 75% from age 0 to age 90.  There is also a considerably lower concn. of high-mol.-wt. proteins in the sol. fraction of postmortem human cerebral cortex than in that of nonhuman species.  Human brain tubulin can be polymd. into microtubules with DEAE-dextran.  The DEAE-dextran-induced microtubules are stable to cold temp. (4Â°) and Ca.  However, in the presence of 1M glutamate, the microtubules become cold labile and depolymerize at 4Â°.  The polymn.-depolymn. steps provided a novel method for purifying polymn.-competent tubulin from fresh or frozen human cerebral cortex.  Human brain tubulin purified by this method is very similar to tubulin from the brains of other mammals in mol. wt., amino acid compn., polymn.-depolymn. parameters, and structural dimensions of the microtubules formed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-DSAkSEpDk7Vg90H21EOLACvtfcHk0ljoklDvrwPaMA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXhs1egsrk%253D&md5=2b8b75661ab4f80f959d9beb14995841</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2FBF00964768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00964768%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DS.%2BB.%26aulast%3DHwang%26aufirst%3DS.%26aulast%3DRustan%26aufirst%3DT.%2BD.%26aulast%3DFrey%26aufirst%3DW.%2BH.%26atitle%3DHuman%2520brain%2520tubulin%2520purification%253A%2520decrease%2520in%2520soluble%2520tubulin%2520with%2520age%26jtitle%3DNeurochem.%2520Res.%26date%3D1985%26volume%3D10%26spage%3D1%26epage%3D18%26doi%3D10.1007%2FBF00964768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katsetos, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DrÃ¡ber, P.</span></span> <span> </span><span class="NLM_article-title">Tubulins as therapeutic targets in cancer: from bench to bedside</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">2778</span>â <span class="NLM_lpage">2792</span>, <span class="refDoi">Â DOI: 10.2174/138161212800626193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.2174%2F138161212800626193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=22390762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC38XoslCrs7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=2778-2792&issue=19&author=C.+D.+Katsetosauthor=P.+Dr%C3%A1ber&title=Tubulins+as+therapeutic+targets+in+cancer%3A+from+bench+to+bedside&doi=10.2174%2F138161212800626193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Tubulins as therapeutic targets in cancer: from bench to bedside</span></div><div class="casAuthors">Katsetos, Christos D.; Draber, Pavel</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2778-2792</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Tubulin is the target of some of the most widely used and time-honored anticancer tubulin-binding agents (TBAs).  The clin. usefulness of many TBAs has been held back as a result of tumor cell drug-resistance.  The elucidation of the three-dimensional structure of Î±Î²-tubulin dimer has provided an opportunity for rational drug design aimed at generating compds. that will target tubulin in therapeutically more efficacious ways compared to presently available drugs.  An issue to be addressed is which one(s) of the tubulin species, their isotypes, or their posttranslationally modified forms, should be specifically targeted in cancer chemotherapy.  This review offers a crit. appraisal of current knowledge on tubulins in cancer and an update on new anti-neoplastic microtubule-targeted treatment strategies.  Specifically, it examines, across disciplines, cellular/mol., biochem., clin./pathol., and pharmacol. aspects of Î²-tubulin isotypes, posttranslational modifications of tubulin dimers, Î³-tubulin and microtubule nucleation, and microtubule regulatory proteins.  Emphasis is placed on the overexpression of (i) the Î²III isotypes, which functions as a survival factor assocd. with dynamic instability of microtubules; (ii) Î³-tubulin, a key microtubule nucleating protein; and (iii) the microtubule severing enzyme spastin, involved in cell motility and proliferation of glioblastoma cells.  The role of Î²III-tubulin in resistance of cancer cells to taxanes is examd.  Attention is called to the novel concept that Î²III-tubulin functions as a "gateway" for prosurvival signals in partnership with GTPases, such as GBP1.  Appraisal is also offered on epothilones and the concept of hypersensitization to TBAs as promising therapeutic strategies in taxane resistant epithelial cancers and in high-grade gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxdmReNG2Qw7Vg90H21EOLACvtfcHk0ljoklDvrwPaMA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XoslCrs7k%253D&md5=cc9638610d51334759aa081a624f7abe</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2174%2F138161212800626193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161212800626193%26sid%3Dliteratum%253Aachs%26aulast%3DKatsetos%26aufirst%3DC.%2BD.%26aulast%3DDr%25C3%25A1ber%26aufirst%3DP.%26atitle%3DTubulins%2520as%2520therapeutic%2520targets%2520in%2520cancer%253A%2520from%2520bench%2520to%2520bedside%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2012%26volume%3D18%26issue%3D19%26spage%3D2778%26epage%3D2792%26doi%3D10.2174%2F138161212800626193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laggner, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pipp, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hainfellner, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preusser, M.</span></span> <span> </span><span class="NLM_article-title">Immunohistochemical detection of class III beta-tubulin in primary brain tumours: variable expression in most tumour types limits utility as a differential diagnostic marker</span>. <i>Histopathology</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">949</span>â <span class="NLM_lpage">952</span>, <span class="refDoi">Â DOI: 10.1111/j.1365-2559.2007.02696.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1111%2Fj.1365-2559.2007.02696.x" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=949-952&issue=7&author=U.+Laggnerauthor=I.+Pippauthor=H.+Budkaauthor=J.+A.+Hainfellnerauthor=M.+Preusser&title=Immunohistochemical+detection+of+class+III+beta-tubulin+in+primary+brain+tumours%3A+variable+expression+in+most+tumour+types+limits+utility+as+a+differential+diagnostic+marker&doi=10.1111%2Fj.1365-2559.2007.02696.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2559.2007.02696.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2559.2007.02696.x%26sid%3Dliteratum%253Aachs%26aulast%3DLaggner%26aufirst%3DU.%26aulast%3DPipp%26aufirst%3DI.%26aulast%3DBudka%26aufirst%3DH.%26aulast%3DHainfellner%26aufirst%3DJ.%2BA.%26aulast%3DPreusser%26aufirst%3DM.%26atitle%3DImmunohistochemical%2520detection%2520of%2520class%2520III%2520beta-tubulin%2520in%2520primary%2520brain%2520tumours%253A%2520variable%2520expression%2520in%2520most%2520tumour%2520types%2520limits%2520utility%2520as%2520a%2520differential%2520diagnostic%2520marker%26jtitle%3DHistopathology%26date%3D2007%26volume%3D50%26issue%3D7%26spage%3D949%26epage%3D952%26doi%3D10.1111%2Fj.1365-2559.2007.02696.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katsetos, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DrÃ¡berovÃ¡, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legido, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumontet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DrÃ¡ber, P.</span></span> <span> </span><span class="NLM_article-title">Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. Class III beta-tubulin</span>. <i>J. Cell. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>221</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">505</span>â <span class="NLM_lpage">513</span>, <span class="refDoi">Â DOI: 10.1002/jcp.21870</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1002%2Fjcp.21870" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=19650075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtF2qtb7L" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=221&publication_year=2009&pages=505-513&issue=3&author=C.+D.+Katsetosauthor=E.+Dr%C3%A1berov%C3%A1author=A.+Legidoauthor=C.+Dumontetauthor=P.+Dr%C3%A1ber&title=Tubulin+targets+in+the+pathobiology+and+therapy+of+glioblastoma+multiforme.+I.+Class+III+beta-tubulin&doi=10.1002%2Fjcp.21870"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. class III Î²-tubulin</span></div><div class="casAuthors">Katsetos, Christos D.; Draberova, Eduarda; Legido, Agustin; Dumontet, Charles; Draber, Pavel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">221</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">505-513</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Glioblastoma multiforme (GBM) is the most common and deadliest form of primary brain cancer in adults.  Despite advances in mol. biol. and genetics of gliomas currently there is no effective treatment or promising molecularly targeted exptl. therapeutic strategies for these tumors.  In previous studies we have shown aberrant overexpression of the class III Î²-tubulin isotype (Î²III-tubulin) in GBM and have proposed that this change may reflect perturbations in microtubule dynamics assocd. with glioma tumorigenesis, tumor progression and malignant transformation into GBM.  This minireview focuses on microtubules and tubulin as emerging targets in potential therapy of GBM using a new class of Î²III-tubulin-targeted drugs in the light of recent developments concerning the function and potential role of this isotype in clin. aggressive tumor behavior, cancer stem cells, tumor hypoxia and chemoresistance to tubulin binding agents, principally taxanes.  J. Cell. Physiol. 221: 505-513, 2009. Â© 2009 Wiley-Liss, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN1Htsz4QeQrVg90H21EOLACvtfcHk0ljPVgxSoISnsQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtF2qtb7L&md5=b56543debf63e7fd09431d84e3ffccb8</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fjcp.21870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.21870%26sid%3Dliteratum%253Aachs%26aulast%3DKatsetos%26aufirst%3DC.%2BD.%26aulast%3DDr%25C3%25A1berov%25C3%25A1%26aufirst%3DE.%26aulast%3DLegido%26aufirst%3DA.%26aulast%3DDumontet%26aufirst%3DC.%26aulast%3DDr%25C3%25A1ber%26aufirst%3DP.%26atitle%3DTubulin%2520targets%2520in%2520the%2520pathobiology%2520and%2520therapy%2520of%2520glioblastoma%2520multiforme.%2520I.%2520Class%2520III%2520beta-tubulin%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2009%26volume%3D221%26issue%3D3%26spage%3D505%26epage%3D513%26doi%3D10.1002%2Fjcp.21870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
der Veldt, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lammertsma, A. A.</span></span> <span> </span><span class="NLM_article-title">In vivo imaging as a pharmacodynamic marker</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2569</span>â <span class="NLM_lpage">2577</span>, <span class="refDoi">Â DOI: 10.1158/1078-0432.CCR-13-2666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1158%2F1078-0432.CCR-13-2666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=24831279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvF2gt7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=2569-2577&issue=10&author=A.+A.+van%0Ader+Veldtauthor=A.+A.+Lammertsma&title=In+vivo+imaging+as+a+pharmacodynamic+marker&doi=10.1158%2F1078-0432.CCR-13-2666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">In Vivo Imaging as a Pharmacodynamic Marker</span></div><div class="casAuthors">van der Veldt, Astrid A. M.; Lammertsma, Adriaan A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2569-2577</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Although numerous anticancer drugs are widely used in the clinic, many questions remain about pharmacokinetics, biodistribution, toxicities, and efficacy.  Positron emission tomog. (PET) using radiolabeled drugs is a promising method to further understand the clin. behavior of anticancer agents.  In addn., it may contribute to better guided treatment planning in individual patients with cancer.  Among the available anticancer drugs, considerable experience has been gained with radiolabeling taxanes.  At present, two radiolabeled taxanes, paclitaxel and docetaxel, are available as PET tracers.  In the present review, data available for the labeled taxanes [18F]paclitaxel and [11C]docetaxel are discussed and linked to clin. observations following paclitaxel and docetaxel therapy, resp.  In addn., the review discusses the applications and the future of PET using radiolabeled drugs.  Experience gained with [18F]paclitaxel and [11C]docetaxel may be extrapolated to other taxanes and may provide a framework for the development and clin. implementation of other radiolabeled anticancer drugs, even outside the taxane era.  See all articles in this section, "Progress in Pharmacodynamic Endpoints.  " Clin Cancer Res; 20(10); 2569-77. Â©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV0cv7pkx3XLVg90H21EOLACvtfcHk0ljPVgxSoISnsQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvF2gt7g%253D&md5=231d9ed92ef93cba49526922df849a68</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-2666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-2666%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BVeldt%26aufirst%3DA.%2BA.%26aulast%3DLammertsma%26aufirst%3DA.%2BA.%26atitle%3DIn%2520vivo%2520imaging%2520as%2520a%2520pharmacodynamic%2520marker%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2014%26volume%3D20%26issue%3D10%26spage%3D2569%26epage%3D2577%26doi%3D10.1158%2F1078-0432.CCR-13-2666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horwitz, S. B.</span></span> <span> </span><span class="NLM_article-title">TaxolÂ®: The first microtubule stabilizing agent</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1733</span>â <span class="NLM_lpage">1744</span>, <span class="refDoi">Â DOI: 10.3390/ijms18081733</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.3390%2Fijms18081733" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=1733-1744&issue=8&author=C.+H.+Yangauthor=S.+B.+Horwitz&title=Taxol%C2%AE%3A+The+first+microtubule+stabilizing+agent&doi=10.3390%2Fijms18081733"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.3390%2Fijms18081733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms18081733%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DC.%2BH.%26aulast%3DHorwitz%26aufirst%3DS.%2BB.%26atitle%3DTaxol%25C2%25AE%253A%2520The%2520first%2520microtubule%2520stabilizing%2520agent%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2017%26volume%3D18%26issue%3D8%26spage%3D1733%26epage%3D1744%26doi%3D10.3390%2Fijms18081733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. D.</span></span> <span> </span><span class="NLM_article-title">Current advances of tubulin inhibitors in nanoparticle drug delivery and vascular disruption/angiogenesis</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1468</span>â <span class="NLM_lpage">1487</span>, <span class="refDoi">Â DOI: 10.3390/molecules21111468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.3390%2Fmolecules21111468" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=1468-1487&issue=11&author=S.+Banerjeeauthor=D.+J.+Hwangauthor=W.+Liauthor=D.+D.+Miller&title=Current+advances+of+tubulin+inhibitors+in+nanoparticle+drug+delivery+and+vascular+disruption%2Fangiogenesis&doi=10.3390%2Fmolecules21111468"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21111468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21111468%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DHwang%26aufirst%3DD.%2BJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26atitle%3DCurrent%2520advances%2520of%2520tubulin%2520inhibitors%2520in%2520nanoparticle%2520drug%2520delivery%2520and%2520vascular%2520disruption%252Fangiogenesis%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26issue%3D11%26spage%3D1468%26epage%3D1487%26doi%3D10.3390%2Fmolecules21111468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hendrikse, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franssen, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Graaf, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaalburg, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vries, E. G.</span></span> <span> </span><span class="NLM_article-title">Visualization of multidrug resistance in vivo</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">283</span>â <span class="NLM_lpage">293</span>, <span class="refDoi">Â DOI: 10.1007/s002590050390</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1007%2Fs002590050390" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1999&pages=283-293&issue=3&author=N.+H.+Hendrikseauthor=E.+J.+Franssenauthor=W.+T.+van+der%0AGraafauthor=W.+Vaalburgauthor=E.+G.+de+Vries&title=Visualization+of+multidrug+resistance+in+vivo&doi=10.1007%2Fs002590050390"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs002590050390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002590050390%26sid%3Dliteratum%253Aachs%26aulast%3DHendrikse%26aufirst%3DN.%2BH.%26aulast%3DFranssen%26aufirst%3DE.%2BJ.%26aulast%3Dvan%2Bder%2BGraaf%26aufirst%3DW.%2BT.%26aulast%3DVaalburg%26aufirst%3DW.%26aulast%3Dde%2BVries%26aufirst%3DE.%2BG.%26atitle%3DVisualization%2520of%2520multidrug%2520resistance%2520in%2520vivo%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D1999%26volume%3D26%26issue%3D3%26spage%3D283%26epage%3D293%26doi%3D10.1007%2Fs002590050390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Levchenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humm, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augensen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Squire, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kothari, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finn, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, S. M.</span></span> <span> </span><span class="NLM_article-title">Evaluation of 11C-colchicine for PET imaging of multiple drug resistance</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">493</span>â <span class="NLM_lpage">501</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=493-501&issue=3&author=A.+Levchenkoauthor=B.+M.+Mehtaauthor=J.+B.+Leeauthor=J.+L.+Hummauthor=F.+Augensenauthor=O.+Squireauthor=P.+J.+Kothariauthor=R.+D.+Finnauthor=E.+F.+Leonardauthor=S.+M.+Larson&title=Evaluation+of+11C-colchicine+for+PET+imaging+of+multiple+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevchenko%26aufirst%3DA.%26aulast%3DMehta%26aufirst%3DB.%2BM.%26aulast%3DLee%26aufirst%3DJ.%2BB.%26aulast%3DHumm%26aufirst%3DJ.%2BL.%26aulast%3DAugensen%26aufirst%3DF.%26aulast%3DSquire%26aufirst%3DO.%26aulast%3DKothari%26aufirst%3DP.%2BJ.%26aulast%3DFinn%26aufirst%3DR.%2BD.%26aulast%3DLeonard%26aufirst%3DE.%2BF.%26aulast%3DLarson%26aufirst%3DS.%2BM.%26atitle%3DEvaluation%2520of%252011C-colchicine%2520for%2520PET%2520imaging%2520of%2520multiple%2520drug%2520resistance%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2000%26volume%3D41%26issue%3D3%26spage%3D493%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voll, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 2-[11C]methoxy-3,17Î²- estradiol to measure the pharmacokinetics of an antitumor drug candidate, 2-methoxy-3,17Î²-estradiol</span>. <i>J. Labelled Compd. Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1117</span>â <span class="NLM_lpage">1124</span>, <span class="refDoi">Â DOI: 10.1002/jlcr.1131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1002%2Fjlcr.1131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12hu73N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1117-1124&author=J.+Munauthor=R.+J.+Vollauthor=M.+M.+Goodman&title=Synthesis+of+2-%5B11C%5Dmethoxy-3%2C17%CE%B2-+estradiol+to+measure+the+pharmacokinetics+of+an+antitumor+drug+candidate%2C+2-methoxy-3%2C17%CE%B2-estradiol&doi=10.1002%2Fjlcr.1131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 2-[11C]methoxy-3,17Î²-estradiol to measure the pharmacokinetics of an antitumor drug candidate, 2-methoxy-3,17Î²-estradiol</span></div><div class="casAuthors">Mun, Jiyoung; Voll, Ronald J.; Goodman, Mark M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1117-1124</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">2-Methoxy-3,17Î²-estradiol, an endogenous estrogen metabolite, showed cytotoxicity in various cancer cell lines and also has antiangiogenic and proapoptotic activities.  Clin. I and II trials of 2-methoxy-3,17Î²-estradiol for multiple myeloma, advanced solid tumors, metastatic breast and prostate cancer are underway.  We prepd. 2-[11C]methoxy-3,17Î²-estradiol to measure the pharmacokinetics and organ distribution of 2-methoxy-3,17Î²-estradiol in clin. trials.  2-[11C]Methoxy-3,17Î²-estradiol was synthesized from a precursor, 2-hydroxy-3,17Î²-O-bis(methoxymethyl)estradiol, in two steps with over 99% radiochem. purity.  The overall reaction time was 45 min and the decay-cor. radiochem. yield was 32.9%.  The distribution coeff. (logP7.4) of 2-[11C]methoxy-3,17Î²-estradiol at pH 7.4 was measured as 2.95.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-PkUkUO5Jx7Vg90H21EOLACvtfcHk0lj52BkFw8hoJg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12hu73N&md5=c8dad2ff26817cbb257c9ffbc42b698a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.1131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.1131%26sid%3Dliteratum%253Aachs%26aulast%3DMun%26aufirst%3DJ.%26aulast%3DVoll%26aufirst%3DR.%2BJ.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26atitle%3DSynthesis%2520of%25202-%255B11C%255Dmethoxy-3%252C17%25CE%25B2-%2520estradiol%2520to%2520measure%2520the%2520pharmacokinetics%2520of%2520an%2520antitumor%2520drug%2520candidate%252C%25202-methoxy-3%252C17%25CE%25B2-estradiol%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2006%26volume%3D49%26spage%3D1117%26epage%3D1124%26doi%3D10.1002%2Fjlcr.1131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voll, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escuin-Borras, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannakakou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span> <span> </span><span class="NLM_article-title">Syntheses and biological activities of novel 2-methoxyestradiol analogs, 2-fluoroethoxyestradiol and 2-fluoropropanoxyestradiol, and a radiosynthesis of 2-[(18)F]fluoroethoxyestradiol for positron emission tomography</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">615</span>â <span class="NLM_lpage">622</span>, <span class="refDoi">Â DOI: 10.1016/j.nucmedbio.2008.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1016%2Fj.nucmedbio.2008.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=18589306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVKnsbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=615-622&issue=5&author=J.+Munauthor=Y.+Wangauthor=R.+J.+Vollauthor=D.+Escuin-Borrasauthor=P.+Giannakakouauthor=M.+M.+Goodman&title=Syntheses+and+biological+activities+of+novel+2-methoxyestradiol+analogs%2C+2-fluoroethoxyestradiol+and+2-fluoropropanoxyestradiol%2C+and+a+radiosynthesis+of+2-%5B%2818%29F%5Dfluoroethoxyestradiol+for+positron+emission+tomography&doi=10.1016%2Fj.nucmedbio.2008.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Syntheses and biological activities of novel 2-methoxyestradiol analogs, 2-fluoroethoxyestradiol and 2-fluoropropanoxyestradiol, and a radiosynthesis of 2-[18F]fluoroethoxyestradiol for positron emission tomography</span></div><div class="casAuthors">Mun, Jiyoung; Wang, Yuefang; Voll, Ronald J.; Escuin-Borras, Daniel; Giannakakou, Paraskevi; Goodman, Mark M.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">615-622</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Introduction: 2-Methoxyestradiol (2ME2) is an endogenous metabolite of the human hormone, estrogen, which has been shown to possess antitumor activity.  2-Fluoroethoxyestradiol (2FEE2) and 2-fluoropropanoxyestradiol (2FPE2), novel analogs of 2-methoxyestradiol, were designed and synthesized to be utilized as F-18 radiotracers for positron emission tomog. (PET), with which the biodistribution and intratumoral accumulations of 2ME2 could be measured in vivo for potential translation to human use.  Methods: 2FEE2 and 2FPE2 were synthesized from 3,17Î²-estradiol in five steps resp.  Drug-induced microtubule depolymn., antiproliferative activity against human cancer cell lines and HIF-1Î± down-regulation by 2FEE2 and 2FPE2 were investigated to examine whether these mols. possess similar antitumor activities as 2-methoxyestradiol.  2-[18F]Fluoroethoxyestradiol was synthesized for PET.  Results: Novel 2ME2 analogs, 2FEE2 and 2FPE2, were synthesized in 29% and 22% overall yield, resp.  2FEE2 and 2FPE2 showed microtubule depolymn. and cytotoxicities against the human ovarian carcinoma cell line, 1A9, and the human glioma cell line, LN229.  HIF-1Î± was down-regulated by 2FEE2 and 2FPE2 under hypoxic conditions.  2-[18F]Fluoroethoxyestradiol (2[18F]FEE2) was prepd. in 8.3% decay-cor. yield in 90 min, based on a prodn. of H[18F]F with more than 98% radiochem. purity.  2FEE2 was chosen as an F-18 radiotracer candidate, since it showed stronger antiproliferative activity than 2ME2 and 2FPE2.  Conclusions: 2FEE2 and 2FPE2 showed similar activity as 2ME2.  2[18F]FEE2 was synthesized to be utilized as a PET radiotracer to measure the biol. efficacy of 2ME2 and its analogs in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotNF4CS9v9_bVg90H21EOLACvtfcHk0lj52BkFw8hoJg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVKnsbo%253D&md5=0c5dfd7cf1a36448225fb95ec242ba7a</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2008.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2008.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DMun%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DVoll%26aufirst%3DR.%2BJ.%26aulast%3DEscuin-Borras%26aufirst%3DD.%26aulast%3DGiannakakou%26aufirst%3DP.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26atitle%3DSyntheses%2520and%2520biological%2520activities%2520of%2520novel%25202-methoxyestradiol%2520analogs%252C%25202-fluoroethoxyestradiol%2520and%25202-fluoropropanoxyestradiol%252C%2520and%2520a%2520radiosynthesis%2520of%25202-%255B%252818%2529F%255Dfluoroethoxyestradiol%2520for%2520positron%2520emission%2520tomography%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2008%26volume%3D35%26issue%3D5%26spage%3D615%26epage%3D622%26doi%3D10.1016%2Fj.nucmedbio.2008.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jalilian, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seyfi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afarideh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shafiee, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a [18F]labeled chelidonine derivative as a possible antitumor agent</span>. <i>Appl. Radiat. Isot.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">407</span>â <span class="NLM_lpage">411</span>, <span class="refDoi">Â DOI: 10.1016/S0969-8043(00)00270-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1016%2FS0969-8043%2800%2900270-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=11214874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtVWlu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2001&pages=407-411&issue=3&author=A.+R.+Jalilianauthor=P.+Seyfiauthor=H.+Afaridehauthor=A.+Shafiee&title=Synthesis+of+a+%5B18F%5Dlabeled+chelidonine+derivative+as+a+possible+antitumor+agent&doi=10.1016%2FS0969-8043%2800%2900270-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a [18F]labeled chelidonine derivative as a possible antitumor agent</span></div><div class="casAuthors">Jalilian, A. R.; Seyfi, P.; Afarideh, H.; Shafiee, A.</div><div class="citationInfo"><span class="NLM_cas:title">Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">407-411</span>CODEN:
                <span class="NLM_cas:coden">ARISEF</span>;
        ISSN:<span class="NLM_cas:issn">0969-8043</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">{(Â±)-[5BRS-(5bÎ±,6Î²,12bÎ±)]-5b,6,7,12b,13,14-hexahydro-13-methyl[1,3]benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridin-6-yl}-4-[18F]-fluorobenzoate (I) an arom. ester of (Â±)-chelidonine was prepd. as a possible PET radiotracer.  I was prepd. in no-carrier-added (n.c.a) form from the 4-N,N,N-trimethylanilinium triflate deriv. in one step.  The best results were obtained using Kryptofix2.2.2/[18F] and DMSO as the solvent at 90Â°C.  Column chromatog. afforded the desired compd. in overall radiochem. yield of 65-70% (EOS) with a specific activity of about 3000 Ci/mmole and radiochem. purity greater than 95% in 15 min.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGRK7LzWWDwbVg90H21EOLACvtfcHk0liM1rENpvwYBg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtVWlu7c%253D&md5=ef6ff1fc16f3623541bf8fcc8aa2fbf5</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0969-8043%2800%2900270-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8043%252800%252900270-0%26sid%3Dliteratum%253Aachs%26aulast%3DJalilian%26aufirst%3DA.%2BR.%26aulast%3DSeyfi%26aufirst%3DP.%26aulast%3DAfarideh%26aufirst%3DH.%26aulast%3DShafiee%26aufirst%3DA.%26atitle%3DSynthesis%2520of%2520a%2520%255B18F%255Dlabeled%2520chelidonine%2520derivative%2520as%2520a%2520possible%2520antitumor%2520agent%26jtitle%3DAppl.%2520Radiat.%2520Isot.%26date%3D2001%26volume%3D54%26issue%3D3%26spage%3D407%26epage%3D411%26doi%3D10.1016%2FS0969-8043%2800%2900270-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kasibhatla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baichwal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skvortsova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skvortsov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">English, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirisoma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pervin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pleiman, C. M.</span></span> <span> </span><span class="NLM_article-title">MPC-6827: a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5865</span>â <span class="NLM_lpage">5871</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-07-0127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1158%2F0008-5472.CAN-07-0127" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=5865-5871&issue=12&author=S.+Kasibhatlaauthor=V.+Baichwalauthor=S.+X.+Caiauthor=B.+Rothauthor=I.+Skvortsovaauthor=S.+Skvortsovauthor=P.+Lukasauthor=N.+M.+Englishauthor=N.+Sirisomaauthor=J.+Dreweauthor=A.+Pervinauthor=B.+Tsengauthor=R.+O.+Carlsonauthor=C.+M.+Pleiman&title=MPC-6827%3A+a+small-molecule+inhibitor+of+microtubule+formation+that+is+not+a+substrate+for+multidrug+resistance+pumps&doi=10.1158%2F0008-5472.CAN-07-0127"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-0127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-0127%26sid%3Dliteratum%253Aachs%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DBaichwal%26aufirst%3DV.%26aulast%3DCai%26aufirst%3DS.%2BX.%26aulast%3DRoth%26aufirst%3DB.%26aulast%3DSkvortsova%26aufirst%3DI.%26aulast%3DSkvortsov%26aufirst%3DS.%26aulast%3DLukas%26aufirst%3DP.%26aulast%3DEnglish%26aufirst%3DN.%2BM.%26aulast%3DSirisoma%26aufirst%3DN.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DPervin%26aufirst%3DA.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DCarlson%26aufirst%3DR.%2BO.%26aulast%3DPleiman%26aufirst%3DC.%2BM.%26atitle%3DMPC-6827%253A%2520a%2520small-molecule%2520inhibitor%2520of%2520microtubule%2520formation%2520that%2520is%2520not%2520a%2520substrate%2520for%2520multidrug%2520resistance%2520pumps%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26issue%3D12%26spage%3D5865%26epage%3D5871%26doi%3D10.1158%2F0008-5472.CAN-07-0127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sirisoma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pervin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willardsen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mather, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pleiman, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasibhatla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, S. X.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-(4-methoxyphenyl)-N,2-dimethylquina- zolin-4-amine, a potent apoptosis inducer and efficacious anticancer agent with high blood brain barrier penetration</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2341</span>â <span class="NLM_lpage">2351</span>, <span class="refDoi">Â DOI: 10.1021/jm801315b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801315b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2341-2351&issue=8&author=N.+Sirisomaauthor=A.+Pervinauthor=H.+Zhangauthor=S.+Jiangauthor=J.+A.+Willardsenauthor=M.+B.+Andersonauthor=G.+Matherauthor=C.+M.+Pleimanauthor=S.+Kasibhatlaauthor=B.+Tsengauthor=J.+Dreweauthor=S.+X.+Cai&title=Discovery+of+N-%284-methoxyphenyl%29-N%2C2-dimethylquina-+zolin-4-amine%2C+a+potent+apoptosis+inducer+and+efficacious+anticancer+agent+with+high+blood+brain+barrier+penetration&doi=10.1021%2Fjm801315b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm801315b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801315b%26sid%3Dliteratum%253Aachs%26aulast%3DSirisoma%26aufirst%3DN.%26aulast%3DPervin%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26aulast%3DAnderson%26aufirst%3DM.%2BB.%26aulast%3DMather%26aufirst%3DG.%26aulast%3DPleiman%26aufirst%3DC.%2BM.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%2520N-%25284-methoxyphenyl%2529-N%252C2-dimethylquina-%2520zolin-4-amine%252C%2520a%2520potent%2520apoptosis%2520inducer%2520and%2520efficacious%2520anticancer%2520agent%2520with%2520high%2520blood%2520brain%2520barrier%2520penetration%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D8%26spage%3D2341%26epage%3D2351%26doi%3D10.1021%2Fjm801315b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Resch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ficner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schobert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biersack, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, T.</span></span> <span> </span><span class="NLM_article-title">Effects of the tumor-vasculature-disrupting agent verubulin and two heteroaryl analogues on cancer cells, endothelial cells, and blood vessels</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">847</span>â <span class="NLM_lpage">854</span>, <span class="refDoi">Â DOI: 10.1002/cmdc.201300531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1002%2Fcmdc.201300531" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=847-854&issue=4&author=K.+Mahalauthor=M.+Reschauthor=R.+Ficnerauthor=R.+Schobertauthor=B.+Biersackauthor=T.+Mueller&title=Effects+of+the+tumor-vasculature-disrupting+agent+verubulin+and+two+heteroaryl+analogues+on+cancer+cells%2C+endothelial+cells%2C+and+blood+vessels&doi=10.1002%2Fcmdc.201300531"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300531%26sid%3Dliteratum%253Aachs%26aulast%3DMahal%26aufirst%3DK.%26aulast%3DResch%26aufirst%3DM.%26aulast%3DFicner%26aufirst%3DR.%26aulast%3DSchobert%26aufirst%3DR.%26aulast%3DBiersack%26aufirst%3DB.%26aulast%3DMueller%26aufirst%3DT.%26atitle%3DEffects%2520of%2520the%2520tumor-vasculature-disrupting%2520agent%2520verubulin%2520and%2520two%2520heteroaryl%2520analogues%2520on%2520cancer%2520cells%252C%2520endothelial%2520cells%252C%2520and%2520blood%2520vessels%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26issue%3D4%26spage%3D847%26epage%3D854%26doi%3D10.1002%2Fcmdc.201300531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chamberlain, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phuphanich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Recht, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenfeld, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadul, C. E.</span></span> <span> </span><span class="NLM_article-title">Brain tumor investigational consortium. A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the Brain Tumor Investigational Consortium (BTIC)</span>. <i>J. Neuro-Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>118</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">335</span>â <span class="NLM_lpage">343</span>, <span class="refDoi">Â DOI: 10.1007/s11060-014-1437-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1007%2Fs11060-014-1437-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=24740196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpt1Oit7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2014&pages=335-343&issue=2&author=M.+C.+Chamberlainauthor=S.+Grimmauthor=S.+Phuphanichauthor=L.+Rechtauthor=J.+Z.+Zhuauthor=L.+Kimauthor=S.+Rosenfeldauthor=C.+E.+Fadul&title=Brain+tumor+investigational+consortium.+A+phase+2+trial+of+verubulin+for+recurrent+glioblastoma%3A+a+prospective+study+by+the+Brain+Tumor+Investigational+Consortium+%28BTIC%29&doi=10.1007%2Fs11060-014-1437-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the brain tumor investigational consortium (BTIC)</span></div><div class="casAuthors">Chamberlain, Marc C.; Grimm, Sean; Phuphanich, Surasak; Recht, Larry; Zhu, Jay Z.; Kim, Lyndon; Rosenfeld, Steve; Fadul, Camilo E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuro-Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">335-343</span>CODEN:
                <span class="NLM_cas:coden">JNODD2</span>;
        ISSN:<span class="NLM_cas:issn">0167-594X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Treatment options are limited for recurrent glioblastoma (GBM).  Verubulin is a microtubule destabilizer and vascular disrupting agent that achieve high brain concn. relative to plasma in animals.  Adults with recurrent GBM who failed prior std. therapy were eligible.  The primary endpoint was 1-mo progression-free survival (PFS-1) for bevacizumab refractory (Group 2) and 6-mo progression-free survival (PFS-6) for bevacizumab naive patients (Group 1).  Verubulin was administered at 3.3 mg/m2 as a 2-h i.v. infusion once weekly for 3 consecutive weeks in a 4-wk cycle.  The planned sample size was 34 subjects per cohort. 56 patients (37 men, 19 women) were enrolled, 31 in Group 1 and 25 in Group 2.  The PFS-6 for Group 1 was 14 % and the PFS-1 for Group 2 was 20 %.  Median survival from onset of treatment was 9.5 mo in Group 1 and 3.4 mo in Group 2.  Best overall response was partial response (n = 3; 10 % in Group 1; n = 1; 4.2 % in Group 2) and stable disease (n = 7; 23 % in Group 1; n = 5; 21 % in Group 2).  In Group 1, 38.7 % of patients experienced a serious adverse event; however only 3.2 % were potentially attributable to study drug.  In Group 2, 44 % of patients experienced a serious adverse event although none were attributable to study drug.  Accrual was terminated early for futility.  Single agent verubulin, in this dose and schedule, is well tolerated, assocd. with moderate but tolerable toxicity but has limited activity in either bevacizumab naive or refractory recurrent GBM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomdh3oV1Ivk7Vg90H21EOLACvtfcHk0lh-9AbOCUTM1g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpt1Oit7Y%253D&md5=9d0edc9a438512b437c0b661fadfe84d</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1007%2Fs11060-014-1437-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11060-014-1437-y%26sid%3Dliteratum%253Aachs%26aulast%3DChamberlain%26aufirst%3DM.%2BC.%26aulast%3DGrimm%26aufirst%3DS.%26aulast%3DPhuphanich%26aufirst%3DS.%26aulast%3DRecht%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DJ.%2BZ.%26aulast%3DKim%26aufirst%3DL.%26aulast%3DRosenfeld%26aufirst%3DS.%26aulast%3DFadul%26aufirst%3DC.%2BE.%26atitle%3DBrain%2520tumor%2520investigational%2520consortium.%2520A%2520phase%25202%2520trial%2520of%2520verubulin%2520for%2520recurrent%2520glioblastoma%253A%2520a%2520prospective%2520study%2520by%2520the%2520Brain%2520Tumor%2520Investigational%2520Consortium%2520%2528BTIC%2529%26jtitle%3DJ.%2520Neuro-Oncol.%26date%3D2014%26volume%3D118%26issue%3D2%26spage%3D335%26epage%3D343%26doi%3D10.1007%2Fs11060-014-1437-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grossmann, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akerley, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glantz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beelen, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Groot, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aiken, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, R. L.</span></span> <span> </span><span class="NLM_article-title">Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme</span>. <i>J. Neuro-Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>110</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">257</span>â <span class="NLM_lpage">264</span>, <span class="refDoi">Â DOI: 10.1007/s11060-012-0964-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1007%2Fs11060-012-0964-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=22932984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFagsrrI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2012&pages=257-264&issue=2&author=K.+F.+Grossmannauthor=H.+Colmanauthor=W.+A.+Akerleyauthor=M.+Glantzauthor=Y.+Matsuokoauthor=A.+P.+Beelenauthor=M.+Yuauthor=J.+F.+De+Grootauthor=R.+D.+Aikenauthor=J.+J.+Olsenauthor=B.+A.+Evansauthor=R.+L.+Jensen&title=Phase+I+trial+of+verubulin+%28MPC-6827%29+plus+carboplatin+in+patients+with+relapsed+glioblastoma+multiforme&doi=10.1007%2Fs11060-012-0964-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme</span></div><div class="casAuthors">Grossmann, Kenneth F.; Colman, Howard; Akerley, Wallace A.; Glantz, Michael; Matsuoko, Yuko; Beelen, Andrew P.; Yu, Margaret; Groot, John F.; Aiken, Robert D.; Olsen, Jeffery J.; Evans, Brent A.; Jensen, Randy L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuro-Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">257-264</span>CODEN:
                <span class="NLM_cas:coden">JNODD2</span>;
        ISSN:<span class="NLM_cas:issn">0167-594X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Verubulin (MPC-6827) is a microtubule-destabilizing agent that achieves high concns. in the brain.  Verubulin disrupts newly formed blood vessels in xenografts.  We detd. the safety and tolerability of verubulin administered in combination with carboplatin in patients with relapsed glioblastoma multiforme (GBM).  Three pre-selected doses of verubulin were tested: 2.1, 2.7, and 3.3 mg/m2 in a std. "3+3" design.  Verubulin was given every second week of a 6-wk cycle in the 2.1 mg/m2 cohort or weekly for 3 wk of a 4-wk cycle in subsequent cohorts.  Carboplatin was administered i.v. at an area under the curve (AUC) dosage 4 every 2 wk for the 2.1 mg/m2 cohort or on day 1 of each 4-wk cycle in subsequent cohorts.  Nineteen patients with GBM in first or second relapse were enrolled.  Four patients (21 %) experienced a grade 3 or greater verubulin- or carboplatin-related adverse event, including hypesthesia, cerebral ischemia, anemia, and thrombocytopenia.  The mean plasma half life of verubulin was 3.2 h (SD = 0.82).  Two patients achieved at least a partial response by Macdonald criteria.  One of these patients remains progression free and off treatment more than 24 mo beyond his initiation of verubulin.  Five patients had stable disease.  Median progression-free survival (PFS) across all patients was 8 wk, and the 6-mo PFS rate was 21 %.  The combination of verubulin at the previously detd. single-agent max. tolerated dose of 3.3 mg/m2 with carboplatin in patients with recurrent/refractory GBM is safe and well tolerated.  In this patient population with a highly vascularized tumor, no cerebral hemorrhage was obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzTGKu9Dd7kLVg90H21EOLACvtfcHk0lh-9AbOCUTM1g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFagsrrI&md5=460e95d82078c2bff2334cac6eda0f9c</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1007%2Fs11060-012-0964-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11060-012-0964-7%26sid%3Dliteratum%253Aachs%26aulast%3DGrossmann%26aufirst%3DK.%2BF.%26aulast%3DColman%26aufirst%3DH.%26aulast%3DAkerley%26aufirst%3DW.%2BA.%26aulast%3DGlantz%26aufirst%3DM.%26aulast%3DMatsuoko%26aufirst%3DY.%26aulast%3DBeelen%26aufirst%3DA.%2BP.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DDe%2BGroot%26aufirst%3DJ.%2BF.%26aulast%3DAiken%26aufirst%3DR.%2BD.%26aulast%3DOlsen%26aufirst%3DJ.%2BJ.%26aulast%3DEvans%26aufirst%3DB.%2BA.%26aulast%3DJensen%26aufirst%3DR.%2BL.%26atitle%3DPhase%2520I%2520trial%2520of%2520verubulin%2520%2528MPC-6827%2529%2520plus%2520carboplatin%2520in%2520patients%2520with%2520relapsed%2520glioblastoma%2520multiforme%26jtitle%3DJ.%2520Neuro-Oncol.%26date%3D2012%26volume%3D110%26issue%3D2%26spage%3D257%26epage%3D264%26doi%3D10.1007%2Fs11060-012-0964-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsimberidou, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akerley, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schabel, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uehara, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chhabra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mather, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodland, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swabb, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurzrock, R.</span></span> <span> </span><span class="NLM_article-title">Phase I clinical trial of MPC-6827 (Azixa), a microtubule destabilizing agent, in patients with advanced cancer</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">3410</span>â <span class="NLM_lpage">3419</span>, <span class="refDoi">Â DOI: 10.1158/1535-7163.MCT-10-0516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1158%2F1535-7163.MCT-10-0516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=21159616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGrsLjN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=3410-3419&issue=12&author=A.+M.+Tsimberidouauthor=W.+Akerleyauthor=M.+C.+Schabelauthor=D.+S.+Hongauthor=C.+Ueharaauthor=A.+Chhabraauthor=T.+Warrenauthor=G.+G.+Matherauthor=B.+A.+Evansauthor=D.+P.+Woodlandauthor=E.+A.+Swabbauthor=R.+Kurzrock&title=Phase+I+clinical+trial+of+MPC-6827+%28Azixa%29%2C+a+microtubule+destabilizing+agent%2C+in+patients+with+advanced+cancer&doi=10.1158%2F1535-7163.MCT-10-0516"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I Clinical Trial of MPC-6827 (Azixa), a Microtubule Destabilizing Agent, in Patients with Advanced Cancer</span></div><div class="casAuthors">Tsimberidou, Apostolia-Maria; Akerley, Wallace; Schabel, Matthias C.; Hong, David S.; Uehara, Cynthia; Chhabra, Anil; Warren, Terri; Mather, Gary G.; Evans, Brent A.; Woodland, Deane P.; Swabb, Edward A.; Kurzrock, Razelle</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3410-3419</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">MPC-6827 (Azixa) is a small-mol. microtubule-destabilizing agent that binds to the same (or nearby) sites on Î²-tubulin as colchicine.  This phase I study was designed to det. the dose-limiting toxicities (DLT), max. tolerated dose (MTD), and pharmacokinetics (PK) of MPC-6827 in patients with solid tumors.  Patients with advanced/metastatic cancer were treated with once-weekly, 1- to 2-h i.v. administration of MPC-6827 for 3 consecutive weeks every 28 days (1 cycle).  Dose escalation began with 0.3, 0.6, 1, and 1.5 mg/m2, with subsequent increments of 0.6 mg/m2 until the MTD was detd.  A 3 + 3 design was used.  Pharmacokinetics of MPC-6827 and its metabolite MPI-0440627 were evaluated.  Forty-eight patients received therapy; 79 cycles were completed (median, 1; range, 1-10).  The most common adverse events were nausea, fatigue, flushing, and hyperglycemia.  The DLT was nonfatal grade 3 myocardial infarction at 3.9 mg/m2 (1/6 patients) and at 4.5 mg/m2 (1/7 patients).  The MTD was detd. to be 3.3 mg/m2 (0/13 patients had a DLT).  Five (10.4%) of the 48 patients achieved stable disease (Response Evaluation Criteria in Solid Tumors) for 4 mo or greater.  MPC-6827 has a high vol. of distribution and clearance.  Half-life ranged from 3.8 to 7.5 h.  In conclusion, MPC-6827 administered i.v. over 2 h at a dose of 3.3 mg/m2 once weekly for 3 wk every 28 days was safe in patients with heavily pretreated cancer.  Clin. trials with MPC-6827 and chemotherapy are ongoing.  Mol Cancer Ther; 9(12); 3410-9.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQxB3bYYYZ1rVg90H21EOLACvtfcHk0lh-9AbOCUTM1g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGrsLjN&md5=97b0a255d67eec98f8bd7c3709cdcf6c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-0516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-0516%26sid%3Dliteratum%253Aachs%26aulast%3DTsimberidou%26aufirst%3DA.%2BM.%26aulast%3DAkerley%26aufirst%3DW.%26aulast%3DSchabel%26aufirst%3DM.%2BC.%26aulast%3DHong%26aufirst%3DD.%2BS.%26aulast%3DUehara%26aufirst%3DC.%26aulast%3DChhabra%26aufirst%3DA.%26aulast%3DWarren%26aufirst%3DT.%26aulast%3DMather%26aufirst%3DG.%2BG.%26aulast%3DEvans%26aufirst%3DB.%2BA.%26aulast%3DWoodland%26aufirst%3DD.%2BP.%26aulast%3DSwabb%26aufirst%3DE.%2BA.%26aulast%3DKurzrock%26aufirst%3DR.%26atitle%3DPhase%2520I%2520clinical%2520trial%2520of%2520MPC-6827%2520%2528Azixa%2529%252C%2520a%2520microtubule%2520destabilizing%2520agent%252C%2520in%2520patients%2520with%2520advanced%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26issue%3D12%26spage%3D3410%26epage%3D3419%26doi%3D10.1158%2F1535-7163.MCT-10-0516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lockman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klimova, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willardsen, J. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of substituted quinazolines: Application to the synthesis of verubulin</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1715</span>â <span class="NLM_lpage">1723</span>, <span class="refDoi">Â DOI: 10.1080/00397911.2010.529730</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1080%2F00397911.2010.529730" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVGhsb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2012&pages=1715-1723&issue=12&author=J.+W.+Lockmanauthor=Y.+Klimovaauthor=M.+B.+Andersonauthor=J.+A.+Willardsen&title=Synthesis+of+substituted+quinazolines%3A+Application+to+the+synthesis+of+verubulin&doi=10.1080%2F00397911.2010.529730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of substituted quinazolines: application to the synthesis of verubulin</span></div><div class="casAuthors">Lockman, Jeffrey W.; Klimova, Yevgeniya; Anderson, Mark B.; Willardsen, J. Adam</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1715-1723</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Through newly adapted methodol., 2-methyl-3H-quinazolin-4-one was activated using a no. of methods followed by displacement to afford 4-aminoquinazolines.  The most useful of these processes utilize the p-toluenesulfonate ester or I2/PPh3 activation.  Using this methodol., the anticancer vascular targeting clin. candidate verubulin (I) was synthesized in a highly efficient manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJpMEOVLXHuLVg90H21EOLACvtfcHk0ljVo5HJItRSkw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVGhsb8%253D&md5=a1563ba9daffe1f09b571718867cbd20</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1080%2F00397911.2010.529730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397911.2010.529730%26sid%3Dliteratum%253Aachs%26aulast%3DLockman%26aufirst%3DJ.%2BW.%26aulast%3DKlimova%26aufirst%3DY.%26aulast%3DAnderson%26aufirst%3DM.%2BB.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26atitle%3DSynthesis%2520of%2520substituted%2520quinazolines%253A%2520Application%2520to%2520the%2520synthesis%2520of%2520verubulin%26jtitle%3DSynth.%2520Commun.%26date%3D2012%26volume%3D42%26issue%3D12%26spage%3D1715%26epage%3D1723%26doi%3D10.1080%2F00397911.2010.529730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houle, S.</span></span> <span> </span><span class="NLM_article-title">An admonition when measuring the lipophilicity of radiotracers using counting techniques</span>. <i>Appl. Radiat. Isot.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">203</span>â <span class="NLM_lpage">208</span>, <span class="refDoi">Â DOI: 10.1016/S0969-8043(00)00269-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1016%2FS0969-8043%2800%2900269-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=11200881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovFSrtLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2001&pages=203-208&issue=2&author=A.+A.+Wilsonauthor=L.+Jinauthor=A.+Garciaauthor=J.+N.+DaSilvaauthor=S.+Houle&title=An+admonition+when+measuring+the+lipophilicity+of+radiotracers+using+counting+techniques&doi=10.1016%2FS0969-8043%2800%2900269-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">An admonition when measuring the lipophilicity of radiotracers using counting techniques</span></div><div class="casAuthors">Wilson, A. A.; Jin, L.; Garcia, A.; DaSilva, J. N.; Houle, S.</div><div class="citationInfo"><span class="NLM_cas:title">Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">203-208</span>CODEN:
                <span class="NLM_cas:coden">ARISEF</span>;
        ISSN:<span class="NLM_cas:issn">0969-8043</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Log P measurements are a fundamental physico-chem. parameter and one of the cornerstones of structure-activity relationships in medicinal chem.  Despite the attractiveness of the method, the use of counting techniques to measure the log P of lipophilic radiotracers is fraught with pitfalls due to the amplifying effects of small quantities of radioactive impurities.  For example, a radiotracer with a log P of 4 contg. only 0.1% of a radioactive impurity with a log P of -1 will have an apparent log P of 3 if measured using conventional shake-flask partition techniques, counting the radioactivity in each phase.  However, pre-washing the radiotracer-contg. org. phase with aq. phase can, in many cases, allay doubts about the validity of such measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr80UKR8GWYeLVg90H21EOLACvtfcHk0ljVo5HJItRSkw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovFSrtLc%253D&md5=452528ce86fd39c9bb6368f83f24df07</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0969-8043%2800%2900269-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8043%252800%252900269-4%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DA.%2BA.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DGarcia%26aufirst%3DA.%26aulast%3DDaSilva%26aufirst%3DJ.%2BN.%26aulast%3DHoule%26aufirst%3DS.%26atitle%3DAn%2520admonition%2520when%2520measuring%2520the%2520lipophilicity%2520of%2520radiotracers%2520using%2520counting%2520techniques%26jtitle%3DAppl.%2520Radiat.%2520Isot.%26date%3D2001%26volume%3D54%26issue%3D2%26spage%3D203%26epage%3D208%26doi%3D10.1016%2FS0969-8043%2800%2900269-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solingapuram
Sai, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattiraju, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almaguel, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craft, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mintz, A.</span></span> <span> </span><span class="NLM_article-title">Radiolabeling and initial biological evaluation of [18F]KBM-1 for imaging RAR-a receptors in neuroblastoma</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1425</span>â <span class="NLM_lpage">1427</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2017.01.093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1016%2Fj.bmcl.2017.01.093" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=1425-1427&issue=6&author=K.+K.+Solingapuram%0ASaiauthor=B.+C.+Dasauthor=A.+Sattirajuauthor=F.+G.+Almaguelauthor=S.+Craftauthor=A.+Mintz&title=Radiolabeling+and+initial+biological+evaluation+of+%5B18F%5DKBM-1+for+imaging+RAR-a+receptors+in+neuroblastoma&doi=10.1016%2Fj.bmcl.2017.01.093"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.01.093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.01.093%26sid%3Dliteratum%253Aachs%26aulast%3DSolingapuram%2BSai%26aufirst%3DK.%2BK.%26aulast%3DDas%26aufirst%3DB.%2BC.%26aulast%3DSattiraju%26aufirst%3DA.%26aulast%3DAlmaguel%26aufirst%3DF.%2BG.%26aulast%3DCraft%26aufirst%3DS.%26aulast%3DMintz%26aufirst%3DA.%26atitle%3DRadiolabeling%2520and%2520initial%2520biological%2520evaluation%2520of%2520%255B18F%255DKBM-1%2520for%2520imaging%2520RAR-a%2520receptors%2520in%2520neuroblastoma%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26issue%3D6%26spage%3D1425%26epage%3D1427%26doi%3D10.1016%2Fj.bmcl.2017.01.093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solingapuram
Sai, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabhakaran, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattiraju, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mintz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, J. S. D.</span></span> <span> </span><span class="NLM_article-title">Radiosynthesis and evaluation of IGF1R PET ligand [11C]GSK1838705A, Bioorg</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">2895</span>â <span class="NLM_lpage">2897</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2017.04.085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;key=10.1016%2Fj.bmcl.2017.04.085" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2895-2897&issue=13&author=K.+K.+Solingapuram%0ASaiauthor=J.+Prabhakaranauthor=A.+Sattirajuauthor=J.+J.+Mannauthor=A.+Mintzauthor=J.+S.+D.+Kumar&title=Radiosynthesis+and+evaluation+of+IGF1R+PET+ligand+%5B11C%5DGSK1838705A%2C+Bioorg&doi=10.1016%2Fj.bmcl.2017.04.085"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.04.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.04.085%26sid%3Dliteratum%253Aachs%26aulast%3DSolingapuram%2BSai%26aufirst%3DK.%2BK.%26aulast%3DPrabhakaran%26aufirst%3DJ.%26aulast%3DSattiraju%26aufirst%3DA.%26aulast%3DMann%26aufirst%3DJ.%2BJ.%26aulast%3DMintz%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DJ.%2BS.%2BD.%26atitle%3DRadiosynthesis%2520and%2520evaluation%2520of%2520IGF1R%2520PET%2520ligand%2520%255B11C%255DGSK1838705A%252C%2520Bioorg%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26issue%3D13%26spage%3D2895%26epage%3D2897%26doi%3D10.1016%2Fj.bmcl.2017.04.085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i15"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00028">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_11137"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00028">10.1021/acs.jmedchem.8b00028</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings of key chemicals (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00028/suppl_file/jm8b00028_si_002.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings of key chemicals (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00028/suppl_file/jm8b00028_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00028/suppl_file/jm8b00028_si_001.csv">jm8b00028_si_001.csv (0.14 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00028/suppl_file/jm8b00028_si_002.pdf">jm8b00028_si_002.pdf (71.84 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00028&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-5%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00028%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00028" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67992e7bccb63c28","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
